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ABSTRACT
RATIONALIZING NANOEMULSION FORMATION FOR ENCAPSULATION,
PROTECTION AND DELIVERY OF BIOACTIVE FOOD COMPONENTS
FEBRUARY 2015
YING YANG, B.S., CHINA AGRUICULTURAL UNIVERSITY
M.S., CHINA AGRUICULTURAL UNIVERSITY
PH.D., UNIVERSITY OF MASSACHUSETTS AMHERST
DIRECTED BY: Professor David Julian McClements
The objective of this thesis was to design and develop novel food-grade
nanoemulsion-based delivery systems for the encapsulation, protection and delivery of
lipophilic bioactive food components.

These delivery systems could be widely applied

in aqueous-based fortified food products, such as beverages, salad dressing and yogurt
etc.
Both the low- and high-energy methods could be used for fabricating
nanoemulsions (r < 100 nm). The microfluidization method could form nanoemulsions
at low surfactant-to-oil ratios (SOR < 0.1), but it required the use of high-energy inputs
and expensive equipment.

On the other hand, the spontaneous emulsification method

could also form ultrafine emulsions and moreover it was simple and inexpensive, but it
required much higher surfactant-to-oil ratios (SOR > 0.5) for forming nanoemulsions.
Q-Naturale® is a natural food-grade surfactant, which is got from the bark of the
Quillaja saponaria Molina

tree.

By

using

high

pressure

homogenization

(microfluidization), Q-Naturale® could form relatively small droplets (d < 200 nm) at low
vi

surfactant-to-oil ratios (SOR < 0.1), but the droplets were not as small as those produced
using Tween 80 under similar conditions (d < 150 nm). The emulsions formed by using
Q-Naturale® as the emulsifier were stable to droplet coalescence over a range of pH
values (2 to 8), salt concentrations (0 to 500 mM NaCl) and temperatures (20 to 90 ºC).
Thus, the design of “all-natural” delivery system for vitamin E by using Q-Naturale® as
the emulsifier were then studied.

Ultrafine emulsions could not be fabricated using pure

α-tocopherol acetate as the oil phase due to its very high viscosity, but they could be
formed when ≥ 20% MCT was incorporated into the oil phase prior to homogenization.
In the absence of glycerol, Q-Naturale® was able to form emulsions containing relatively
small droplets (d < 400 nm) from oil phases containing relatively high vitamin levels (60
to 80%).

The addition of glycerol into the aqueous phase could help decreasing this

droplet size.

Q-Naturale® was more effective than Tween 80 at producing small

droplets with oil phase containing high levels of vitamin E acetate.
The influence of carrier oil type on the bioaccessibility and molecular form of
vitamin E encapsulated in Q-Naturale® delivery system was then examined using a
simulated gastrointestinal model.

The total bioaccessibility of vitamin E after digestion

was higher for LCT- than MCT-emulsions, which was attributed to the greater
solubilization capacity of mixed micelles formed from long chain fatty acids.

The

conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion was also
considerably higher for LCT- than MCT-emulsions, which may impact the subsequent
vii

absorption of the vitamin E. Morever, by using emulsion titration assay for further
quantifying the kinetics and extent of vitamin E and vitamin E acetate solubilization in
model mixed micelles, the solubilization capacities were depended on the composition of
the mixed micelles: micelle solubilization of vitamin E was increased by the presence of
phospholipid (DOPC), but did not depend strongly on the presence of free fatty acid
(octanoic acid or linoleic acid).

The solubilization capacity of the mixed micelles for

vitamin E was higher than that for vitamin E acetate, which was attributed to differences
in the ability of the vitamin molecules to be incorporated into the micelle structure.
Finally, all the key factors impacting on the bioaccessibility of emulsified vitamin
E, such as calcium ions, phospholipids, carrier oil type etc., were then overall studied
using a simulated small intestine model.

The addition of calcium (CaCl2) to the SSIF

increased the extent of lipid digestion in LCT-emulsions, but had little impact in
MCT-emulsions.

The bioaccessibility of vitamin E increased in the presence of calcium

and phospholipids (DOPC) in LCT-emulsions, but decreased in MCT-emulsions.

The

highest bioaccessibility (≈ 66%) was achieved for LCT-emulsions when the SSIF
contained both calcium and DOPC.

The conversion of α-tocopherol acetate to

α-tocopherol after in vitro digestion was considerably higher for LCT-emulsions when
calcium ions were present in the SSIF, but was not strongly affected by SSIF composition
for MCT-emulsions.
Overall, the results obtained in these studies will provide guidelines for rationally
viii

designing effective nanoemulsion-based delivery systems for encapsulating, protecting
and delivering lipophilic bioactive components.

These delivery systems could be used

in various industrial products, such as fortified foods, pharmaceuticals, cosmetics, and
personal care products in the future.

ix
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CHAPTER 1
INTRODUCTION
Nowadays consumers pay more attention to the safety and healthiness of food
products, which leads to an increasing interest within the food industries in the
development of delivery systems for the encapsulation, protection and delivery of
lipophilic bioactive components, such as ω-3 fatty acids, carotenoids, flavonoids and
vitamins [1-4].

These days, food industries are interested in fortifying food and

beverages with various kinds of functional food ingredients, such as flavors, colors,
vitamins and nutraceuticals and the growth of fortified beverages had been estimated to
be around 19 % from 2009 to 2014 [5].
Since most of these bioactive food components (e.g. vitamins, carotenoids, and
polyunsaturated triglycerols etc.) are lipophilic compounds, O/W emulsions are one of
the most effective delivery systems for helping these ingredients incorporated into the
aqueous-based food products. Typical conventional emulsions have droplets with mean
diameters between 100 nm and 100 µm.

The droplet sizes in conventional emulsions

are close to the light wavelength so that they can scatter light strongly which will lead to
the turbid or opaque appearance of the emulsions [6].
emulsions have a relatively low thermodynamic stability.

Moreover, conventional

Thus, a considerable amount

of research has been done to optimize the design and fabrication of emulsion-based
delivery systems.
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Recently, food industries are very interested in avoiding using synthetic
ingredients by using natural “label friendly” alternatives instead [7, 8].

Hence, there has

been a focus on identifying and characterizing natural emulsifiers that can be successfully
used in emulsion-based food and beverage products.

Biopolymer-based emulsifiers,

such as proteins (whey, soy and egg) and polysaccharides (gum arabic and modified
starch), have been shown to be effective at forming and stabilizing emulsions [8-11].
However, biopolymer emulsifiers often have limitations in their functional performance.
Protein stabilized emulsions have lower stability at pH values around their isoelectric
point, at high ionic strengths, and at elevated temperatures [12].

On the other hand, it is

often difficult to produce oil droplets with very small sizes (d < 200 nm) using
polysaccharide-based emulsifiers [9, 10, 13].

Q-Naturale® is an extract isolated from

the bark of the Quillaja saponaria Molina tree and which contains surface active
components that are capable of forming surfactant micelles and stabilizing O/W
emulsions [14-16].

The major components within this extract have been reported to be

saponins [17, 18], which are high molecular weight glycosides consisting of a sugar
moiety attached to a triterpene or a steroid aglycone [19].
Vitamin E is an essential micronutrient for both humans and animals due to its
antioxidant and non-antioxidant biological activities.

Vitamin E could work as an

antioxidant by inhibiting the formation of reactive oxygen species (ROS) during the lipid
oxidation.

According to the activities of vitamin E in queching free radicals, vitmain E
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is believed to prevent some chronic diseases that are related with the generation of free
radicals.

Due to its antioxidant or non-antioxidant activities, vitamin E provides a lot of

health benefits for human beings, such as enhancing immune systems, anti-inflammation
by inhibiting the release of reactive oxygen species (ROS) and preventing cardiovascular
diseases by inhibiting the oxidation of low-density (LDL) [20].
The term “vitamin E” actually refers to a group of fat-soluble vitamins that are
widely used as functional ingredients in food, pharmaceutical, and cosmetic preparations
[21].

Vitamin E is a kind of highly hydrophobic vitamin that cannot be directly

dispersed into aqueous solutions [22].

Therefore, appropriate emulsion-based delivery

systems need to be developed for helping dispersing vitamin E into the aqueous
environment [23].
A major objective of this study was to carry out research to develop a novel
emulsion-based delivery systems for lipophilic bioactive food components by using a
newly available natural emulsifier – Q-Naturale®.

Following fabrication, these delivery

systems will be evaluated for its physical properties, its chemical and environmental
stability.

The impact of different delivery systems on the stability and release properties

of bioactive compounds will also be investigated.

The results gained from this research

should facilitate the utilization of nanotechnology to design functional delivery systems,
thereby enhancing bioactive utilization and bioavailability in the diet.

3

CHAPTER 2
LITERATURE REVIEW
2.1 Emulsion-based Delivery System
2.1.1 Emulsions
Emulsions are systems containing two non-mixable liquids (usually oil and water)
and in the system one of the liquids is dispersed as small droplets in the other [24-26].
Emulsions could be found in all kinds of natural and processed foods, such as milk,
cream, beverages, salad dressings, mayonnaise, sauces, ice cream, coffee whitener,
spreads, butter, and margarine etc.

Emulsion technology is particularly suitable for the

encapsulation, protection and delivery of lipophilic functional food ingredients, e.g. ω-3
fatty acids, oil-soluble vitamins and nutraceuticals.
systems,

such

as

conventional

Variety of emulsion-based delivery

oil-in-water

(O/W),

multilayer

(OM/W),

water-in-oil-in-water (W/O/W), and oil-in-water-in-water (O/W/W) emulsions, could be
used for incorporating these food components [26, 27].
2.1.2 Emulsion Particle Characteristics
2.1.2.1 Particle Size
The particle size of the emulsion droplets would greatly influence some emulsion
properties, such as the appearance, stability and rheology etc.

Either volume-weighted

(d4,3=∑dini4/∑dini3) or surface-weighted mean diameter (d3,2=∑dini3/∑dini2) could be used
for representing the droplet sized, where ni is the number of droplets of diameter di.
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The

mean particle size of emulsion droplets depends on homogenization conditions (e.g.,
intensity or duration of energy input) and system composition (e.g., emulsifier type and
concentration) [28].

The particle size distribution could be measured by light scattering

or microscopy methods.

A monodisperse emulsion refers to the emulsion with droplets

of the same size while a polydisperse emulsion means the emulsions with a range of
different droplet sizes (Figure 2.1).

Real food emulsions are usually polydisperse

emulsions so that the droplet size description of real food is more complicated.

Monodisperse Emulsion

Polydisperse Emulsion

Figure 2.1 Schematic representation of monodisperse and polydisperse emulsions [28].
2.1.2.2 Particle Charge
Due to the adsorption of ionized emulsifiers, mineral ions, or biopolymers to the
surface, the droplets in the emulsions often have an electrical charge, which impacts
many emulsion properties.

The characteristics of the emulsifiers are the key factor

impacting the droplet electrical charge.

Emulsions formed by using non-ionic

emulsifier (e.g., Tweens and Spans) usually have no or small charge while emulsions
formed by using anionic emulsifier (e.g., lecithin and fatty acids) are negative charged
5

and emulsions stabilized by cationic emulsifier (e.g., lauric arginate) have positive
charge.
2.1.2.3 Particle Concentration
Particle concentration refers to the number, mass, or volume of droplets per unit
volume or mass of emulsion [28].

Because of the core-shell structure of emulsion

droplets, the overall effective volume fraction (Ceffective) is including both the volume
fraction of the core (Ccore) and the shell (Cshell).

The effective volume fraction of

emulsion droplets could be calculated by the following equation [29, 30]:
𝐶!""!#$%&!   = 𝐶 1 +

𝑡
𝑟

!

According to the equation, the real effective volume fraction of the oil droplets
(Ceffective) in emulsions may be much larger than the real volume fraction of the oil phase
(Ccore).

This effect could be applied for developing novel emulsion-based food products,

such as low fat foods with same viscosity at much lower oil concentration.
2.2 Emulsion Formation
Generally, there are two main approaches for emulsions fabrication: high-energy
methods and low-energy methods.
2.2.1 High Energy Emulsification Methods
In the food industry, the most common ways for producing food-grade emulsions
are high-energy methods, such as microfluidization, high-pressure valve homogenization,
and sonication.

These high-energy methods can be used with a wide variety of different
6

oil and emulsifier types [31-35].

The principles of these high-energy methods are to

mechanically breakup the oil phase into small droplets which could be dispersed evenly
within the aqueous phase by applying intense disruptive forces [36].
2.2.1.1 High Pressure Valve Homogenizer
High-pressure valve homogenizers (HPVHs) are the most popular emulsification
method in the food industry.
before using HPVHs.

Usually, a coarse emulsion needs to be prepared first

As shown in Figure 2.2, after fed into HPVHs, the coarse

emulsion experiences a combination of intense shear, cavitational and turbulent flow
conditions, which cause the larger droplets to break into small droplets as homogenized
products [37].

The final product are strongly depends on the number of passes and the

pressure applied.

Meanwhile, the characteristics of the material used for

homogenization (e.g., the disperse-to-continuous phase viscosity ratio, concentration of
emulsifier) also greatly impact the fine emulsion formation [38, 39].
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Figure 2.2 Schematic representation of High-pressure valve homogenizers
2.2.1.2 Microfluidizer
Microfluidizer can be used for fabricating very small emulsion droplets directly
from individual oil phase and water phase.

Microfluidizer has similar principle as

high-pressure valve homogenizers but microfluidizer could generate higher intense shear
forces.

After fed into microfluidizer, the coarse emulsion flowing was divided into two

streams and each stream passed through a separate fine channel.

The two streams of

coarse emulsions would then impinge on each other in an interaction chamber.

As a

result of that, intense disruptive forces are generated, which lead to highly efficient
droplet disruption.

Previous researches have shown that the microfluidization is more

effective at creating more uniform emulsion droplets with smaller droplet size.

The

major factors for the products of microfluidizer include pressure, number of passes,
8

oil-water interfacial tension, oil-water viscosity ratio, and emulsifier type and
concentration [8, 33, 40, 41].
Microfluidization

Emulsion split
into two streams

Emulsion streams
collide with each
other

Coarse
emulsion

Fine
emulsion

Droplet
disruption

Spontaneous
Emulsification

Figure 2.3 Schematic representation of microfluidizer
Oil phase:
Oil + Watersoluble Surfactant

2.2.1.3 Sonication

Aqueous phase:
Water

Ultrasonic emulsification is also a kind of high-energy emulsification methods
oil &
commonly used for ultrafine emulsion Bring
formation.
aqueous phases
into contact

Interfacial
Spontaneous
Wood
and Loomis
first reported
“budding”
mechanism

droplet formation

ultrasonic emulsification in 1927 and the first patent of sonication emulsification was
granted in 1944 in Switzerland [42, 43].

Sonication emulsification was recognized as

fast and efficient technique for formulating stable, uniform and small emulsion droplets
[44].
Sound waves (frequency > 20 kHz) will be used to cause ultrasound-driven
mechanical vibrations, followed by the formation of acoustic cavitation.

Thus, the

coarse emulsions will be broken into tiny emulsion droplets by the powerful shocks from
cavitation bubble collapse [45].

There are several factors which influence the output

droplet size of the sonication emulsification system, such as ultrasonic power input,
9

processing time, oil concentration, emulsifier type and concentration, mixing ratio of oil
and surfactant, viscosity of continuous phase, processing time [46].

Figure 2.4 Schematic representation of Sonication
2.2.2 Low Energy Emulsification Methods
Ultrafine emulsions can also be produced using a variety of low-energy methods,
such as phase inversion and spontaneous emulsification methods.
Compared with high-energy methods, low-energy approaches may have
advantages for certain applications within the food and beverage industries: they are often
more effective at producing very fine droplets; they have lower equipment and energy
costs; they are simpler to implement.

However, at the same time, some potential

disadvantages may also exist in low-energy systems, such as higher concentration of
emulsifier, limitations of oil types and surfactant types that could be applied in
low-energy systems etc.

10

2.2.2.1 Spontaneous Emulsification
Spontaneous emulsification is a process that emulsions are spontaneously formed
without the aid of external energy supply when two immiscible fluids with very low
interfacial tension get in contact with each other [47]. The spontaneous emulsification
method is originally widely used in the pharmaceutical industry [48, 49]. Systems
prepared using this method is often referred to as self-emulsifying drug delivery systems
(SEDDS) or self-nano-emulsifying drug delivery systems (SNEDDS) based on some
literature. In the spontaneous emulsification method, emulsions will be formed
immediately as two immiscible fluids placed in contact with each other (Figure 1)
[50-52]. Practically, this method can be carried out in a number of different ways to form
ultrafine emulsions: the compositions of the two phases can be varied; the environmental
conditions can be varied (e.g., temperature, pH and ionic strength); and/or, the mixing
conditions can be varied (e.g., stirring speed, rate of addition, and order of addition) [53].
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Figure 2.5 Schematic representation of spontaneous emulsification
2.2.2.2 Phase Inversion Temperature (PIT) Method
The phase inversion temperature (PIT) method is also a low-energy method which
has attracted quite a lot of interests nowadays since it is an organic, solvent-free method
[54].

Shinoda and Saito first introduced the PIT concept.

The PIT method realizes the

formation of ultrafine emulsions by utilizing the specific ability of surfactants, usually
nonionic surfactants such as polyethoxylated surfactants.

Their affinities for water and

oil were modified in function of the temperature, and therefore to undergo a phase
inversion. Indeed, the so-called transitional emulsion phase inversion occurs when, at
fixed composition, the relative affinity of the surfactant for the different phases is
changed, resulting in a gradual modification of the temperature [55, 56].

Oil, water and

nonionic surfactants are all mixed together at room temperature and slightly stirred. Then,
the mixture is gradually heated up.

As a result, the surfactant solubility progressively

changes from the aqueous to the oily phase.

Above the phase inversion temperature the

surfactant is fully solubilized in oil and thus the mixture undergoes a phase inversion,
from an oil-in-water (o/w) to a water-in-oil (w/o) emulsion.
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Figure 2.6 Schematic diagram of the formation of emulsions by the Phase Inversion
Temperature (PIT) method [57].
2.3 Emulsifier
Beeswax used in skin lotion by a Greek physician named Galen of the 2nd
century (in AD 131–203) was the earliest emulsifier on record whereas egg yolk was the
first emulsifier on record used for food applications and egg yolk was used to help
mixing liquid oil phase into an acidified aqueous phase of mayonnaise in the early 19th
century [58].
Emulsifiers facilitate the formation of emulsions by adsorbing to the interfaces
between oil and water during homogenization [59, 60].

Emulsifier molecules are

amphoteric molecules containing both nonpolar and polar regions.

The nonpolar group

could be aromatic, aliphatic or alicyclic groups while the polar groups include
13

heteroatoms like oxygen, nitrogen, and sulfur and the polar groups in the emulsifier
molecules are the main reason for making the emulsifier anionic, cationic or nonionic
[61].
The emulsifier plays a critical role in both droplet break-up and coalescence.
The most important functions during the homogenization process for emulsifiers include:
(i) aiding in the droplet break-up by decreasing the interfacial tension between oil an
aqueous phase by reducing free energy needed for breaking large droplets; (ii) forming a
protective coating around the droplets to prevent the droplets from aggregation and
re-coalescence [62].

Thus small molecule emulsifiers are the most suitable emulsifiers

for the nanoemulsion formation according to the requirements of both droplet break-up
and coalescence as they may quickly absorbed to the interfaces and they have lower
interfacial tensions.
Every year approximately 500,000 metric tons of emulsifiers, valued at USD
600-700 million, are produced and sold in the global market [63].
Each type of emulsifier has its unique chemical structure so that each type of
emulsifier has its special functional properties.
be applied in all kinds of situations.

There is no single emulsifier that could

The thermodynamic stabilities of emulsions are

quite low due to the unfavorable contact between the two non-mixable liquids [64].
Therefore stabilizers will be necessary to prevent the emulsions from breaking down.
The type and concentration of emulsifier will greatly influence the droplet size
14

distribution and stability of the emulsion [65].

Various emulsifiers, such as small

molecular weight surfactants, phospholipids and biopolymers, could all be used for food
application.

Compared with biopolymers, small molecular surfactants are usually more

effective in fabricating fine emulsions since they can be adsorbed to the newly formed
droplet surface fast and prevent droplets from re-coalescence.

Small molecular

surfactants can be used in both low- and high-energy emulsification procedures while
biopolymers can only be used in high-energy emulsification systems [46].
Hydrophilic–lipophilic balance (HLB) is a concept for categorizing emulsifiers.
Usually, surfactants with a high HLB (8–18) could be used for forming O/W emulsions
while low HLB surfactants (3-8) could be used for W/O emulsion formation (Figure 2.7)
[66].

W/O emulsions
Low HLB (3~8)

O/W emulsions
High HLB (8~18)

Figure 2.7 Emulsions formed by emulsifiers with different HLB value
Emulsifier could also be categorized by their electric properties: cationic
surfactants (lauric arginate), anionic surfactants (rhamnolipid) and non-ionic surfactants
(sorbitan fatty acid esters (spans), polyoxyethylene sorbitan fatty acid esters (tweens),
sugar esters and monoglycerides) [67-69].
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Table 2.1 Emulsifiers in food products [58, 70]
Food Products

Emulsifiers

Functionality

Peanut butter

Mono/diglycerides

Dispersion stabilization

Chocolate

Lecithin

Viscosity modification

Citrus beverages

Polyglycerol esters, SAIB

Clouding (weighting)

Sponge cakes, desserts

Mono/diglycerides

Aeration

Ice cream, whipped
toppings

Polysorbate 80,
polyglycerol esters

Controlled fat
agglomeration

The surface load (Γ) of a surfactant can be calculated from the interfacial tension
(γ) versus surfactant concentration (c) data using the following formula [16]:
⎛ 1 ⎞ dγ
Γ = −⎜
⎟
⎝ RT ⎠ d ln c

(1)

Here R is the gas constant, T is the absolute temperature, and c is expressed in
moles per liter [71].
The surface activity (K) of an emulsifier can be conveniently characterized by the
following relationship [26]:

K=

1
c1 / 2

⎛ ΔGads ⎞
= exp⎜ −
⎟
⎝ RT ⎠

(2)

Here c½ is the surfactant concentration where half of the available adsorption sites
on the oil-water interface are covered by surfactant, and ΔGads is the free energy change
associated with surfactant adsorption.
2.3.1 Synthetic Emulsifiers
Most of synthetic emulsifiers are petroleum/hydrocarbon derivatives and many of
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them have been used in the food industry for a long time without any evidence of harmful
effects.

Synthetic emulsifiers were designed to contain naturally or non-naturally

occurring molecules which prevented them from being metabolized their passage through
the human bodies GI tract [70].
• Mono- and Diacylglycerols: Mono- and diacylglycerols are the most common used
synthetic emulsifiers in the food industry (about 70 % of total emulsifier used in the
food industry) and they were first synthesized in 1853 by Berthelot [70].

There are

small quantities of mono- and diacylglycerols in natural fats and oils because of the
hydrolysis reaction.

The use of mono- and diacylglycerols in the 1930s in the

margarine industry on a large scale was a great breakthrough in the application history
of mono- and diacylglycerols [2].

High ratio shortenings containing mono- and

diglycerides made oil droplets dispersed into the dough better, resulting in the increase
of the strength in cake batters.

Moreover, the application of mono- and diglycerides

in ice cream was then patented in 1936.
• Sorbitan esters and polysorbates: Sorbitan esters and polysorbates (Figure 2.8) are
both non-ionic emulsifiers.

Sorbitan esters are generated from the simultaneous

esterification and cyclization reactions that are caused by heating a mixture of fatty
acids, sorbitol and a catalyst under an inert atmosphere (Figure 2.9).

Sorbitol, which

is initial material for sorbitan esters, was generated from the hydrogenation of sucrose.
These days, there is an alternative way for producing sorbitol from D-glucose.
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D-glucose, which is got from corn syrups (maize) or tapioca, reacts with hydrogen gas
under pressure in the presence of a catalyst (e.g., nickel phosphate) [72].
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Figure 2.8 Structures of sorbitan monostearate (Span 60) and Polyoxyethylene (20)
sorbitan monolaurate (Tween 20)
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Figure 2.9 Cyclization and esterification of sorbitol
2.3.2 Natural Emulsifiers
For more than 20 years, the food industry has a growing interest in replacing
synthetic ingredients with natural “label friendly” alternatives such as lecithin, protein
and polysaccharide in an effort to produce natural food products [7, 13].

Consequently,

there have been many studies that focus on identifying and characterizing natural
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emulsifiers that can be successfully used in emulsion-based food and beverage products.
Natural emulsifiers are obtained from various nuts, berries and leaves.
• Protein: Protein is one of the most frequently used emulsifier in the food industry.
Proteins have been considered to be a kind of good emulsifiers because of their ability
to absorb fast enough to the interface between the oil droplets and the aqueous phase to
lowering the interfacial tension [26].

The protein film around the lipid droplets is

highly viscoelastic preventing the rupture or displacement by other surface active
component [73].

Depending on the protein molecular structure and the ionic content

of the aqueous medium, the stabilisation of dispersed particles and droplets by
adsorbed protein can be explained in terms of a combination of polymeric (steric) and
electrostatic interactions [24, 74].

Emulsions stabilized by proteins, however, are

often unstable to aggregation at pH values around their isoelectric point, at high ionic
strengths, and at elevated temperatures [12].

Adsorbed proteins lose their net charge

around the isoelectric point thereby promoting extensive droplet aggregation.
Conformation changes of proteins occur above their thermal denaturation temperature
(Tm) and after interfacial adsorption, which exposes non-polar and sulfhydryl groups
[75].
• Polysaccharides: Some polysaccharides such as gum arabic and modified starch
adsorb at oil–water interfaces.

Hence they have the capacity to function as

emulsifiers and emulsion stabilizers by means of interfacial action.
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Polysaccharides

may increase emulsion stability to aggregation and environmental stresses by the
formation of a thick interfacial layer, increasing the steric repulsion and decreasing the
van der Waals attraction [28].

However, it is often difficult to produce oil droplets

with very small sizes (d < 200 nm) using polysaccharide-based emulsifiers [9, 10, 13].
In addition, due to the low efficiency of polysaccharides for lowering surface tension,
emulsions stabilized by polysaccharides, require a considerable higher amount of
polysaccharide, which will increase the manufacturing cost.
• Lecithin: Certain types of lecithin are also suitable for utilization as natural
emulsifiers in food and beverage products, e.g., phospholipids derived from egg, soy,
or milk [67, 76].

However, natural lecithin (which has two non-polar tails) usually

has to be chemically or enzymatically modified to lysolecithin (which has one
non-polar tail) before it can be successfully used to stabilize oil-in-water emulsions.
• Q-Naturale®: Q-Naturale® is a food ingredients just marketed by the National Starch
company (Bridgewater, NJ) and it is an extract isolated from the bark of the Quillaja
saponaria Molina tree (an evergreen native to Chile and Peru) and it has surface
activities of forming surfactant micelles and stabilizing oil-in-water emulsions [14-16].
The major components within this extract have been reported to be saponins [17, 18],
which are high molecular weight glycosides consisting of a sugar moiety attached to a
triterpene or a steroid aglycone [19].

The saponins are surface active substances

because they contain both hydrophilic regions (such as rhamnose, xylose, arabinose,
20

galactose, fucose, and glucuronic acid) and hydrophobic regions (such as quillaic acid
and gypsogenic acid) on the same molecule [16, 77].
2.4 Vitamin E as Lipophilic Bioactive Food Components
The term “Vitamin E”, which was first characterised in wheat-germ oil and
lettuce, introduced in 1922 by Evans and Bishop described a dietary factor in animal
nutrition considered at the time to be especially important for normal reproduction [78].
“Vitamin E” refers to a group of fat-soluble vitamins that have been widely used as
functional ingredients in food, pharmaceutical, and cosmetic industries [21].

Vitamin E

is a highly lipophilic molecule that cannot be directly dispersed into aqueous solutions
[22].

Thus, it must be incorporated into an appropriate colloidal delivery system prior to

its dispersion into the aqueous-based food products [23].

A number of previous studies

have shown that vitamin E can be successfully incorporated into emulsion-based delivery
systems, such as microemulsions [21, 79], nanoemulsions [80-82], emulsions [23, 83]
and liposomes .

One major problem of vitamin E is that it is only partially absorbed at

the intestinal site, which reduces its bioavailability.

Former studies have shown that the

absorption of fat-soluble vitamins, including vitamin E, will be increased with the
presence of surfactants or emulsions, compared to when they are incorporated into bulk
oils [84-86].
2.4.1 Structure and Chemical Properties of vitamin E
Natural vitamin E encompasses eight different forms, the α-, β-, γ- and
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δ-tocopherols and the α-, β-, γ- and δ-tocotrienols (Figure 2.10). Eight different vitamin
E molecule forms have a common structural feature: a chromanol ring and a phytol side
chain.

α-tocopherol is the only one active form of vitamin E that could be found in

human bodies so that it is also vitamin E with the largest quantities found in blood and
tissues [25].
α-tocopherol molecules can help protecting membrane lipids against the lipid
oxidation since α-tocopherol can trap peroxyl radicals which are responsible of the
initiation of lipid oxidation [87, 88].
α-tocopherol

are

α-tocopherol

The principle oxidation metabolites of
quinone,

α-tocopherol

hydroquinone,

2,3-epoxy-α-tocopherol quinone, and 5,6-epoxy-α-tocopherol quinone (Figure 2.11).
α-tocopherol molecules could also help stabilizing membranes mechanically due to Van
der Waals interactions [69].

Vitamin E quinone has the activities of preventing blood

clotting since it can help inhibiting the activities of vitamin K dependent carboxylase,
which regulates blood clotting [71].

The digestion procedure of vitamin E is similar to

vitamin A and carotenoids digestion and α-tocopherol can utilize SR-B1 to enter into
enterocytes [72].
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2.4.2 Food Source and Intake
Vegetable oils such as olive oil, sunflower oil, safflower oil and nuts are the main
natural source of tocopherol (Toc) while tocotrienol, a minor plant constituent, is
abundant especially in rice bran, cereals, grains, palm oil, green vegetables and annatto
seeds [90].

α-, β-, γ-, and δ-tocopherols and tocotrienols can all be found in natural
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foods but the amounts of each kinds of vitamin E are quite different.
Table 2.2 Distribution of tocotrienol and tocopherol in food sources (mg/kg)
(http://www.ars.usda.gov/ba/bhnrc/ndl)
Food

α-tocopherol (mg)

ϒ-tocopherol (mg)

Olive oil (1 tablespoon)

1.9

0.1

Soybean oil (1 tablespoon)

1.1

8.7

Corn oil (1 tablespoon)

1.9

8.2

Canola oil (1 tablespoon)

2.4

3.8

Safflower oil (1 tablespoon)

4.6

0.1

Sunflower oil (1 tablespoon)

5.6

0.7

Almonds (1 ounce)
Hazelnuts (1 ounce)

7.4
4.3

0.2
0

Peanuts (1 ounce)

2.4

2.4

Spinach (1/2 cup, raw)

0.3

0

Carrots (1/2 cup, raw chopped)

0.4

0

Avocado (1 fruit)

2.7

0.4

Vitamin E uptake into plasma is similar to fat uptake through the small intestine.
Bile acid secreted into the small intestinal facilitate the formation of micelles containing
vitamin E and oil hydrolysis products, which passed through the membrane of intestinal
cells and were then transported as lipoproteins (e.g., chylomicrons) in the lymph and
blood system [91, 92].

The RDA of vitamin E is 15 mg/day and deficiency might occur

in case of fat malabsorption or for premature infants.
Table 2.3 The Recommended Dietary Allowance (RDA) for α-Tocopherol [20]
Age

Males (mg/day)

Females (mg/day)

0-6 months

4 mg

4 mg

7-12 months

5 mg

5 mg

1-3 years

6 mg

6 mg
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4-8 years

7 mg

7 mg

9-13 years

11 mg

11 mg

14-18 years

15 mg

15 mg

19 years and older

15 mg

15 mg

Pregnancy (all ages)

-

15 mg

Breast-feeding (all ages)

-

19 mg

2.4.3 Health Benefits of vitamin E
Previous researches show that tocopherols have quite a lot health benefits for
human beings, such as reducing heart disease, delaying Alzheimer’s disease, and
preventing cancer [93].

Compared with polyunsaturated fatty acids, vitamin E works

1000 times faster in quenching peroxyl radicals (ROO·) [94].

As vitamin E may

functions in scavenging peroxyl radicals, it may works as an antioxidant which slows
down the propagation of free radicals in membranes and in plasma lipoproteins and
breaks the chain of lipid oxidation [95].

Severe vitamin E deficiency may lead to

neuromuscular abnormalities characterized by spin cerebellar ataxia and myopathies in
human beings [96-102].
2.4.3.1 Inflammatory
Inflammation was related with the release of some reactive oxygen species, such
.
as O2−, OH , H2O2 and singlet oxygen (1O2).

Previous researches indicated that the

symptoms in patients who were suffering from several types of acute or chronic
inflammatory conditions could be relieved with the consumption of vitamin E [103].

In

many occasions vitamin E works effectively as standard drug treatment but the
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side-effects were much lower [104].
O2- generation will be inhibited as a result of the addition of α-tocopherol to
polymorphonuclear cells [105-107].

Vitamin E supplements have significant effects on

inhibiting the release of reactive oxygen species and the section of IL-1 beta from
monocytes and preventing the monocyte-endothelial cell adhesion.

The inhibition of

protein kinase C activities, which are caused by α-tocopherol, will result in the inhibition
of the release of reactive oxygen species and of lipid oxidation [105].
2.4.3.2 Cardiovascular Diseases (CVD)
The increase of vitamin E consumption in daily diet has been demonstrated to
help reducing the risk of death from heart disease in both males and females.

Vitamin E

shows several potentially health benefits for cardiovascular diseases, such as preventing
the oxidation of low-density lipoproteins (LDL) and inhibiting the proliferation of
smooth muscle cell [108].

During the in-vitro studies, vitamin E were found to inhibit

the oxidation of low-density lipoprotein (LDL) cholesterol, which is the main reason for
causing atherosclerosis since its atherogenicity will be enhanced due to the oxidative
damage to LDLs [20].
Previous researches have been done to study vitamin E uptake in presumably
healthy people and these people were then studied for several years to find out how many
of them were diagnosed with or died as a result of heart disease. People who had more
than 7 mg/day of α-tocopherol from daily diet were less risky (~35 %) to die from heart
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disease compared with those people who got less than 3-5 mg/day of α-tocopherol [109,
110].

Moreover, based on another two large studies, a significant reduce in the risk of

heart disease will happen in women and men who consumed at least 100 IU of
supplemental RRR-α-tocopherol (67 mg of RRR-α-tocopherol) daily [111, 112].
According to a study bases on approximately 90,000 nurses, the highest intakes of
vitamin E primarily from supplements would prevent heart disease by 30% to 40% [112].
2.4.3.3 Immune Function
Adequate vitamin E has been proved to be essential for the maintenance of the
immune system.

Vitamin E consumption with higher than recommended dietary levels

will result in stronger immunity response of human bodies while the deficiency of
vitamin E will lead to weaker immunity response [113].

For elderly adults who are

given 200 mg of synthetic α-tocopherol (equivalent to 100 mg of RRR-α-tocopherol or
150 IU of RRR-tocopherol) per day for several months, an increased formation of
antibodies in response to hepatitis B vaccine and tetanus vaccine injection could be
observed [114].
2.5 Bioavailability of Vitamin E Encapsulated in the designed delivery system
96% of American women and 93% of men do not meet the current vitamin E
recommended dietary allowance (RDA), which is 15 mg (22 IU RRR-) α-tocopherol per
day [20, 115]; the average intake of α-tocopherol in the US are only s 6.9 mg/day [116].
Because of vitamin E’s deficiencies of poor solubility either in water or in most of
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inorganic solvents and poor stability to O2, light or temperature, vitamin E is treated as
capsules with the disadvantages of low bioavailability and being hardly dispersed in
aqueous environemnt.

Conversion of the capsules to water-soluble liquid is the ideal

ways to overcome the above problems [79].

Vitamin E absorption is greatly influenced

by the digestion processes and the absorption of diet fat.

The procedure of the

absorption of vitamin E through the small intestine is quite similar to fat uptake.

Bile

salts secreted by the intestinal lumen could induce the formation of micelles to
incorporate vitamin E and the micelles could pass through the small intestinal cell
membranes and then be transported as lipoproteins in the lymph and blood [91, 95].
The isomer RRR-α-tocopherol is the form of α-tocopherol exsiting in all natural
food.

However, although vitamin E supplements usually contain 100 IU to 1,000 IU of

α-tocopherol, not all the α-tocopherol are isomer RRR-α-tocopherol (d-alpha-tocopherol),
Which is the most favorable α-tocopherol for human beings. Actually the most common
one in fortified foods and supplements is synthetic α-tocopherol (all-rac-α-tocopherol or
dl-α-tocopherol) containing all eight isomers of α-tocopherol.

Compared with

RRR-α-tocopherol, synthetic α-tocopherol is less bioavailable since part of α-tocopherol
isomers present in all-rac-α-tocopherol cannot by utilized by human bodies.
Previous researches have proved that O/W emulsion which encapsualtes vitamin
E inside could help increasing the bioavailability of vitamin E in human bodies.

The

bioavailability of the guest molecules incorporated in the emulsions will be greatly
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improved expecially as the surfactants stablizing the droplets could enhance
transmembrane passage across the digestive tract and transdermal drug permeability
[117].
During the digestion, fat-soluble nutrients including α-tocopherol need to be
packaged into micelles to get to be absorbed.

The in vitro model mimics the digestion

precedure in human bodies and can be used to quantify the fraction of a nutrient that has
been micellarised and thereby made bioaccessible [118]. According to previous in vitro
digestion study, the bioaccessibility of α-tocopherol will greatly depend on the food
source.

The bioaccessibility of α-tocopherol from bananas and bread was 100 %

whereas the bioaccessible α-tocopherol were only 29% and 22% from cheese and milk
respectively [119].
Vitamin E is a kind of fat soluble vitamin transported by lipoproteins so that
tissue vitamin E transportation will be greatly impacted by lipid and lipoprotein
metabolism and its tissue depletion takes decades rather than weeks [92].

The

concentration of α-tocopherol in plasma are regulated by the liver (the α-tocopherol
transfer protein (α-TTP)) and also by vitamin E metabolism and excretion [92].
The absorption and disposition of labeled vitamin E were studied by using
short-term studies (from 3 to 72 h).

Longer protocols were used for evaluing the

delivery and transportation of labeled vitamin E to peripheral tissues by administering
large oral doses (e.g., 400 IU) [120].

Although various tocopherols are absorbed and
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transported in chylomicrons, α-tocopherol is the only form of vitmain E that will be
maintained

in

plasma

and

tissues

[121,

122].

The

plasma

half-life

of

RRR-α-tocopherol’s plasma half-life (48 to 60 h) is much longer than systhetic
α-tocopherol (15 h) [123, 124]. Due to the rapid recirculation between the liver and the
plasma, the entire circulating α-tocopherol pool nearly gets to be replaced everyday[124].
The fraction of vitamin E absorbed were found to be around 55 to 79% according to the
study taken from 1960-1970 by utilizing radioactive α-tocopherol during the study [125,
126].

These days, there are some more accurate studies in which the results were got

from the observed plasma-labeled α-tocopherol concentrations and absorption ratio of
α-tocopherol in humans was only 33 % [127].

These studies are very important for

suggesting people’s daily uptake of vitamin E since only part of the vitmain E consumed
would be absorbed.
The fraction of the ingested food ingredients that reaches the systemic circulation
could be defined as bioavailability (F), which can be got by: F = FB × FT × FM. In this
equation, FB - the bioaccessibility coefficient or the lipid fraction released from the food
matrix into the the GI tract juices; FT - the transport coefficient or the released lipid
component fraction which is transported across the intestinal epithelium; FM – the lipid
component

fraction

reaching

the

systemic

circulation

without

experiencing

metabolization [128].
As the food components reach the systemic circulation, they will be distributed
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into different tissues, where they may be stored, utilized or excreted [129, 130].
Nowadays the in-vitro studies are still good ways for examining the relative
bioavailability of α-tocopherol from various food sources and also for fast screening the
effectiveness of different α-tocopherol delivery systems as it is relatively difficult in
assessing the in-vivo bioavailability of α-tocopherol.
2.5.1 In-vitro digestion model
Emulsions will experience diffenent conditions after ingestion, such as dilution by
mixing with mucin in the mouth, expose to acidic environment in the stomach etc.
In-vitro digestion models have been widely applied for studying the bioaccessibility of
encapsulated lipophilic nutraceuticals.

The ideal in-vitro digestion method should

provide accurate results in a short time and it should act as a useful alternative to animal
and human models.

In this way, it should work as a rapid screening tool for foods or

delivery systems with different compositions and structures (Figure 2.12) [131].
• Mouth: Mouth is the first environment that an emulsion encounters after ingestion.
After consumption, emulsions will experience a series of processing, such as mixing
with saliva, temperature change to body temperature, changes in ionic strength and
pH, contacting with biological surfaces (tongue, teeth, and cheeks) and breaking
down during mastication [132, 133].

Emulsions will react with digestive enzymes

in mouth (e.g. lingual lipase, amylase and protease).

As food first passes through

the mouth, saliva and mucin would induce emulsion flocculation and then a rapid
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depletion flocculation was observed in all kinds of emulsions.
• Stomach: Food product passes from the mouth through to the esophagus and then
enters into the stomach.

The time that food product stays in stomach mainly

depends the nature of the food, such as composition, size, pH and ionic properites etc.
[134, 135].

Gastric fluids containing enzymes (pepsin and gastric lipase), minerals

(Na+, Ca2+ etc.) and various surface-active components are going to mix with food
products and food products will undergo a very acidic condition (pH ≈ 1–3)
[136-138].

Meanwhile, food products will also experience mechanical agitation

because of the stomach motility [139, 140].

The pH value in human stomach was

between 1 and 3 under fasting conditions and an apparent increase in stomach content
pH value will be observed after food ingestion and then the pH value will gradually
decrease over the next hour or so to reach around pH 2 [137, 138, 141].

The natural

properties (initial pH, composition, structures etc.) of food ingested are the key factor
that influence the pH-time profile [141].

The high acidic environment in the

stomach enables enzymes activation, food components hydrolysis, microorganisms
inactivation.

The ionic strength in stomach will also significantly increase after

consuming food because of the ions from the food.

Furthermore, gastric lipase

could also hydrolyze some emulsified triacylglycerols (TAGs) to diacylglycerols
(DAGs), monoacylglycerols (MAGs), and free fatty acids (FFAs) [142-144].
Usually when 10–30% of the fatty acids are released from the TAGs, lipid hydrolysis
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will stop.
• Small Intestine: Food emulsions will get into the small intestine after passing
through the stomach.

The secretion of bile salts, phospholipid, cholesterol ester and

pancreatic fluids will be motivated by the entering of lipids into the small intestine.
Pancreatic lipase complexing with co-lipase acts at the surface of the emulsified TG
droplets to hydrolyze TAG to MAG (sn-2 position) plus FFA [128, 145].

Pancreatic

lipase/co-lipase, called carboxylic-ester hydrolase or bile salt stimulated lipase along
with pancreatic lipase, is able to split TAG molecule [146].

During the digestion

procedure in small intestine, natural surface-active components such as bile salts
impact the digestion and absorption of lipids significantly and bile salts will facilitate
the formation of micelles containing MAG, FFA and phospholipids and their
transport by passive diffusion across the intestinal mucosa [147] (Figure 2.13).
These days, the pH-stat method has been widely used in pharmaceutical and food
area for mimicking the small intestinal condition and in vitro digestion study
[30,31,37,38].

The principle of pH-stat is to record the amount of alkali solution

(0.25 M NaOH) that had to be added to the reaction chamber to maintain the pH at
7.0 and then determine the percentage of free fatty acids (FFA) released from lipids,
usually triacylglycerols [148].
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Figure 2.12 Overview of physicochemical processes that occur when a bioactive
component trapped within an emulsified carrier lipid is exposed to the small intestine
[149]
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Figure 2.13 Schematic representations of the possible changes of emulsions as they pass
through the GI tract and the physicochemical conditions in digestive tract [128]
2.5.2 Cell Culture Study of Bioaccessibility of Vitamin E
Bioavailability, which is defined as the fraction of an ingested nutrient available
for physiologic use or storage in the body, may be estimated by using an in-vitro model
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to apply the micelles got from an in-vitro digestion to a Caco-2 intestinal cell culture
(Figure 2.14) [150].

These days cell culture models have also been commonly utilized

as part of in-vitro digestion models.

In particular, the Caco-2 cell culture model has

been widely used as a predictive tool for the absorption of bioactive components from
foods and nutrient supplements.
Nowadays the major steps and molecular mediators of vitamin E transportation
from the luminal micelle phase into the enterocyte have not been well defined yet.
Vitamin E uptake is rapid, saturable and temperature dependent in Caco-2 cells [151].
Intestinal cellular uptake of vitamin E from mixed micelles has been traditionally
recognized as a simple process of passive diffusion but the recent researches indicated the
importance of the scavenger receptor class B type I (SR-BI) in the cellular uptake of
vitamin E [152]. α-tocopherol is absorbed by the intestinal absorptive cells via diffusion
or protein-mediated mechanisms [153].

Vitamin E will be temperately stored in the

microsome fraction before being secreted by chylomicrons or HDL after an ATP binding
cassette A1-mediated efflux [151].

The same route as α-tocopherol may probably also

be used for the transportation of α-tocopheryl acetate in human bodies if it is not
converted into the latter compound by the intestinal or pancreatic esterase(s) [154-157].
The in-vitro digestion/Caco-2 cell culture model provides a rapid, low-cost
method for fast screening foods and food matrix for studying the bioavailability of
bioactive components before more definitive human trials [158, 159].
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In the present

study, we have employed an in-vitro digestion procedure coupled with a Caco-2 cell
model system to compare the micellarisation, cell uptake and secretion of α-tocopherol
from supplemented minced meat (pork, beef and turkey) with other supplemented food
products (apple sauce, bread and mayonnaise).

The Caco-2 transwell model is a

well-established method for the assessment of nutrient bioavailability from a range of
foodstuffs [160-162].
Mixed micelle

Apical Side

Caco-2 monolayer

ApoB Analysis

VE Analysis

Basolateral Side
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Figure 2.14 Schematics for the Caco-2 cell monolayer model for absorption and
transport of vitamin E across the intestinal epithelial.
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CHAPTER 3
FABRICATION OF ULTRA-FINE EDIBLE EMULSIONS: COMPARISON OF
HIGH-ENERGY AND LOW-ENERGY HOMOGENIZATION METHODS
3.1 Introduction
There is considerable interest within the food and beverage industries in the
utilization of ultrafine emulsions (also referred to as nanoemulsions) to encapsulate and
deliver lipophilic functional agents, such as flavors, colors, antimicrobials, micronutrients,
and nutraceuticals [3, 22, 27, 163, 164].

Ultrafine emulsions can be fabricated from

food-grade ingredients using relatively simple processing operations, such as mixing,
shearing, and homogenization [29, 165].

Ultrafine emulsions are thermodynamically

unstable systems that typically consist of surfactant, oil, and water [34, 39, 166].
Oil-in-water emulsions contain surfactant-coated lipid droplets dispersed within an
aqueous continuous phase.

The radius of the droplets in ultrafine emulsions (r < 100

nm) is relatively small compared to the wavelength of light (λ = 390 to 750 nm) and so
they tend to be either transparent or only slightly turbid [163, 167].

One of the most

promising potential applications of ultrafine emulsions is therefore to incorporate
lipophilic active ingredients (e.g., vitamins, nutraceuticals, and antimicrobials) into
aqueous-based foods or beverages that need to remain optically transparent, such as some
fortified waters, soft drinks, sauces, and dips [163].

Another potential advantage of

these systems is that they often have better stability to particle aggregation and
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gravitational separation than conventional emulsions due to their small particle size [39].
In particular, Brownian motion effects become important for small particles (r < 100 nm),
which counterbalances the tendency for gravitational separation to occur [29].

The fact

that the interfacial layer of ultrafine droplets makes up an appreciable part of the total
particle volume means that ultrafine emulsions can be produced that are much more
viscous than conventional emulsions with the same oil content [34, 39, 166], which may
have interesting applications in food products where a paste or gel is required.

The

small size of the droplets in ultrafine emulsions has also been shown to increase the
bioavailability of certain types of lipophilic substances [168], which may be useful for
increasing the bioactivity of some nutraceuticals.
In the food industry, ultrafine emulsions are usually produced using high-energy
methods, such as microfluidization, high pressure valve homogenization, and sonication
[31-35].

These methods generate intense disruptive forces that mechanically breakup

the oil phase into tiny droplets that are dispersed within the aqueous phase [36].

There

are a number of limitations in using high-energy methods to produce ultrafine emulsions,
such as high initial equipment and operating costs, high power requirements, potential for
equipment breakdown, and difficulties in producing very fine droplets from certain kinds
of food ingredients (e.g., highly viscous oils or slowly-adsorbing emulsifiers) [29].
Ultrafine emulsions can also be produced using a variety of low-energy methods,
such as phase inversion and spontaneous emulsification methods [29, 169, 170].
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These

low-energy methods are based on the spontaneous formation of fine oil droplets in
surfactant-oil-water

(SOW)

systems

under

specific

environmental

conditions

(composition, temperature, stirring), which are then trapped in a metastable state [57,
171].

Low-energy approaches may have advantages over high-energy approaches for

certain applications within the food and beverage industries: they are often more effective
at producing very fine droplets; they have lower equipment and energy costs; they are
simpler to implement.

On the other hand, there are also some potential disadvantages of

low-energy systems, including limitations on the types of oils and surfactants that can be
used to form stable ultrafine emulsions, and the fact that relatively high surfactant-to-oil
ratios (SOR) are typically needed to produce them.
The purpose of this study was to compare the effectiveness of a high-energy
method (microfluidization) that is widely used in the food industry to produce ultrafine
emulsions with a low-energy method (spontaneous emulsification) that has been shown
to work for many non-food applications. The microfluidizer works on the principle of
dividing an emulsion flowing through a channel into two streams, passing each stream
through a separate fine channel, and then directing the two streams at each other in an
interaction chamber. Intense disruptive forces are generated within the interaction
chamber when the two fast moving streams of emulsion impinge upon each other, leading
to highly efficient droplet disruption.

A number of previous studies have shown that

microfluidization is particularly efficient at creating ultrafine emulsions from food grade
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ingredients, and have identified some of the major factors that influence homogenization
efficiency, including oil-water interfacial tension, oil-water viscosity ratio, and emulsifier
type and concentration [8, 33, 40, 41].

In the spontaneous emulsification method an

emulsion is immediately formed when two liquids are mixed together (Figure 3.1)
[50-52]. Practically, this method can be carried out in a number of different ways to form
ultrafine emulsions: the compositions of the two phases can be varied; the environmental
conditions can be varied (e.g., temperature, pH and ionic strength); and/or, the mixing
conditions can be varied (e.g., stirring speed, rate of addition, and order of addition) [53].
The spontaneous emulsification method has been widely used to produce ultrafine
emulsions in the pharmaceutical industry, where they are usually referred to as
self-nano-emulsifying drug delivery systems (SNEDDS) [48, 49].
Microfluidization
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Figure 3.1 Underlying principles for droplet formation in high-energy (microfluidization)
and low-energy (spontaneous emulsification) methods of producing emulsions.
In this study, we compared the efficacy of the microfluidization and spontaneous
emulsification methods at producing ultrafine emulsions from food grade oils (MCT) and
surfactants (Tweens), and we then tested the stability of the resulting emulsions to
environmental stresses that they might encounter in the food industry.

This research

may be useful for identifying the most appropriate homogenization method for different
food and beverage applications.
3.2 Materials and methods
3.2.1 Materials
Non-ionic surfactants, POE(20) sorbitan trioleate (Tween 85) and POE(20)
sorbitan monoolieate (Tween 80), were purchased from Sigma-Aldrich Co. (St. Louis,
MO).

Medium chain triglyceride (MCT) oil (Miglyol 812) was purchased from

Coletica (Northport, NY).
3.2.2 Emulsion preparation
3.2.2.1 Emulsions produced by microfluidization
Oil, water and surfactant were mixed together in a beaker, and then blended
together using a high-shear mixer (Bamix, Biospec Products, Bartlesville, OK) for two
minutes to form a coarse emulsion. The total weight of each sample was 100 g, and the
overall composition of the samples was 20 wt% oil (MCT), 0.1 to 20 wt% surfactant
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(Tween 80 and/or Tween 85), and 79.9 to 60 wt% water (pH 3.5, buffer solution). The
emulsion premix samples were then passed through a microfluidizer (Microfluidics,
Newton, MA) three times at 10,000 psi (68.95 MPa) at ambient temperature.
3.2.2.2 Emulsions produced by spontaneous emulsification
Initially, oil and surfactant were placed in a container and then blended using a
high shear mixer for two minutes to prepare a homogeneous solution.

The oil-surfactant

mixture was then poured into a water phase (pH 3.5 buffer solution) at a rate of about 10
g per minute with continuous stirring (500 rpm) using a magnetic stirrer for 15 minutes to
keep the system homogeneous. At this pouring rate, the formation of an optically opaque
emulsion was observed to occur as soon as the oil-surfactant mixture came into contact
with the water phase. However, it was noticed that if the oil-surfactant mixture was
poured into the water phase too quickly (> 20 g per minute) then large clots were formed
that were difficult to disperse, and therefore we always used slower rates.
3.2.3 Emulsion characterization
The particle size distributions of the samples were measured using a static light
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, U.K.). All
measurements were performed on at least two freshly prepared samples (i.e., new
samples were prepared for each series of experiments) and were reported as means and
standard deviations.
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3.2.4 Surfactant – Oil – Water (SOW) Phase behavior
The phase behavior of surfactant, oil, and water mixtures was determined using a
dilution experiment: increasing amounts of water were added to a surfactant-oil mixture.
Initially, MCT was mixed with surfactant (Tween 80, Tween 85, or 1:1 Tween 80/Tween
85) at a mass ratio of 1 part oil to 1 part surfactant.

A series of samples with different

water contents were then prepared by adding increasing amounts of double distilled water
drop-wise into the surfactant-oil mixtures (25 ± 1 °C). The resulting SOW systems were
then mixed at a low speed using a magnetic stirrer to ensure the different components
were thoroughly mixed. After equilibration, the appearance of the systems was observed
visually and using optical microscopy (Nikon Eclipse 80i, Nikon Instrument Inc.,
Melville, NY).
3.3 Results and discussion
3.3.1 Comparison of emulsions formed by high- and low-energy methods
Initially, we examined the influence of homogenization method and system
composition on the formation of oil-in-water emulsions.

Our aim was to establish the

influence of these parameters on the size of the droplets produced using the
microfluidization and spontaneous emulsification methods, as well as to establish the
minimum amount of surfactant needed to produce emulsions containing small droplets (r
< 100 nm).
Microfluidizaiton: For the microfluidization method, there was a steep decrease in
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mean particle radius of the 20 wt% MCT oil-in-water emulsions when the surfactant
concentration was increased from 0 to 2 wt% (SOW from 0 to 0.2), after which the
particle size reached a relatively constant level (Figure 3.2).

The minimum particle

radius attained at high surfactant levels was 55 ± 2 nm for all three systems (averaged
over the data from 5 to 20 wt% surfactant).

The dependence of particle size on

surfactant concentration can be conveniently divided into two distinct regimes for high
pressure

homogenization

“surfactant-rich zone”.

[172,

173]:

the

“surfactant-limited

zone”

and

the

At low surfactant concentrations, there was insufficient

surfactant present to cover the new surfaces created within the homogenizer when larger
droplets were broken down to smaller ones (Figure 3.1).

Consequently, two or more

small oil droplets that collided with each other would tend to coalesce because there was
insufficient surfactant present at their surfaces to prevent them from coming into close
contact.

Coalescence tends to continue until all of the droplets are covered by sufficient

surfactant to prevent them from merging together.

Hence, the droplet size in the

surfactant-limited zone is primarily determined by the type and amount of surfactant
present.

The minimum mean droplet radius (r32) that is obtained in this region is given

by the following equation [174]:

rmin =

3 ⋅ Γ ⋅φ
3 ⋅ Γ ⋅φ
=
cS
c' S (1 − φ )

(1)

Here, Γ is the surface load of the surfactant (in kg m-2), φ is the disperse phase
44

volume fraction, cS is the total surfactant concentration in the emulsion (in kg m-3) and
c’S is the total surfactant concentration in the continuous phase (in kg m-3).

This

equation assumes that all of the surfactant adsorbs to the droplet surfaces, and that the
droplets do not grow after formation e.g., due to Ostwald ripening or coalescence.

In

our study, the emulsions contained 20 wt% oil droplets (φ ~ 0.20) and 0.1 to 20 wt%
surfactant in the aqueous phase (c’S ∼ 1 to 200 kg m-3).

If we assume that all of the

surfactant adsorbed to the oil-water interface, then we can use the measured values of rmin
(55 nm) to predict the surface load of the surfactants.

The value of c’S was taken to be

the minimum surfactant concentration required to reach the smallest droplet radius (i.e.,
the value at the end of the surfactant-limited zone), which was approximately 2 wt% (20
kg m-3).

Consequently, the value of the surface load calculated for the surfactants using

Equation 1 was: Γ = 1.5 mg m-2 (1.5 × 10-6 kg m-3), which is close to published values for
this parameter [174, 175].

In practice, the surfactant molecules will be distributed

through many different environments (e.g., oil-water interface; micelles and monomers in
the aqueous phase: and, reverse micelles and monomers in the oil phase), and so not all of
the surfactant will go to the oil-water interface.

Nevertheless, this amount would be

expected to be relatively small since the critical micelle concentrations of the Tweens are
typically very low < 0.002 wt% [176].

In addition, the droplet surfaces may not need to

be completely covered by surfactant in order for protection against coalescence to occur.
The above value should therefore only be seen as a rough estimate of the actual surface
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load.
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Figure 3.2 Influence of surfactant concentration on the mean particle radius (r32) of 20 wt%
MCT oil-in-water emulsions formed by a high-energy method (microfluidization).
Emulsions were passed through the homogenizer three times at 10,000 psi.
At relatively high surfactant concentrations there is sufficient surfactant present to
rapidly cover all of the small oil droplets created within the homogenizer, and so the
droplet size is limited by the maximum disruptive forces generated by the homogenizer
rather than by surfactant properties.

In this regime, adding more surfactant therefore has

little impact on the size of the droplets produced during homogenization.
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Previous

studies have shown that the particle size can be decreased in this regime by increasing the
homogenization pressure (P) to facilitate further droplet disruption [8, 41, 60].
Typically, there is a linear decrease in log(d) with increasing log(P) for oil-in-water
emulsions prepared using small molecule surfactants in a microfluidizer, with the slope
depending on homogenizer design.
In general, the two surfactants and their mixture showed similar trends in their
particle size versus surfactant concentration dependences, but there were some
differences (Figure 3.2).

In the surfactant-limited zone, the decrease in mean particle

size with increasing surfactant concentration was steeper for the Tween 80 than for the
Tween 85, and the mixture was somewhere in between.

Thus, for the same surfactant

concentration smaller droplets were produced for Tween 80 than for Tween 85 in the
surfactant-limited zone. There are a number of possible explanations to account for this
difference, e.g., there were differences in the adsorption rate of the surfactants to the
oil-water interface, or in the ability of the surfactants to stabilize the droplets against
coalescence within the homogenizer.

Tween 85 is more lipophilic than Tween 80 and

therefore there will have been a greater fraction of this surfactant initially present within
the oil phase.

The oil phase is more viscous than the aqueous phase and therefore

Tween 85 in the oil phase may have moved to the droplet interface more slowly than
Tween 80 in the water phase.
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Figure 3.3 Influence of surfactant concentration on the mean particle radius (r32) of 20 wt%
MCT oil-in-water emulsions formed by a low-energy method (spontaneous
emulsification). The preparation procedure is described in the manuscript.
Spontaneous emulsification: The spontaneous emulsification (SE) method was
also used to prepare 20 wt% MCT oil-in-water emulsions using the same type and
concentrations of surfactant (Figure 3.3), so as to directly compare the results with those
obtained using the microfluidization method (Figure 3.2).

The influence of surfactant

concentration on the full particle size distribution of the samples prepared using the SE
method is also reported (Figure 3.4).

The SE method was capable of forming
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emulsions with small mean droplet radius (r < 100 nm), but the amount of surfactant
required to form small droplets with a monomodal distribution was considerably higher
than the microfluidization method (Figures 3.3 and 3.4).

For example, a

surfactant-to-oil ratio (SOR) of < 0.1 was typically required to form small droplets (r <
100 nm) using the microfluidization method, but a SOR > 1 was required to form small
droplets using the SE method.

Thus, approximately ten-fold more surfactant was

needed to produce similarly-sized droplets using the low-energy approach than using the
high-energy approach.

This clearly highlights one of the major disadvantages of the

spontaneous emulsification method for forming food-grade ultrafine emulsions.

For the

Tween 80 and the Tween 80/Tween 85 system, the particle size progressively decreased
with increasing surfactant concentration with the smallest mean droplet radius being
obtained at 20% surfactant: r = 77 nm for Tween 80 and r = 55 nm for the Tween
80/Tween 85 mixture.

For the Tween 85 system there was a decrease in mean particle

radius from 0 to 8% surfactant, followed by an increase at higher surfactant
concentrations (Figure 3.3).

A minimum droplet radius of around 87 nm was observed

at 8% surfactant for this system.

These results show that at low and intermediate

surfactant concentrations (< 8%) the smallest lipid droplets can be formed with Tween 85,
but at higher surfactant concentrations the smallest droplets can be formed with the
Tween 80/Tween 85 mixture.

The full particle size distributions showed that the

droplets formed were monomodal at sufficiently high surfactant concentrations for the
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Tween 80 (Figure 3.4a) and mixed systems (Figure 3.4b), and at intermediate
concentrations for the Tween 85 system (Figure 3.4c).
Figure 3.4a
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Figure 3.4 The particle size distributions of MCT oil-in-water emulsions formed by
using different concentrations of surfactants prepared by the spontaneous emulsification
method: (a) Tween 80; (b) Tween 80/Tween 85; (c) Tween 85.
The fundamental relationship between system composition and the size of the
droplets produced by the spontaneous emulsification method is less well understood than
for high energy methods such as microfluidization.

A number of studies have

empirically examined the relationship between particle size, system composition and
preparation conditions [177-180].

Fernandez and co-workers proposed that ultrafine oil

droplets were formed when water was added to a surfactant/oil mixture due to phase
inversion: the system went from a W/O microemulsion to a bicontinuous system to an
O/W emulsion [1].

Recently, Mercuri and co-workers proposed the following

mechanism for the spontaneous formation of emulsion droplets based on a study of the
phase behavior and microstructure of ternary mixtures of oil (soybean oil), surfactant
(Tween 80 and Span 80) and water [181].

When an aliquot of surfactant/oil mixture is

brought into contact with a water phase a boundary is initially formed between the S/O
and W phases.

Water then penetrates into the S/O phase causing it to swell, leading to

the formation of W/O microemulsions and then to liquid crystalline phases.

Eventually,

a fragment (≈ 50 µm) of the liquid crystalline S/O phase breaks off from the S/O-W
boundary and moves into the water phase.

These relatively large fragments may then

further dissociate into the nano-sized lipid droplets eventually formed.
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An alternative

hypothesis proposed by Anton and co-workers to account for spontaneous emulsification
is the movement of surfactant molecules from the S/O phase into the water phase after
the two phases come into contact, which leads to spontaneous formation of nano-sized
droplets at the boundary due to a budding mechanism (Figure 3.1) [50].

In reality, it is

likely that water will penetrate into the S/O phase and that surfactant will move into the
water phase, although the relative rate and influence of these two processes is currently
unknown.

Nevertheless, neither of these mechanisms can currently be used to

quantitatively account for the influence of system composition on the size of the droplets
formed by the SE method.
The fact that a minimum in droplet size was observed for the Tween 85 system at
around 8 wt% is currently not well understood.

Previous studies have also reported a

minimum in the droplet size for surfactant-oil-water systems containing Tween 85 and
MCT [182, 183]. These authors reported that the mean particle size obtained using the SE
method had a minimum value at a surfactant-to-oil ratio of Tween 85-to-MCT of about
3-to-7 (0.43-to-1), which is very similar to the value of 8-to-20 (0.40-to-1) found in our
work. Pouton and co-workers hypothesized that high concentrations of this surfactant
led to the formation of viscous gels at the S/O-W boundary that retarded
self-emulsification by limiting molecular diffusion processes [182, 183].

The influence

of system composition on the physicochemical characteristics of the SOW systems is
reported in Section 3.3.

It is clear that further work is required to rationalize the
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formation

of

oil-in-water

emulsions

with

specific

droplet

sizes

using

the

self-emulsification approach.
3.3.2 Stability of the emulsion formed by spontaneous emulsification
The long-term stability of an emulsion is one of the most important factors
determining its suitability for application within the food and beverage industries [184,
185]. For this reason, the stability of the emulsions produced in this study was assessed
by measuring changes in their droplet sizes and appearance during storage at ambient
temperature (~20 ºC) for one month.

Emulsions formed using microfluidization

remained stable to droplet aggregation (there was no change in their particle size
distribution) and gravitational separation (there was no visible evidence of creaming)
throughout a 30 day period, which can be attributed to their relatively small particle sizes
(data not shown).
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Figure 3.5 Influence of storage at ambient temperature on the particle size distribution of
20 wt% MCT oil-in-water emulsions formed by using different surfactants: (a) Tween 80;
(b) Tween 85. Like the Tween 80 system, the mixed surfactant system (Tween 80/Tween
85) was also stable to droplet growth during storage (data not shown).
For the emulsions formed using the spontaneous emulsification method, light
scattering measurements indicated that the emulsions stabilized by Tween 80 and by
Tween 80 / Tween 85 were stable to particle growth during one month storage, with no
significant change in mean particle radius (Table 3.1) or particle size distribution (Figure
3.5a).

On the other hand, there was an appreciable increase in the mean particle radius

of the emulsions stabilized by Tween 85 during storage (Table 3.1), which can be
attributed to an increase in the fraction of larger droplets present in the particle size
distribution (Figure 3.5b).

The observed differences in emulsion stability can be
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attributed to differences in the influence of the molecular characteristics of the surfactants
on droplet coalescence. It is known that the rate of droplet coalescence tends to increase
as the hydrophile-lipophile balance (HLB) of non-ionic surfactants decreases from high
to intermediate values [186].

Surfactants with high HLB numbers (> 15) tend to be

water soluble, form micelles, and stabilize oil-in-water emulsions, whereas surfactants
with intermediate HLB numbers (5 to 9) tend to be soluble in both the oil and water
phases, form lamellar structures, and are not particularly good at stabilizing either O/W
or W/O emulsions [187].

The physicochemical origin of this effect is that the interfacial

tension at the oil-water interface tends to become very low as the HLB number tends
towards 7 (the surfactant curvature tends towards unity), which means the interface
becomes highly mobile and susceptible to coalescence through “hole” formation [188].

Tween 80

Tween 80 /Tween 85
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Figure 3.6 Photographs of the influence of surfactant type and concentration on the
stability of 20 wt% MCT oil-in-water emulsions produced by the spontaneous
emulsification method to gravitational separation after 30 days storage.
Visual observation of the 20 wt% MCT oil-in-water emulsions after 30 days
storage indicated that homogenization method, surfactant type, and surfactant
concentration also had a major impact on their stability to gravitational separation.

As

mentioned earlier, all the emulsions prepared using microfluidization remained stable to
gravitational separation during storage, which may be attributed to their relatively small
droplet sizes (data not shown).

A number of the samples prepared by the spontaneous

emulsification method exhibited evidence of creaming instability after storage, with an
optically opaque cream layer being observed at the top of the samples and a slightly
turbid serum layer at the bottom (Figure 3.6).

For the Tween 80 samples, the height of

the cream layer increased as the surfactant concentration increased, suggesting the
samples were more stable to creaming at higher surfactant concentrations.

For the

Tween 85 samples, the emulsions were fairly stable to creaming at low and intermediate
surfactant concentrations (4 to 12 %), but showed extensive creaming at higher surfactant
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concentrations (16 and 20%).

For the mixed surfactant samples, the emulsions were

unstable at the lowest surfactant concentration (4%), were stable at intermediate
concentrations (8 and 12%), and showed some evidence of creaming again at the higher
values (16 and 20%).
A number of factors may contribute to the creaming stability of the emulsions.
First, the creaming velocity of a lipid droplet increases as its radius increases, so that
emulsions containing larger droplets will cream more rapidly than those containing
smaller ones [174].

Consequently, the emulsions prepared with low surfactant

concentrations are likely to be unstable to creaming because they contain relatively large
droplets.

The emulsions prepared with relatively low levels of Tween 85 had smaller

droplet sizes than those prepared with Tween 80 or the mixed system (Figure 3.3), which
may account for their better creaming stability at low surfactant concentrations (Figure
3.6).

On the other hand, the relatively poor creaming stability of the Tween 85 samples

at high surfactant concentrations (Figure 3.6) may be due to their relatively large particle
size (Figure 3.3).

Second, creaming may be induced at intermediate surfactant levels

due to the presence of non-adsorbed surfactant micelles that generate a depletion
attraction between the droplets [189].

The strength of the depletion attraction increases

with increasing surfactant concentration, and above a critical surfactant level (which
increases with decreasing droplet size) flocculation may be induced, leading to rapid
creaming.

This phenomenon may account for the fact that some creaming was observed
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in the Tween 85 and mixed surfactant systems at high surfactant concentrations, even
though they had relatively small droplet sizes.
Table 3.1 Surfactant properties and influence of surfactant type on mean particle radius
of emulsions formed by spontaneous emulsification after 0 and 30 days storage. The
surfactant concentration is the value where the minimum droplet size was produced by
the SE method.

Data for the surfactants were taken from the literature [176].

Surfactant Type

MW
(g/mol)

HLB

CMC

Surfactant

Radius

Radius

(mg/100g)

Concentration

Day 0

Day 30

Tween 85

1310

15

1.31

8%

87 nm

183 nm

Tween 80

1839

11

0.033

20 %

78 nm

77 nm

Tween 80:Tween 85

1575

13

-

20 %

55 nm

55 nm

3.3.4 Phase behavior of SOW systems
The phase behavior of the system at the oil/surfactant-water boundary plays a key
role in the formation of lipid droplets by the spontaneous emulsification process [190].
We therefore used dilution experiments and optical microscopy measurements to provide
some information about the phase behavior of the SOW systems used in this study.
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Figure 3.7 Photographs of the influence of surfactant type on the appearance and
properties of surfactant-oil-water (SOW) mixtures containing different SO-W ratios, but
a fixed SO ratio (1:1).

Annotation: the numbers x/y represent the mass ratio of SO to W,

e.g., 9/1 means there was 9 g of surfactant-oil mixture and 1 g of water.
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Figure 3.8 Micrographs of the influence of surfactant type on the appearance of
surfactant-oil-water (SOW) mixtures containing different SO-W ratios, but a fixed SO
ratio (1:1).

Annotation: the numbers x/y represent the mass ratio of SO to W, e.g., 9/1

means there was 9 g of surfactant-oil mixture and 1 g of water. The small white bar in the
lower right hand corner of each image represents 10 µm.
A series of mixtures with different mass fractions of surfactant (S), oil (O), and
water (W), but with a fixed surfactant-to-oil ratio (S:O = 1:1) was prepared, and then
their overall appearance (Figure 3.7) and microstructure (Figure 3.8) was measured.
Visual observations suggested that all of the surfactants exhibited relatively similar
behavior when the amount of water present in the system was increased: at high SO-to-W
ratios (low water contents) a viscous transparent oily solution was formed; at
intermediate SO-to-W ratios a gel-like translucent material was formed; at high SO-to-W
ratios (high water contents) a low viscosity milky liquid was formed (Figure 3.7).
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Examination of the SOW systems using optical microscopy indicated that surfactant type
did have an appreciable influence on their microstructures (Figure 3.8).

The Tween 80

sample was relatively homogeneous at low and high SO-to-W ratios, suggesting that
large particles were not present in the oil or water continuous systems.

At high

SO-to-W ratios, this corresponds to the transparent oily liquid observed at low water
contents.

At low SO-to-W ratios, this corresponds to the milky liquid formed at high

water contents.

A highly heterogeneous microstructure was observed under the

microscope at intermediate SO-to-W ratios i.e. 7:3 (Figure 3.8), which corresponded to
the gel-like structure observed visually (Figure 3.7).

The Tween 85 showed quite

different behavior, with large heterogeneous structures being formed at all surfactant/oil
to water ratios studied (Figure 3.8).

The precise nature of these structures is currently

unknown, although it is likely that they are some kind of liquid crystalline phase.

Large

heterogeneous structures were only observed in the Tween 80/85 system at a SO-to-W
ratio of 8:2 (data not shown), otherwise there was no large structures formed (Figure 3.8).
Observation of the same systems using cross-polarized optical microscopy indicated that
they had some order, i.e., the structures rotated polarized light and gave a white
appearance against a black background (data not shown).

This birefringent behavior

suggests that the surfactants formed liquid crystalline structures at intermediate SO-to-W
ratios.
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3.4 Conclusions
This study has highlighted some of the advantages and disadvantages of low and
high energy approaches for creating oil-in-water emulsions containing ultrafine oil
droplets.

The high energy method (microfluidization) was able to produce emulsions

with small droplets (r < 100 nm) using low surfactant-to-oil ratios (< 1:10), but it
required relatively expensive specialized equipment and has relatively high operating
costs.

On the other hand, the low energy method (spontaneous emulsification) is

inexpensive and can be implemented using simple equipment (stirring), but it requires
high surfactant-to-oil ratios (> 5:10) to produce small droplets.

The usage of relatively

high surfactant levels may cause problems in some food and beverage products due to
high ingredient costs, off flavors, and safety concerns.

In addition, high surfactant

levels may lead to emulsion instability due to depletion flocculation or due to accelerated
droplet growth through Ostwald ripening effects.

Further work is required to establish

whether low energy methods can be developed that produce small droplet sizes without
the need for high surfactant levels.
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CHAPTER 4
FORMATION AND STABILITY OF EMULSIONS USING A NATURAL SMALL
MOLECULE SURFACTANT: QUILLAJA SAPONIN (Q-NATURALE®)
4.1 Introduction
Small molecule surfactants are widely used in the food industry to form and
stabilize emulsion-based food and beverage products [67, 191].

Surfactants facilitate

the formation of oil-in-water emulsions by adsorbing to oil-water interfaces during
homogenization, thereby reducing the interfacial tension and enhancing further droplet
disruption [59, 60].

In addition, adsorbed surfactants provide a protective coating

around oil droplets, which inhibits their aggregation and improves the long-term stability
of emulsions [24, 192].

A large number of surfactants are available for utilization

within the food industry, which vary according to their molecular, physicochemical, and
functional properties, as well as their ease of utilization, legal status, and costs [67].
Some of the most important practical characteristics of surfactants for commercial use are:
(i) the minimum amount required to produce small droplets; (ii) the smallest droplet size
that can be achieved under specified homogenization conditions; (iii) the stability of the
droplets formed to environmental stresses, such as pH, ionic strength, and temperature
[193].

There are wide variations in the performance of surfactants depending on their

molecular characteristics, e.g., head group and tail group structure [194]. Consequently,
food and beverage manufacturers must select the most appropriate surfactant for a
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particular application [193].
Recently, there has been increasing interest within the food industry in replacing
synthetic ingredients with natural “label friendly” alternatives [7, 13].

Consequently,

there has been a focus on identifying and characterizing natural emulsifiers that can be
successfully used in emulsion-based food and beverage products.

Biopolymer-based

emulsifiers, such as proteins (whey, soy and egg) and polysaccharides (gum arabic and
modified starch), have been shown to be effective at forming and stabilizing emulsions
[9-11, 13].

Nevertheless, biopolymer emulsifiers often have limitations in their

functional performance.

Protein-coated oil droplets are often unstable to aggregation at

pH values around their isoelectric point, at high ionic strengths, and at elevated
temperatures [12].

On the other hand, it is often difficult to produce oil droplets with

very small sizes (d < 200 nm) using polysaccharide-based emulsifiers [9, 10, 13].
Certain types of lecithin are also suitable for utilization as natural emulsifiers in food and
beverage products, e.g., phospholipids derived from egg, soy, or milk [67, 76].
However, natural lecithin (which has two non-polar tails) usually has to be chemically or
enzymatically modified to lysolecithin (which has one non-polar tail) before it can be
successfully used to stabilize oil-in-water emulsions.

In this study, we investigated the

suitability of a natural saponin-based surfactant that has recently become commercially
available as a food ingredient to form and stabilize oil-in-water emulsions.
An extract isolated from the bark of the Quillaja saponaria Molina tree (an
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evergreen native to Chile and Peru) has been found to contain surface active components
that are capable of forming surfactant micelles and stabilizing oil-in-water emulsions
[14-16]. The major components within this extract have been reported to be saponins [17,
18] , which are high molecular weight glycosides consisting of a sugar moiety attached to
a triterpene or a steroid aglycone [19].

The saponins are surface active substances

(Figure 4.1) because they contain both hydrophilic regions (such as rhamnose, xylose,
arabinose, galactose, fucose, and glucuronic acid) and hydrophobic regions (such as
quillaic acid and gypsogenic acid) on the same molecule [16, 77].

A food ingredient

based on the quillaja saponin extract has recently been marketed by the National Starch
company (Bridgewater, NJ) under the trade name Q-Naturale®.
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Figure 4.1 Structural representations of quillaja saponin – a proposed major surface
active component of the food ingredient Q-Naturale.
In this study, we characterized the interfacial properties of influence of
homogenization conditions on the formation of oil-in-water emulsions using Q-Naturale®,
and then studied the influence of environmental stresses (pH, ionic strength, and
temperature) and long-term storage on the stability of the resulting emulsions to droplet
growth and gravitational separation.

The performance of Q-Naturale® was compared to

that of a synthetic surfactant (Tween 80) that is currently widely used in the food and
beverage industry to formulate emulsion-based products.
4.2 Materials and methods
4.2.1 Materials
The non-ionic surfactant polyoxyethylene (20) sorbitan monooleate (Tween 80)
was purchased from Sigma-Aldrich Co. (St. Louis, MO). Quillaja saponin (Q-Naturale®
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200) was provided by National Starch LLC (Bridgewater, N.J.).

The molecular weights

of Tween 80 (Sigma-Aldrich, St. Louis, MO) and quillaja saponin [16] have been
reported to be 1310 and 1650 g mol-1, respectively.

Medium chain triglyceride (MCT)

oil (Miglyol 812) was purchased from Coletica (Northport, NY).
4.2.2 Emulsion preparation
Oil-in-water emulsions were prepared by homogenizing 10 wt% lipid phase
(MCT) with 90 wt% aqueous phase.

The aqueous phase consisted of surfactant (Tween

80 or Q-Naturale®) and buffer solution (10 mM sodium phosphate buffer, pH 7.0).

A

coarse emulsion premix was prepared by blending the lipid and aqueous phases together
using a high-speed mixer (Bamix, Biospec Products, Bartlesville, OK) for 2 min at room
temperature. Fine emulsions were formed by passing the coarse emulsions through an
air-driven microfluidizer (Microfluidics, Newton, MA, USA). The coarse emulsions were
fed into the microfluidizer through a 100 ml glass reservoir, and were passed through the
homogenization unit for different numbers of passes at various homogenization pressures.
The type and amount of surfactant added to the aqueous phase prior to homogenization
was varied in some experiments.

The commercial Q-Naturale® ingredient contained 14%

of surfactant (active ingredient) dispersed within an aqueous solution, and therefore we
reported its concentration based on the amount of active surfactant present (rather than
the overall ingredient).
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4.2.3 Emulsion stability testing
The stability of the prepared emulsions to a series of environmental stresses that
might be encountered in commercial practice was tested:
Thermal processing: Emulsion samples were placed in glass test tubes and then
incubated in water baths set at different temperatures (30 to 90 ºC) for 30 min.

The

samples were then cooled to room temperature and stored for 24 hours at ambient
temperature prior to analysis.
pH and salt: The pH and ionic strength of emulsions was adjusted to a specified
level using NaOH, HCl, and/or NaOH solutions.

Emulsion samples were then placed in

glass test tubes and incubated for 24 hours at ambient temperature prior to analysis.
Long-term storage: Emulsion samples were placed in glass test tubes and then
incubated in temperature controlled rooms (5, 37, and 55 °C) for one month prior to
analysis.
4.2.4 Particle characterization
The particle size distributions of the samples were measured using a static light
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, U.K.).

The

droplet charge (ζ-potential) of emulsions was determined using a particle electrophoresis
instrument (Zetasizer Nano ZS series, Malvern Instruments, Worcestershire, UK).
Samples were diluted with buffer solutions of the appropriate pH prior to analysis to
avoid multiple scattering effects.
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4.2.5 Interfacial tension measurements
The interfacial tension versus surfactant concentration was measured at the MCT
oil – water interface using a drop shape analysis instrument (DSA 100, Kruss GmbH,
Hamburg Germany).

The surface pressure (π) was calculated from the interfacial

tension (γ) data using the following formula: π = γ – γ0, where γ and γ0 are the interfacial
tensions measured in the presence and absence of surfactant.
4.2.6 Optical microscopy measurements
A Nikon optical microscope (Nikon Eclipse 80i, Nikon Instrument Inc., Melville,
NY) with a 60× objective lens (NA 0.75) was used to capture images of emulsion
samples.
4.2.7 Statistical analysis
All measurements were performed on at least two freshly prepared samples (i.e.,
new samples were prepared for each series of experiments) and were reported as means
and standard deviations.
4.3 Results and discussion
4.3.1 Interfacial characteristics
The interfacial activity of surfactants plays an important role in determining their
ability to form and stabilize emulsions [195, 196], and therefore we measured the
interfacial tension versus surfactant concentration profiles for the two surfactants used
(Figure 4.2).

For both surfactants, the interfacial tension decreased appreciably with
69

increasing surfactant concentration indicating that the surfactants adsorbed to the
oil-water interface.

A fairly constant interfacial tension was reached at high surfactant

levels (γ ≈ 5 mN m-1), which indicated that the interfaces had become saturated with
∞

surfactant [71].

Q-Naturale and Tween 80 both had fairly similar interfacial tension

versus surfactant concentration profiles, which indicated that they had similar surface
activities.

The critical micelle concentration (CMC) of the two surfactants was

determined from the interfacial tension versus logarithm of surfactant concentration
profiles using the method described previously, i.e., determining the intersect between
linear plots extrapolated from high and intermediate surfactant concentrations [16].

We

estimated the CMC values from the data shown in Figure 4.2 to be around 0.003 and
0.01 wt% for the Tween 80 and Q-Naturale, respectively. These values is in reasonable
agreement with reported values of 0.0022 wt% for Tween 80 [197] and 0.01 to 0.07 wt%
for quillaja saponin from various sources [16].
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Figure 4.2 Influence of Tween 80 and Q-Naturale concentration on the interfacial tension
measured at the MCT oil-water interface.
The surface load (Γ) of a surfactant can be calculated from the interfacial tension
(γ) versus surfactant concentration (c) data using the following formula [16]:

⎛ 1
Γ = −⎜
⎝ RT

⎞ dγ
⎟
⎠ d ln c

(1)

Here R is the gas constant, T is the absolute temperature, and c is expressed in
moles per liter [71].

We used this expression to determine the surface load of the two

surfactants from the slope of the γ versus ln c data (Figure 4.2): Γ = 3.1 and 2.9 mg m-2
for Tween 80 and Q-Naturale, respectively.

The area (A) occupied per molecule at the

oil-water interface can be calculated from the surface load: A = 1/(ΓNA), where NA is
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Avogadro’s number [16].

We obtained values of A = 72 and 96 Å2 per molecule for

Tween 80 and Q-Naturale, respectively.

The value for Q-Naturale is in good agreement

with the value of 83 Å-2 reported for quillaja saponin in previous studies [16].
The surface activity (K) of an emulsifier can be conveniently characterized by the
following relationship [26]:

K=

1
c1 / 2

⎛ ΔGads ⎞
= exp⎜ −
⎟
⎝ RT ⎠

(2)

Here c½ is the surfactant concentration where half of the available adsorption sites
on the oil-water interface are covered by surfactant, and ΔGads is the free energy change
associated with surfactant adsorption.

To a rough approximation, c½ can be taken to be

equal to the surfactant concentration where the surface pressure is half its maximum
value (π ).
∞

In this study, we calculated the following parameters from the interfacial

pressure versus surfactant concentration profiles: for Tween 80, c½ = 0.0014 wt% (10.7
µM), K = 94,000, and ΔGads = -11.4 RT; for Q-Naturale, c½ = 0.0010 wt% (6.1 µM), K =
165,000, and ΔGads = -12.0 RT.
Overall, our measurements show that both surfactants were highly effective at
reducing the interfacial tension at an oil-water interface, and that both had fairly similar
interfacial characteristics (Figure 4.2).
4.3.2 Influence of surfactant type and concentration on emulsion formation
In this section, the influence of surfactant type and concentration on the particle
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size of 10 wt% MCT oil-in-water emulsions produced using a high pressure homogenizer
(microfluidizer) under standardized homogenization conditions (10,000 psi, 4 passes)
was examined (Figure 4.3).

As expected, there was a decrease in mean particle

diameter (d32) with increasing surfactant concentration for both types of surfactant used.
This effect can be attributed to two main factors: (i) a higher surfactant concentration
means that a larger surface area can be stabilized during homogenization; (ii) a higher
surfactant concentration leads to faster coverage of the droplet surfaces by surfactant
molecules, and therefore better protection against recoalescence [192]. The dependence
of oil droplet size on surfactant concentration can be conveniently divided into two
distinct regimes for emulsions prepared by high pressure homogenization [172, 173]: the
“surfactant-limited zone” and the “surfactant-rich zone”. At low surfactant concentrations,
there is insufficient surfactant present to cover the new surfaces created within the
homogenizer when larger droplets are broken down to smaller ones.

Consequently, two

or more small oil droplets that collide tend to coalesce because there is insufficient
surfactant present at their surfaces to prevent them from coming into close contact.
Coalescence tends to continue until all of the droplets are covered by sufficient surfactant
to prevent them from merging together. Hence, the droplet size in the surfactant-limited
zone is primarily determined by the type and amount of surfactant present.

At

sufficiently high surfactant concentrations, the droplet size is primarily governed by the
maximum disruptive energy that can be generated by the homogenizer, rather than the
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amount of surfactant present.

Nevertheless, the droplet size may still depend somewhat

on surfactant type since this will determine interfacial characteristics that influence
droplet disruption such as interfacial tension and rheology.
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Figure 4.3 Influence of surfactant concentration on the mean particle diameter (d32) of 10
wt% MCT oil-in-water emulsions containing either Tween 80 or Q-Naturale produced
using standardized homogenization conditions (10,000 psi, 4 passes).
There were appreciable differences in the particle size versus surfactant
concentration profiles obtained for the two types of surfactants (Figure 4.3).

Smaller

droplets could be produced at high surfactant concentrations using Tween 80 (d ≈ 120 nm)
than using Q-Naturale (d ≈ 170 nm). In addition, a lower surfactant concentration was
required to produce small droplets (d < 200 nm) for Tween 80 (≈ 0.3 to 0.5%) than for
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Q-Naturale (≈ 0.8 to 1.1 %). These experiments indicate that both types of surfactants
were effective at producing small droplets, but that Tween 80 was more efficient than
Q-Naturale.

The differences in the effectiveness of the two surfactants may be due to a

number of factors that impact droplet disruption and coalescence within homogenizers,
including the speed at which they adsorb to the oil-water interface, their ability to reduce
the oil-water interface tension, their influence on the dynamic interfacial rheology, and
their effectiveness at generating repulsive interactions between droplets [59, 60, 192].
The surface activities of the two surfactants (measured under static conditions) were
fairly similar (Section 3.1), which suggest that some of the other factors mentioned may
be more important.
The minimum droplet size that can be theoretically produced during
homogenization given a fixed amount of surfactant can be calculated from the following
expression [174]:

d min =

6 ⋅ Γ ⋅φ
6 ⋅ Γ ⋅φ
=
cS
c' S (1 − φ )

(3)

Here, Γ is the surface load (in kg m-2), φ is the disperse phase volume fraction, cS
is the concentration of emulsifier in the emulsion (in kg m-3) and c’S is the concentration
of emulsifier in the continuous phase (in kg m-3).

In our study, the emulsions contained

10 wt% of oil droplets (φ ~ 0.1) and a maximum surfactant concentration of 2 wt% in the
aqueous phase (c’S ∼ 20 kg m-3).

The surface load of the two surfactants was calculated
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from the interfacial measurements in the previous section to be around 3 mg m-2 (Γ = 3 ×
10-6 kg m-2). Hence, the minimum mean droplet diameter (d32) that could be achieved
assuming that all of the surfactant adsorbed to the droplet surfaces during
homogenization is about dmin = 100 nm.

The mean droplet diameters produced in our

study were somewhat higher than this value, which suggested that there was more than
enough emulsifier initially present to cover all of the droplets formed by the
microfluidizer.

The fact that the observed minimum droplet diameter (∼120 - 170 nm)

achieved was higher than the predicted value may have been because the surfactant did
not adsorb quickly enough during homogenization, or because the homogenizer was
incapable of generating sufficiently intense disruptive forces at the pressures used.
4.3.3 Influence of homogenization conditions on emulsion formation
Previous studies have shown that the size of the droplets in emulsions produced
by high pressure homogenization depends on processing conditions such as
homogenization pressure and number of passes [8, 33, 198, 199].

We therefore

examined the influence of these experimental parameters on the size of the droplets
produced by the two surfactants used in this study.

The mean droplet diameter

decreased with increasing homogenization pressure (Figure 4.4) and number of passes
(Figure 4.5) for both types of surfactant, which is in agreement with previous studies [13,
41, 173, 200].
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Figure 4.4 Influence of number of passes through a high pressure homogenizer on the
mean particle diameter (d32) of 10 wt% MCT oil-in-water emulsions containing either 1
wt% Tween 80 or Q-Naturale produced at a constant homogenization pressure (10,000
psi).
At a fixed homogenization pressure, the mean droplet diameter decreased with
increasing number of passes (Figure 4.4), which can be attributed to the fact that a higher
proportion of the droplets will have had a chance to pass through the most disruptive
zone within the homogenizer. The largest decrease in mean droplet diameter occurred
when the coarse emulsion premix (zero passes) was initially passed through the
homogenizer (one pass).

After one pass through the homogenizer, there was only a

slight decrease in droplet size upon further passes indicating that this type of
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homogenizer is highly effective at droplet disruption.

This is commercially important

since food and beverage manufacturers aim to minimize the number of passes required to
form an emulsion since this reduces processing time and cost.

The limiting droplet size

obtained after a high number of passes is determined by the maximum disruptive energy
that can be generated by the homogenizer at the pressure used (provided there is
sufficient surfactant present to cover all the droplet surfaces produced).
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Figure 4.5 Influence of homogenization pressure on the mean particle diameter (d32) of
10 wt% MCT oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale
passed four times through the homogenizer.
There was a linear decrease in the logarithm of the mean droplet diameter with the
logarithm of the homogenization pressure for emulsions stabilized by either Tween 80 or
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Q-Naturale (Figure 4.5), which is in agreement with previous studies that indicate there
should be a linear relationship providing there is sufficient emulsifier present [201]. The
slope determined from the log10(d) versus log10(P) plots was around -0.93 when Tween
80 was used as the surfactant and around -0.86 when Q-Naturale was used (Figure 4.5).
These values are somewhat higher than previously reported values of around -0.6 to -0.8
for high pressure homogenizers [202, 203].

This difference may be due to differences in

the homogenizer design, homogenization valve, or particle sizing methods used in
different studies.
4.3.4 Influence of environmental stresses on emulsion stability
Practically, an emulsion-based food or beverage should remain stable throughout
the anticipated shelf life of the final product.

Emulsions may become unstable through

a number of different instability mechanisms (e.g., flocculation, coalescence, Ostwald
ripening, and gravitational separation), which depend on storage conditions such as pH,
ionic strength, and temperature [28].

We therefore examined the influence of

environmental stresses on the stability of emulsions stabilized by the two different kinds
of surfactant.
4.3.4.1 Influence of Thermal Processing
Emulsions prepared using either Tween 80 or Q-Naturale were both stable to
thermal processing across the entire temperature range studied (30 to 90 ºC), with little
change in mean particle diameter (Figure 4.6) or visible evidence of gravitational
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separation, i.e., all the emulsions appeared white and homogeneous (data not shown).
Lipid droplets stabilized by non-ionic surfactants may become unstable to droplet
coalescence when they are heated close to a critical temperature (the “phase inversion
temperature” or PIT) because of dehydration of the polar surfactant head groups [50, 204].
Dehydration causes a change in the optimum curvature of the surfactant molecules at the
oil-water interface, as well as their relative solubilities (and partitioning) in the oil and
water phases, which favors droplet coalescence [205].

The PIT depends on the

chemical structure of the surfactant, as well as the nature of the oil phase [177, 178].
Our results suggest that both Tween 80 and Q-Naturale are stable to droplet coalescence
during relatively short term heating when MCT is used as the oil phase, presumably
because the PIT is sufficiently far above the highest temperature used in this study.
Nevertheless, we did seem some instability in the Tween 80 stabilized emulsions when
they were heated at elevated temperatures for prolonged times (see Section 4.3.4.4),
which suggests that they may have been unstable to coalescence at elevated temperatures.
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Figure 4.6 Influence of thermal processing on the mean particle diameter (d32) of 10 wt%
MCT oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.
Emulsions were held for 30 minutes at the specified temperature, and then cooled to
ambient temperature prior to analysis.
4.3.4.2 Influence of pH
The influence of pH on the mean particle diameter, ζ-potential, creaming stability,
and microstructure of the emulsions stabilized by the two different surfactants was
examined.

For the Tween 80 stabilized emulsions, the electrical charge on the droplets

went from slightly negative (- 9 mV) at pH 9 to slightly positive (+ 2 mV) at pH 2 with a
point of zero charge around pH 3.5 (Figure 4.7a).

Tween 80 is a non-ionic surfactant

and would therefore not be expected to have any charge, although previous studies have
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shown that droplets stabilized by non-ionic surfactants may be charged due to the
presence of ionizable surface active impurities (such as free fatty acids) or due to
preferential adsorption of hydroxyl ions (OH-) at high pH or hydrogen ions (H+) at low
pH to the droplet surfaces [26]. Emulsions containing Tween 80 appeared to be stable to
droplet aggregation and gravitational separation at all pH values studied, with no
evidence of droplet growth in the light scattering data (Figure 4.7b), no change in
microstructure in optical microscopy images (data not shown), and no visible evidence of
creaming (data not shown).

The fact that the droplets had little net charge across the

entire pH range studied suggests that droplet aggregation was mainly prevented by steric
repulsion due to the relatively large hydrophilic (polyoxyethylene) head groups of the
adsorbed Tween molecules [76].
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Figure 4.7a Influence of storage pH on the droplet charge (ζ-potential) of 10 wt% MCT
oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.
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Figure 4.7b Influence of storage pH on the mean particle diameter (d32) of 10 wt% MCT
oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.
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83
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Figure 4.7c Influence of storage pH on the appearance of 10 wt% MCT oil-in-water
emulsions containing either 1 wt% Tween 80 or Q-Naturale.

Note that extensive

creaming occurred at pH 2 in the Q-Naturale stabilized system.

Figure 4.7d Microstructure of 10 wt% MCT oil-in-water emulsions containing 1 wt%
Q-Naturale at pH 2.

Extensive droplet flocculation can clearly be observed.

All other

emulsions appeared uniform in appearance under the microscope.
The Q-Naturale stabilized emulsions had a high negative charge (-69 mV) at pH 9,
which decreased in magnitude as the pH was increased until it reached a value close to
zero at pH 2 (- 1 mV) (Figure 4.7a).

The origin of the negative charge can be attributed

to the presence of a carboxylic acid group within the structure of quillaja saponin (Figure
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4.1).

Typically, carboxylic acid groups have pKa values around pH 3.5, which would

account for the large decrease in ζ-potential observed around this value (Figure 4.7a).
At high pH values (pH >> pKa) this group would be fully charged (-COO-) whereas at
low pH values (pH << pKa) it would be uncharged (-COOH).

The presence of a strong

negative charge on the droplets might play an important role in determining the
functional properties of this surfactant for certain applications: (i) a high negative charge
may make emulsions susceptible to flocculation due to electrostatic bridging by cationic
multivalent ions (such as calcium) [206, 207]; (ii), a high negative charge may attract
cationic pro-oxidants (such as transition metals) to the droplet surfaces and thereby
promote lipid oxidation [208, 209]; (iii) a high negative charge may cause droplets to
adhere to cationic surfaces [210].

Our light scattering measurements indicated that the

droplets were stable to droplet aggregation across the entire pH range studied (Figure
4.7b).

On the other hand, visual observation of the emulsions indicated that extensive

creaming occurred at pH 2 (Figure 4.7c), and optical microscopy images showed that the
emulsions containing Q-Naturale were highly aggregated at pH 2 (Figure 4.7d).

Taken

together these results suggest that the emulsions were highly flocculated at pH 2, but that
they were stable to coalescence (otherwise we would have seen an increase in the mean
droplet diameter at pH 2 in the light scattering data). The light scattering measurements
were performed on highly diluted samples, and so any flocculated droplets may have
become dissociated prior to analysis.

These results indicate that emulsions stabilized by
85

quillaja saponin are stable across most of the pH range present within food products (pH
3 to 8), but that they might become unstable to flocculation in highly acidic products or
within the human stomach after ingestion.
4.3.4.3 Influence of ionic strength
The influence of ionic strength was examined by adding different amounts of salt
(0 to 500 mM NaCl) to the samples and then measuring their stability after storage
overnight (Figure 4.8).

Emulsions containing Tween 80 were stable at all salt

concentrations studied, exhibiting no change in mean particle diameter (Figure 4.8a), no
evidence of creaming (data not shown), and no change in microstructure (data not shown).
These results highlight the fact that the oil droplets in the Tween 80 emulsions are mainly
stabilized against aggregation by steric (rather than electrostatic) repulsion [26].
Emulsions containing Q-Naturale appeared to be stable to droplet aggregation at all salt
concentrations studied when analyzed by light scattering, with no evidence of an increase
in droplet diameter at any NaCl concentration (Figure 4.8b).

However, creaming

stability and optical microscopy measurements indicated that Q-Naturale emulsions were
stable at low salt concentrations (< 300 mM NaCl), but unstable to creaming (Figure
4.8b) and aggregation (Figure 4.8c) at higher salt concentrations.

The fact that the

mean particle size data determined by light scattering indicated that the droplets remained
small at all salt concentrations studied suggests that droplet aggregation was due to
flocculation rather than coalescence in the presence of high salt levels.
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These results

suggest that both electrostatic and steric repulsion play an important role in stabilizing
Q-Naturale® coated droplets against aggregation.

At low salt concentrations the

long-range electrostatic repulsion between the droplets is strong enough to prevent
aggregation, but at high salt concentrations the long-range attractive interactions (e.g.,
van der Waals) become stronger than the long-range repulsion interactions (e.g.,
electrostatic), leading to droplet association.

Nevertheless, at high salt concentrations

the short-range steric repulsion between droplets still seems to be sufficiently strong to
prevent the droplets from coming close enough together to merge together and coalesce.
The fact that the Tween 80 emulsions were stable to flocculation at high salt
concentrations whereas the Q-Naturale emulsions were unstable suggests that the
polymeric head groups of Tween 80 are thicker than those of Q-Naturale.
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Figure 4.8a Influence of salt concentration on the mean particle diameter (d32) of 10 wt%
MCT oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.
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Figure 4.8b Influence of salt concentration on the appearance of 10 wt% MCT
oil-in-water emulsions containing either 1 wt% Tween 80 or Q-Naturale.

Creaming was

observed at the higher salt concentrations in the Q-Naturale emulsions (arrow).

Figure 4.8c Influence of high salt concentration (500 mM) on the microstructure of 10 wt%
MCT oil-in-water emulsions containing 1 wt% Q-Naturale.
4.3.4.4 Influence of storage time and temperature
The long-term stability of emulsions is one of the most important factors
determining their shelf life in commercial food and beverage applications [28]. We
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therefore compared the stabilities of emulsions formed using Q-Naturale with those
formed using Tween 80 during storage at different temperatures (5, 37, and 55 °C) for
one month.

These experiments were carried out using emulsions at neutral pH in the

absence of added salt.

We observed no change in the visible appearance of emulsions

containing Q-Naturale at any of the storage temperatures (data not shown) and little
change in particle size distribution (Figure 4.9).

We also found only a small increase in

mean droplet diameter of the Q-Naturale emulsions after one month storage (Table 4.1),
indicating that they were fairly stable to droplet growth and gravitational separation.
We also did not observe any change in the appearance (data not shown) or mean particle
diameter (Table 4.1) of the Tween 80 stabilized emulsions stored at 5 or 37 ºC for one
month indicating that they were also stable to droplet growth and creaming.

On the

other hand, we did observe a thin layer of oil on top of the Tween 80 stabilized emulsions
stored at 55 °C for one month, and an appreciable increase in mean droplet diameter
(Table 4.1).

Interestingly, we did not observe an appreciable change in mean droplet

diameter or oiling off after heating the Tween 80 stabilized emulsions at high
temperatures for short times (e.g., 60-90 ºC for 30 minutes) as described earlier (Section
4.3.4.1).

These results suggest that emulsions stabilized by this non-ionic surfactant

may be unstable to long-term storage at elevated temperatures, but may be stable during
short-term thermal processing operations.

A possible explanation for this phenomenon

is that Tween surfactants may chemically degrade (hydrolyze) when stored at elevated
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temperatures for prolonged periods and therefore lose their surface activity [211].
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Figure 4.9 Influence of long-term storage (one month) on the particle size distribution of
10 wt% MCT oil-in-water emulsions containing Q-Naturale.
Table 4.1 Particle size changes of emulsions formed by Tween 80 and Q-Naturale
respectively after one month storage
0 day
5 °C
Tween 80

Q-Naturale

One month later
129 nm

37 °C

133 nm

132 nm

55 °C

155 nm

5 °C

200 nm

37 °C

188 nm

55 °C

204 nm
209 nm
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4.4 Conclusions
We have carried out a detailed study of the interfacial, emulsion forming, and
emulsion stabilizing properties of Q-Naturale, a natural food-grade surfactant based on
quillaja saponin that has recently become commercially available.

Q-Naturale was

found to be highly surface active, and had similar interfacial properties as Tween 80 a
synthetic non-ionic surfactant widely used in the food industry.

Q-Naturale-coated

droplets had a large negative charge at neutral pH, which decreased in magnitude at
acidic pH values, which was attributed to the presence of a carboxylic acid group.
Q-Naturale was able to form oil-in-water emulsions with relatively small droplet sizes (d
< 200 nm) at low surfactant-to-oil ratios (SOR ≈ 1:10), which were stable to a range of
thermal treatments (30 to 90 ºC), salt concentrations (≤ 300 mM NaCl), and pH
conditions (pH 3 to 8).

In addition, they had good long-term stability (one month) when

stored at various holding temperatures (5, 37, and 55 °C).

The emulsions were unstable

to flocculation and creaming (but stable to coalescence) when stored at highly acidic (pH
2) or high ionic strength (400 or 500 mM NaCl) conditions, which was attributed to the
reduction in the electrostatic repulsion operating between the droplets.

Overall, our

results show that Q-Naturale is an effective natural surfactant that may be suitable for
utilization in a variety of food and beverage products.
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CHAPTER 5
ENCAPSULATION OF VITAMIN E IN EDIBLE EMULSIONS FABRICATED
USING A NATURAL SURFACTANT
5.1 Introduction
There is increasing interest within the food and biomedical industries in the
creation of delivery systems to encapsulate, protect, and release lipophilic bioactive
compounds, such as ω-3 fatty acids, phytosterols, flavonoids, carotenoids, vitamins, and
drugs [3, 212-214].

These delivery systems should be designed so that they can

incorporate appreciable amounts of the bioactive component, protect it from physical or
chemical degradation during storage, and deliver it to the appropriate site of action after
ingestion.

They should also be designed so that they are compatible with the delivery

vehicle in which they are to be incorporated, e.g., for food and beverage products they
should not adversely affect their appearance, stability, texture or flavor.

In addition, for

food and beverage applications delivery systems must be fabricated entirely from
food-grade ingredients using economic and commercially viable processing operations.
Emulsion-based delivery systems are particularly suitable for this type of application,
since they can be fabricated entirely from generally recognized as safe (GRAS) food
ingredients and processing operations [128, 215].
The term “vitamin E” refers to a group of fat-soluble vitamins that are widely
used as functional ingredients in food, pharmaceutical, and cosmetic preparations [216].
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Vitamin E comes in eight different molecular forms that have a common structural
feature: a chromanol ring and a phytol side chain [23].

The different molecular forms of

vitamin E are classified as either tocopherols (α, β, γ, and δ) or tocotrienols (α, β, γ, and
δ), with α-tocopherol being the most biologically active form [217]. The major biological
function of Vitamin E appears to be as an oil-soluble antioxidant [218].

Various other

health benefits of vitamin E have also been claimed, such as reducing cardiovascular
disease, diabetes and cancer [219-221].

For these reasons, there has been interest in

fortifying many processed foods and beverages with Vitamin E [22]. Some studies
suggest that the bioavailability of Vitamin E may be increased when it is delivered in
colloidal form rather than bulk form [222].

Vitamin E is unstable to oxidation in food

many food products and may therefore be lost during processing, storage, and utilization
[223, 224].

For this reason, vitamin E acetate (rather than vitamin E) is used in many

food and beverage applications since it has a higher oxidative stability.

After

consumption vitamin E acetate is broken down to vitamin E in the gastrointestinal tract
by the action of pancreatic esterases [225].

The recommended daily intake (RDI) of

Vitamin E is 15 mg/day, although deficiency only usually occurs in the case of
individuals with diseases that inhibit fat absorption or in premature infants [23, 218].
Vitamin E is a highly lipophilic molecule that cannot be directly dispersed into
aqueous solutions [22].

Instead, it must be incorporated into an appropriate colloidal

delivery system prior to dispersion [23].

A number of previous studies have shown that
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vitamin E can be successfully incorporated into emulsion-based delivery systems, such as
microemulsions

[79,

216],

nanoemulsions

[80-82]

and

emulsions

[23,

83].

Encapsulation of vitamin E has been reported to improve its physicochemical stability
during storage and its biological activity after consumption [226, 227]. In the current
study, we focus on the development of oil-in-water emulsions suitable for incorporating
vitamin E in functional food and beverage products designed to improve human health
and wellness.

O

O
O

Figure 5.1 Structure of Vitamin E acetate – a highly lipophilic bioactive molecule.
Recently, there has been increasing interest within the food industry in replacing
synthetic ingredients with natural “label friendly” alternatives [7, 8]. Consequently, there
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has been a focus on identifying and characterizing natural emulsifiers that can be
successfully used in emulsion-based food products.

In this study, we investigate the

emulsifying properties of a recently developed compound extracted from the bark of the
Quillaja saponaria Molina tree.

The major components within quillaja extract have

been reported to be saponins [17, 18] , which are high molecular weight glycosides
consisting of a sugar moiety attached to a triterpene or a steroid aglycone [19].

The

surface activity of saponins arises from the fact that they contain both hydrophilic regions
(sugar groups) and hydrophobic regions (such as quillaic and gypsogenic acids) on the
same molecule [16, 77].

Saponins have previously been shown to form surfactant

micelles in aqueous solutions and to stabilize oil-in-water emulsions [228, 229]. A food
ingredient based on a quillaja saponin extract has recently been marketed by the National
Starch Company (Bridgewater, NJ) under the trade name Q-Naturale®.
We investigate a number of factors expected to influence the size of the oil
droplets formed in oil-in-water emulsions produced by high pressure homogenization: oil
phase composition (Vitamin E to medium chain triglyceride (MCT) ratio); aqueous phase
composition (glycerol to water ratio); and, surfactant type (Q-Naturale® versus Tween 80
®

).

Our aim was to identify optimum conditions for fabricating all-natural

emulsion-based delivery systems for encapsulating vitamin E.

These delivery systems

may be suitable for application in a variety of industrial applications, including food,
beverage, pharmaceutical, cosmetic, and healthcare products.
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5.2 Materials and methods
5.2.1 Materials
The non-ionic surfactant polyoxyethylene (20) sorbitan monooleate (Tween 80)
was purchased from Sigma-Aldrich Co. (St. Louis, MO). Quillaja saponin (Q-Naturale®
200) was provided by National Starch LLC (Bridgewater, N.J.).

The molecular weights

of Tween 80 (Sigma-Aldrich, St. Louis, MO) and quillaja saponin [228] have been
reported to be 1310 and 1650 g mol-1, respectively.

Medium chain triglyceride (MCT)

oil (Miglyol 812) was purchased from Coletica (Northport, NY).

Vitamin E acetate

(Figure 1) was obtained from BASF (Florham Park, NJ).
5.2.2 Emulsion preparation
Oil-in-water emulsions were prepared by homogenizing 10 wt% lipid phase
(MCT) with 90 wt% aqueous phase.

The aqueous phase consisted of surfactant (1 wt%

Tween 80 or Q-Naturale®) and buffer solution (10 mM sodium phosphate buffer, pH
7.0).

A coarse emulsion premix was prepared by blending the lipid and aqueous phases

together using a high-speed mixer (Bamix, Biospec Products, Bartlesville, OK) for 2 min
at room temperature. Fine emulsions were formed by passing the coarse emulsions
through an air-driven microfluidizer (Microfluidics, Newton, MA, USA). The coarse
emulsions were passed through the homogenization for 4 passes at 9,000 psi. The
commercial Q-Naturale® ingredient contained 14 % of surfactant (active ingredient)
dispersed within an aqueous solution, and therefore we reported its concentration based
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on the amount of active surfactant present (rather than the amount of overall ingredient).
5.2.3 Particle characterization
The particle size distributions of the samples were measured using a static light
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, UK) after
samples had been diluted with buffer solution.
5.2.4 Rheological properties measurements
The rheological behavior of samples was measured using a dynamic shear
rheometer (Kinexus Rotational Rheometer, Malvern Instruments, Malvern, U.K). A cup
and bob geometry consisting of a rotating inner cylinder (diameter 25 mm) and a static
outer cylinder (diameter 27.5 mm) was used in viscosity and oscillation measurements.
The samples were loaded into the rheometer measurement cell and allowed to equilibrate
at 25 °C for 5 min before beginning all experiments.

Shear viscosity (η) measurements

were carried out at different shear rates (0.01 to 10 s-1).
5.2.5 Interfacial tension measurements
The interfacial tension was measured at oil – water interfaces using a drop shape
analysis instrument (DSA 100, Kruss GmbH, Hamburg Germany).
5.2.6 Turbidity measurement
The turbidity of selected samples was measured using a UV-visible
spectrophotometer (Agilent 7010 Particle Size Analyzer, Agilent Technologies. Inc, CA,
USA). Samples were diluted in buffer solution to a range of different oil droplet
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concentrations, and the turbidity was determined at 600 nm using buffer solution as a
blank.
5.2.7 Statistical analysis
All measurements were performed on at least two freshly prepared samples (i.e.,
new samples were prepared for each series of experiments) and were reported as means
and standard deviations.
5.3 Results and discussion
5.3.1 Impact of droplet composition: Vitamin E to MCT ratio
Initially, we examined the influence of oil phase composition on the formation of
oil-in-water emulsions by high-pressure homogenization. Ideally, we aimed to produce
emulsions containing a high percentage of vitamin E acetate within the oil phase so as to
increase their loading capacity.

However, vitamin E acetate is an oily material that is

difficult to homogenize alone due to its relatively high viscosity.

We therefore

examined the effect of mixing it with medium chain triglycerides (MCT), which is edible
oil with a relatively low viscosity.

The influence of oil phase composition on emulsion

formation was compared for systems prepared using either Q-Naturale or Tween 80.

98

Tween 80

50

Relative Particle Volume (%)

45
40

100%

35
80%

30
25

60%

20
40%

15
10

20%

5
0
0.01

0%
0.1

1

10

100

1000

Particle Diameter (mm)

Q-Naturale

50

Relative Particle Volume (%)

45
40

100%

35
80%

30
25

60%

20
40%

15
10

20%

5
0
0.01

0%
0.1

1

10

100

Particle Diameter (mm)

99

1000

Figure 5.2 Influence of Vitamin E acetate concentration in the oil phase (Vitamin E
acetate + MCT) on the particle size distributions of 10 wt% oil-in-water emulsions
produced using high pressure homogenization.

Emulsions were created using either

Tween 80 or Q-Naturale or as surfactant
A series of 10 wt% oil-in-water emulsions with different oil phase compositions
were produced using the microfluidizer (9,000 psi, 4 passes) and then the particle size
distributions (Figure 5.2) and mean particle diameters (Figure 5.3) were measured.
Monomodal particle size distributions were observed for both surfactant types when the
oil phase contained from 0 to 80% vitamin E acetate, i.e., 100 to 20% MCT (Figure 5.2).
On the other hand, broad bimodal distributions were observed for the two surfactants
when the oil phase contained 100% vitamin E acetate.

For both surfactants, there was a

slight increase in mean droplet diameter (d32) with increasing vitamin E acetate
concentration from 0 to 80%, followed by a much steeper increase from 80 to 100%
(Figure 5.3). Tween 80 appeared to be more effective at forming small droplets at
relatively low vitamin E acetate concentrations (≤ 40 wt%), but Q-Naturale was more
effective at relatively high vitamin E acetate concentrations (60 - 80 wt%).
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Figure 5.3 Influence of Vitamin E acetate concentration in oil phase (Vitamin E acetate +
MCT) on mean particle diameter (d32) of 10 wt% oil-in-water emulsions produced using
high pressure homogenization.

Emulsions were created using either Q-Naturale or

Tween 80 as surfactant
Previous research has shown that droplet disruption becomes more difficult as the
viscosity of the disperse phase increases for various types of mechanical homogenizers
[201, 230, 231].

This effect can be attributed to the increase in time required for the

droplets to become deformed within the disruption zone of a homogenizer as the disperse
phase viscosity increases [201, 203].

Hence, more viscous oil droplets are difficult to

breakup within a homogenizer because they may leave the disruption zone before they
have had time to become deformed and disrupted.
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An empirical expression has been proposed to relate measurements of mean
droplet diameter (d) to disperse phase viscosity (ηD) for emulsions produced by high
pressure homogenizers [232, 233]:

d = Aη DB

(1)

A and B are empirically determined constants, with B being reported to lie
between 0.2 and 0.9 for high pressure homogenizers with the actual value depending on
the major disruption mechanism involved [232]. To examine the influence of disperse
phase viscosity on droplet size we measured the viscosities of a series of oil phases
containing different amounts of Vitamin E acetate and MCT (Figure 5.4).

The shear

viscosity of all the oil phases was Newtonian over the shear rates studied (data not
shown).

The shear viscosity of pure vitamin E acetate (η ≈ 2.95 Pa.s) was over two

orders of magnitude higher than that of pure MCT (η ≈ 0.028 Pa.s).

The viscosity

increased with increasing vitamin E acetate concentration, particularly steeply between
80 and 100%.

The relationship between droplet diameter and the disperse phase

viscosity for emulsions prepared using the two different surfactants is shown in Figure
5.5.

The empirical parameters in Equation 1 were calculated from linear regression

analysis of the log[d] versus log[ηD] data: A = 0.681, B = 0.476 for Tween 80; A = 0.622,
B = 0.335 for Q-Naturale.

The B values lie within the range reported previously for

high pressure homogenizers [232]. The observation that the droplet diameter was
somewhat less dependent on disperse phase viscosity for Q-Naturale® than for Tween 80
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may be due to a number of physicochemical phenomena. First, since the molecule of
Q-Naturale® is a little bigger than Tween 80, Q-Naturale® may have been adsorbed more
slowly to the surfaces of droplets than Tween 80 and therefore more droplet
re-coalescence may occurre within the homogenizer.

Second, Q-Naturale® may have

formed a coating around the oil droplets that was more resistant to disruption within the
homogenizer, therefore retarding droplet breakup within the disruption zone.
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Figure 5.4 Shear viscosities and interfacial tensions of oil phases containing different
amounts of vitamin E acetate and MCT.

The interfacial tension was measured against

buffer solution.
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Figure 5.5 Influence of disperse phase viscosity (ηD) on the mean droplet diameter of 10
wt% oil-in-water emulsions produced using high pressure homogenization.

Emulsions

were created using either Q-Naturale or Tween 80 as surfactant.
Interfacial tension also plays an important role in the formation of small droplets
during homogenization, since it is proportional to the force required to deform and
disrupt droplets within the homogenization zone [234, 235].

We therefore measured the

interfacial tension at the oil-water interface of oil phases with different compositions
(Figure 5.4). The interfacial tension increased appreciably as the Vitamin E acetate
concentration in the oil phase increased, changing from ≈ 25.8 mN m-1 for pure MCT to ≈
30.3 mN m-1 for pure vitamin E acetate.

This increase suggests that vitamin E acetate is

a more hydrophobic molecule than MCT, i.e., there is a greater free energy penalty to
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increase the oil-water interface.

The observed increase in mean droplet diameter with

increasing vitamin E acetate concentration in the oil phase may therefore be partly due to
this increase in interfacial tension, since this would make it harder to disrupt the droplets
in the homogenizer.

However, one also has to consider how quickly the surfactants

adsorb to the oil-water interface during homogenization, since this will determine the
actual interfacial tension at the droplet surfaces.
5.3.2 Impact of aqueous phase properties on particle size
The size of the droplets in an oil-in-water emulsion produced using high pressure
homogenization also depends on aqueous phase properties, such as viscosity and
interfacial tension.

Previous studies have found that smaller droplets can be formed

when the disperse-to-continuous phase viscosity ratio (ηD/ηC) is close to unity and the
disperse-to-continuous phase interfacial tension is lowered [60, 199, 236].

We therefore

examined the possibility of producing smaller vitamin E droplets by changing the
composition of the aqueous phase to alter the viscosity ratio and interfacial tension.
And this aim was achieved by adding different amounts of glycerol to the aqueous phase.
The shear viscosity of the aqueous phase increased as the glycerol concentration
increased, with their being over a 5-fold increase when the glycerol level was raised from
0 to 50% (Figure 5.6).

This effect can be attributed to the fact that the viscosity of pure

glycerol is much higher than that of pure water.

On the other hand, there was a decrease

in the interfacial tension of the aqueous phase as the glycerol concentration increased
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(Figure 5.7), which occurs because glycerol is less polar than water.
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Figure 5.7a Influence of aqueous phase concentration (glycerol:water) on the mean
particle diameter of 10 wt% oil-in-water emulsions (pH 7) stabilized by 1 wt%
Q-Naturale.
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Figure 5.7b Influence of aqueous phase concentration (glycerol:water) on the mean
particle diameter of 10 wt% oil-in-water emulsions (pH 7) stabilized by 1 wt% Tween 80.
The influence of aqueous phase properties on droplet size was studied by
preparing a series of 10 wt% oil-in-water emulsions with the same oil phase compositions
(60 or 80% vitamin E acetate) and same concentrations of emulsifier (1 wt% Tween 80 or
Q-Naturale), but different aqueous phase compositions (0 to 50% glycerol) using fixed
homogenization conditions (9,000 psi, 4 passes). For all systems studied, there was a
decrease in the mean particle diameter with increasing glycerol concentration (Figure
107

5.8).

This decrease can be attributed to two different effects of glycerol on the

physicochemical properties of the aqueous phase: as the glycerol concentration increases,
the viscosity ratio decreases and the interfacial tension decreases, both of which favor the
formation of smaller droplets.

At the same glycerol concentration, smaller droplets

were produced using Q-Naturale than using Tween 80, which supports the experiments
described in Section 3.1 at high vitamin E acetate concentrations.

Smaller droplets were

produced when the dispersed phase contained 60% rather than 80% vitamin E acetate,
which can be attributed to the lower viscosity of the former system facilitating droplet
disruption within the homogenizer (Section 5.3.1).
An expression similar to Equation 1 can be used to model the influence of
disperse phase viscosity on droplet size produced by high pressure homogenization [233]:

d = A'η CB '

(2)

Here A’ and B’ are empirical constants and ηC is the continuous phase viscosity.
In homogenizers where droplet disruption is primarily due to turbulence, droplet size is
not believed to be strongly dependent on continuous phase viscosity, i.e., B’ < -0.03 [237].
On the other hand, in homogenizers where shear forces play an important role in droplet
disruption, the droplet diameter should decrease with increasing continuous phase
viscosity [203]. In this study, we found B’ ≈ -0.32 for Tween 80 and ≈ -0.13 for
Q-Naturale (at 60% vitamin E acetate) and B’ ≈ -0.30 for Tween 80 and ≈ -0.18 for
Q-Naturale (at 80% vitamin E acetate).

The fact that the B’ values are appreciably
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smaller than -0.03 suggests that shear forces played an appreciable role in droplet
disruption [203].

The emulsions containing Q-Naturale as a surfactant appeared to be

less sensitive to changes in continuous phase viscosity than those containing Tween 80.
The values measured in this study are in reasonable agreement with those reported
previously of B’ ≈ -0.24 for an anionic surfactant (SDS) using a similar homogenizer
[236].

Q-Naturale

Q-Naturale
+ Glycerol

Q-Naturale
+ Glycerol
+ Lysolecithin

Figure 5.8 Foaming problem observed during emulsion preparation when Q-Naturale®
was used solely as a surfactant. From left to right: Images of 10 wt% oil-in-water
emulsions prepared using Q-Naturale dissolved in buffer solution, buffer + 50% glycerol,
or buffer + 50% glycerol + 0.1% lecithin, respectively.
Overall, the ability to produce smaller droplets at higher glycerol concentrations
can be attributed to a number of different physicochemical mechanisms [28, 201]. First,
ease of droplet disruption within the homogenizer decreases as the viscosity ratio tends
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towards unity [238].

Second, the amount of re-coalescence occurring within the

homogenizer decreases as the continuous phase viscosity increases since this retards
droplet encounters [45, 231]. Third, the ease of droplet disruption decreases as the
interfacial tension decreases since the Laplace pressure resisting droplet deformation is
reduced [60].
Despite the advantages of using glycerol to produce smaller droplets in the
Q-Naturale stabilized emulsions, we should note a practical difficulty that we
encountered that could limit its commercial application.

We found that adding glycerol

to the continuous phase caused foaming of the emulsions containing Q-Naturale®, which
sometimes caused the homogenizer to be become blocked.

This effect was attributed to

the ability of the high viscosity aqueous phase to trap air bubbles formed during the
mixing and homogenization stages.

We observed that this effect could be greatly

reduced by adding a small amount of lysolecithin (0.1%) as an antifoaming agent to the
aqueous phase prior to homogenization (Figure 5.8).
5.3.3 Influence of viscosity ratio on particle size
Our previous experiments indicated that both the dispersed phase and continuous
phase viscosities had a major impact on the size of the droplets formed.

In this section,

we directly examined the influence of the viscosity ratio (ηD/ηC) on the droplet size
produced during homogenization. The mean droplet diameters were plotted against the
viscosity ratio for the various emulsions studied (Figure 5.9). We included data for
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emulsions that had different oil phase compositions (60 % & 80 % Vitamin E) as well as
different aqueous phase compositions (0 to 50 wt% glycerol). All the systems studied
were 10 wt% oil-in-water emulsions stabilized by 1 wt% emulsifier prepared using fixed
homogenization conditions (9,000 psi, 4 passes).
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Figure 5.9 Influence of ratio of oil-to-aqueous phase viscosity ratio on the mean particle
diameter for 10 wt% oil-in-water emulsions (pH 7) prepared by high pressure
homogenization (9,000 psi, 4 passes) for systems stabilized by 1 wt% Tween 80 or
Q-Naturale.
Previous studies suggest that there is an optimum range of disperse-to-continuous
phase viscosity ratios (0.1 < ηD/ηC < 5) for producing small droplets in various kinds of
homogenizers [201, 239, 240]. In this study, we were able to cover a viscosity ratio

111

ranging from about ηD/ηC = 35 to 600 by in the vitamin E acetate emulsions.

It was not

possible to reach lower viscosity ratios due to the very high viscosity of the disperse
phase.

The slope of a log(d) versus log(ηD/ηC) was around 0.34 for emulsions

containing Tween 80 and around 0.16 for emulsions containing Q-Naturale® (Figure 5.9).
These results again highlight that emulsions containing Tween 80 are more sensitive to
viscosity changes of the dispersed and continuous phases than those containing
Q-Naturale®.

The smallest droplets that we could prepare were for emulsions

containing 60 % Vitamin E in the oil phase and 50% glycerol in the aqueous phase: d =
179 nm for Tween 80 and d = 215 nm for Q-Naturale®.

The smallest droplets that we

could prepare for emulsions containing 80 % Vitamin E in the oil phase and 50%
glycerol in the aqueous phase were: d = 260 nm for Tween 80 and d = 237 nm for
Q-Naturale®.

These droplet sizes are relatively small and should lead to the formation

of stable colloidal dispersions of vitamin E.

Indeed, storage tests showed no increase in

the mean particle diameter of any of the emulsions after being kept at ambient
temperature for one month (data not shown).
5.3.4 Optical properties of emulsions
For many practical applications, the optical properties of emulsion-based delivery
systems are important. For example, for the application in clear beverage, it is necessary
to use an optically transparent delivery system, whereasto opaque foods this is
unimportant and to impart cloudiness to some soft drinks it may even be desirable to
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have a turbid delivery system.

The overall appearance of emulsion-based products is

determined by the way in which they interact with light waves through absorption and
scattering phenomenon [241, 242].
In this section, the optical properties of the vitamin E emulsions were
characterized in terms of their turbidity increments, i.e., the increase in turbidity per unit
increase in droplet concentration.

Emulsions were prepared using 60 wt% Vitamin E in

the oil phase and either 0 % or 50 % glycerol in the aqueous phase, using both Tween 80
and Q-Naturale.

The turbidity of these emulsions was then measured at 600 nm as a

function of droplet concentration (Figure 5.10). These emulsions were diluted with
buffer solution (at least 1:100) so that the final glycerol concentration (< 0.5%) would not
affect the refractive index of the aqueous phase and therefore the overall light scattering
characteristics of the final emulsions.

For both surfactants, the turbidity increment was

higher for emulsions containing 0% glycerol than those containing 50% glycerol during
homogenization, which can be attributed to differences in droplet size.

The emulsions

prepared at higher glycerol concentrations had smaller droplet sizes, which therefore
scattered light less strongly in this particle size range [167].

The differences in the

turbidity increments between emulsions containing 0% and 50% glycerol were greater for
Tween 80 than for Q-Naturale, which is because the size of the droplets in Tween 80
emulsions was more sensitive to changes in continuous phase composition (Section 3.2).
At 0% glycerol, the turbidity increment was higher for Tween 80 (d = 0.35 µm) than for
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Q-Naturale (d = 0.28 µm) emulsions because Tween 80 produced the largest droplets.
On the other hand, at 50% glycerol the turbidity increment was higher for Q-Naturale (d
= 0.22 µm) than for Tween 80 (d = 0.18 µm) emulsions because Tween 80 produced the
smallest droplets.

Thus, there was a close correlation between the particle size data and

the turbidity data for these systems.
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Figure 5.10 Impact of glycerol content and surfactant type on turbidity of 10 wt%
oil-in-water emulsions diluted to different droplet concentrations (1 wt% Tween 80 or
Q-Naturale, 9,000 psi, 4 passes).
To prepare beverage emulsions that appear visually transparent the turbidity
should be < 0.05 cm-1 [243].

The turbidity increments reported in Figure 5.10 can be

used to estimate the oil droplet concentrations required to reach this level: 0.0018 and
0.0022 wt% for Q-Naturale and 0.0017 and 0.0026 wt% for Tween 80, for emulsions
prepared from aqueous phases initially containing either 0 or 50% glycerol, respectively.
These emulsions contained 60% vitamin E acetate in the oil phase, and so the maximum
amount of the vitamin that can be incorporated into a transparent beverage is around
0.0010 to 0.0016%.

If we assume that the serving size for a typical beverage product is

8 ounces (240 mL), then this amount would correspond to about 2.4 to 3.8 mg of vitamin
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E acetate per serving.

The daily recommended intake of vitamin E for adults is 15 mg

[218], and therefore it should be possible to prepare clear beverages containing
biologically active amounts of vitamin E using the emulsions described in this work.
5.4 Conclusions
The purpose of this study was to determine whether a natural surfactant
(Q-Naturale®) based on quillaja saponin isolated from tree bark could be used to form
and stabilize oil-in-water emulsions containing vitamin E acetate.

We compared the

performance of Q-Naturale® with a synthetic non-ionic surfactant that is currently used in
the food, pharmaceutical and cosmetic industries to form emulsions (Tween 80).

Tween

80 was more effective at producing small droplets at relatively low vitamin loadings (≤
40%), whereas Q-Naturale® was more effective at relatively high vitamin loadings (60%
- 80%). The size of the droplets in the emulsions could be reduced by decreasing the
vitamin concentration in the oil phase, or increasing the amount of glycerol in the
aqueous phase.

These effects were attributed to changes in the viscosities and

interfacial tensions of the dispersed and continuous phases, since these parameters are
known to influence droplet disruption and coalescence during homogenization.

This

study has important implications for the development of “label friendly” delivery systems
for incorporating lipophilic nutraceuticals (such as oil-soluble vitamins) into foods and
beverages, as well as other commercial products.
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CHAPTER 6
VITAMIN E BIOACCESSIBILITY: INFLUENCE OF CARRIER OIL TYPE ON
DIGESTION AND RELEASE OF EMULSIFIED ΑLPHA-TOCOPHEROL
ACETATE
6.1 Introduction
Vitamin E is known to be an essential micronutrient for maintaining the health
and wellbeing of humans and other animals due to its antioxidant and non-antioxidant
biological activities [244-246]. Nevertheless, the precise biological mechanisms by which
it exerts its beneficial effects are still unclear, and are currently the focus of extensive
research efforts [246, 247].

The term “vitamin E” actually refers to a group of related

fat-soluble molecules that are found in many natural sources and are widely used as
functional ingredients in food, pharmaceutical, and cosmetic preparations [216, 248]. The
most important biologically active form of Vitamin E is α-tocopherol, and therefore this
form tends to be used in commercial products.

There has been considerable interest in

fortifying foods, beverages, and supplements with vitamin E due to its beneficial
nutritional qualities [215, 249].

However, there are a number of challenges associated

with incorporating vitamin E into commercial products due to its chemical instability,
poor water-solubility, and variable bioavailability.
The α-tocopherol form of Vitamin E is highly unstable to oxidation and may
therefore be lost during the processing, storage, and utilization of commercial products
117

due to its chemical degradation [223, 224].

For this reason, a more chemically stable

esterified form (α-tocopherol acetate) is typically used in commercial products rather than
the free form [250].

Another challenge associated with the utilization of vitamin E is

that it is a highly lipophilic molecule with a low very water-solubility, which means that
it cannot be directly dispersed into aqueous media [163, 251].

Instead it must either be

dispersed into a lipid phase or incorporated into a suitable delivery system [23, 215].

A

well-designed delivery system can encapsulate lipophilic nutraceuticals in a form that
that does not adversely affect product quality (such as appearance, taste, texture, or
stability), protect them from chemical degradation during storage, and increase their
bioavailability after ingestion [215, 252].
developed

for

encapsulating

A wide variety of delivery systems have been

lipophilic

nutraceutical

ingredients,

including

microemulsions, nanoemulsions, emulsions, solid lipid nanoparticles, and polymer
particles [128, 163, 212, 253, 254].

Each of these delivery systems has specific

advantages and disadvantages related to the nature of the nutraceutical to be encapsulated,
the food matrix that it is to be dispersed within, and the processing, storage, and transport
conditions it is exposed to.
After ingestion, it is important that a nutraceutical component has a high
bioavailability so that it can effectively deliver its beneficial biological effects.

Previous

studies have shown that the bioavailability of vitamin E may be highly variable (ranging
from < 1% to 100%) depending on its chemical form and the nature of the food matrix it
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is incorporated within [119, 255].

Typically, vitamin E must be first released from the

food matrix, then incorporated into mixed micelles, and then transported across the
mucous layer before it is absorbed by epithelium cells in the small intestine [248, 256].
The mixed micelles are comprised of bile salts and phospholipids from the bile and
pancreatic juices, as well as lipid digestion products (free fatty acids and
monoacylglycerols) from the action of lipases on ingested triacylglycerol oils [257].
The bioaccessibility of lipophilic nutraceuticals and drugs has previously been shown to
increase as the total amount of mixed micelles increases, as well as to depend on nature
of the mixed micelles formed after lipid digestion [257-259], which may account for
some of the observed variations in vitamin E bioavailability. It has also been reported that
the esterified form of vitamin E (α-tocopheryl acetate) is less bioaccessible than the free
form (α-tocopherol) [260-263], and so it has to be converted into α-tocopherol by
digestive enzymes (e.g., pancreatic esterases) within the gastrointestinal tract prior to
absorption [244, 264].

However, studies using an in vitro digestion model have shown

that α-tocopheryl acetate may be absorbed by Caco-2 cells to a similar extent as
α-tocopherol [225].

Some of the observed variations in vitamin E bioaccessibility may

therefore also be due to differences in the chemical nature of the ingested form, e.g., free
versus esterified.

The wide variability reported in the bioavailability of vitamin E

makes it difficult to interpret the results of clinical trials on the efficacy of vitamin E
supplementation, and to develop appropriate guidelines on the consumption levels of
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vitamin E [248]. The development of suitable delivery systems for vitamin E may be able
to overcome some of the challenges associated with its varying bioavailability.
In this study, we utilized an emulsion-based delivery system fabricated from a
natural surfactant (quillaja saponin) that we have recently shown to be suitable for
encapsulating vitamin E acetate [265].

There is a major drive in the food industry

towards developing consumer friendly labels e.g., “all natural”. There are few natural
surfactants currently available for utilization within the food industry.

Hence, the

availability of a natural surfactant to form and stabilize emulsions would be an advantage
for many functional food and beverage applications.

Our primary focus was to examine

the influence of carrier oil composition (medium chain versus long chain fatty acids) on
the bioaccessibility of vitamin E acetate using an in vitro gastrointestinal tract (GIT)
model, since previous studies have shown that the nature of the ingested fatty acids
influences the bioaccessibility of lipophilic nutraceuticals and drugs [266-269].

We

measured the change in the microstructure and properties of vitamin E-enriched fat
droplets throughout the simulated GIT (mouth, stomach, and small intestine)C.

We also

monitored the bioaccessibility and conversion of α-tocopherol acetate to α-tocopherol
after the small intestine stage.

The results of this study provide valuable information

about the potential biological fate of ingested emulsion-based delivery systems for
vitamin E, as well as their potential for controlling the bioavailability of this important
nutrient in functional foods and beverages.
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6.2 Materials and methods
6.2.1 Materials
Quillaja saponin (Q-Naturale® 200) was provided by National Starch LLC
(Bridgewater, NJ). Corn oil (Mazola, ACH Food Companies, Inc., Memphis, TN) was
used as an example of a long chain triglyceride (LCT) and was purchased from a local
supermarket.

Corn oil we used in our experiment contains 2 g saturated fat, 8 g

polyunsaturated fat and 4 g monounsaturated fat in every serving size (14 g).

Medium

chain triglyceride (MCT) oil (Miglyol 812) was purchased from Coletica (Northport, NY).
Vitamin E acetate was kindly supplied by BASF (Florham Park, NJ).

Lipase (from

porcine pancreas pancreatin, activity>2.0 USP units/mg, Type II, L3126, Batch #
020M1589) and bile extract (porcine) were also obtained from the Sigma Chemical
Company (St. Louis, MO).
lipases.

Type II lipase contains amylase and protease, as well as

Lipase activity is one unit will hydrolyze 1.0 microequivalent of fatty acid from

triacetin in 1 hr at pH 7.4 at 37°C.

All other chemicals used were of analytical grade.

Double distilled water was used for the preparation of all solutions and emulsions.
Double distilled water was got by using Milli-Q®.
6.2.2 Emulsion preparation
Oil-in-water emulsions were prepared by homogenizing 10 wt% lipid phase and
90 wt% aqueous phase.

The lipid phase consisted of vitamin E acetate dispersed in

either corn oil (LCT) or medium chain triglyceride oil (MCT).
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The aqueous phase

consisted of surfactant (1 wt% Q-Naturale®) and buffer solution (10 mM sodium
phosphate buffer, pH 7.0).

A coarse emulsion premix was prepared by blending the

lipid and aqueous phases together using a high-speed mixer (Bamix, Biospec Products,
Bartlesville, OK) for 2 min at room temperature. Emulsions containing fine droplets were
formed by passing the coarse emulsions through an air-driven microfluidizer
(Microfluidics, Newton, MA, USA) four times at 9,000 psi.

The Q-Naturale® ingredient

contained 14 % of surfactant (active ingredient) dispersed within an aqueous solution,
and therefore we reported its concentration based on the amount of active surfactant
present (rather than the amount of overall ingredient).
6.2.4 Particle characterization
The particle size distributions of the samples were measured using a static light
scattering instrument (Mastersizer 2000, Malvern Instruments, Malvern, U.K.).

The

droplet charge (ζ-potential) of emulsions was determined using a particle electrophoresis
instrument (Zetasizer Nano ZS series, Malvern Instruments, Worcestershire, UK).
Samples were diluted with buffer solutions of the appropriate pH prior to analysis to
avoid multiple scattering effects.
6.2.5 In vitro digestion
Each emulsion sample was passed through a three-step simulated GIT model,
which includes a mouth, gastric, and small intestine stage.
Mouth stage:

Simulated saliva fluid (SSF) was prepared according to a
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previous study [270].

10 mL of emulsion (1 w/w% oil) was placed in a 250 mL flask

containing 10 mL of SSF.

This mixture was adjusted to pH 6.8 and then shaken

continuously at the rate of 100 rpm in a temperature controlled incubator (37 ºC) for 10
min (Innova Incubator Shaker, Model 4080, New Brunswick Scientific, New Jersey,
USA).
Gastric stage:

Simulated gastric fluid (SGF) was prepared by placing 2 g NaCl,

7 mL HCl, and 3.2 g pepsin into a flask, adding water to make up to 1 L, and then
adjusting the pH to 1.2 using 1.0 M HCl (United States Pharmacopeial Convention, 2000).
The sample from the mouth stage was then mixed with SGF at a 1:1 mass ratio so that the
final mixture contained 0.5 % (w/w) oil.

The mixture was then adjusted to pH 2.5 by

using 1M NaOH and incubated with continuous shaking at 100 rpm at 37 ºC for up to 2 h
to mimic stomach conditions.
Small intestinal stage: Digesta samples (30 mL) from the simulated gastric stage
were added to a clean beaker, then incubated in a water bath (37 ºC) for 10 min, and then
adjusted to pH 7 using NaOH solution (range from 0.05 to 1 M).

The mixture was then

incubated for 2 h at 37 ºC with simulated small intestinal fluid (SIF) containing 2.5 mL
pancreatic lipase (4.8 mg mL-1), 4 mL bile extract solution (5 mg mL-1) and 1 mL
calcium chloride solution (750 mM).

A pH-stat (Metrohm, USA Inc.) was used to

monitor and control the pH (at pH 7.0) of the digestion solution after the SIF was added
[271]. The amount of alkali solution (0.25 M NaOH) that had to be added to the reaction
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chamber to maintain the pH at 7.0 was recorded, and used to determine the percentage of
free fatty acids (FFA) released from the system [148].

Samples were also taken for

physicochemical and structural characterization after 2 h in vitro digestion in the small
intestinal stage.
6.2.6 Bioaccessibility Determination
The bioaccessibility of lipophilic bioactive components is normally defined as the
fraction that is solubilized within the mixed micelle phase after lipid digestion [119, 272].
After the full in vitro digestion was completed, 10 ml of sample was collected and
centrifuged (4000 rpm, Thermo Scientific, CL10 centrifuge) at 25 ºC for 40 min.

The

emulsions separated into an opaque sediment phase at the bottom, a clear micelle phase
in the middle, and sometimes a thin oily or creamed phase at the top.

An aliquot (0.5 ml)

of the micelle phase or the raw digesta was vortexed with an organic solvent mixture (1:3
isopropanol and isooctane) at 1:5 to extract the vitamin E and then centrifuged at 1750
rpm for another 10 min.

1 mL of the top layer was removed and dried using a vacuum

centrifuge drier and stored in the -80 ºC refrigerator prior to further analysis.

Before

detection by HPLC, samples were dissolved in 200 µL methanol.
HPLC Detection: Vitamin E concentrations in the samples were determined
using HPLC (Shimadzu, Kyoto, Japan).

A C18 reverse-phase column (150 - 4.6 mm, 5

µm, Beckman Coulter) was used for the chromatographic separation of α-tocopherol
acetate and α-tocopherol.

The flow rate of the mobile phase was 1.0 mL/min and the
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sample injection volume was 20 µL.

An isocratic elution was carried out using

HPLC-grade solvent (95 % methanol and 5 % double distilled water containing 0.5 %
phosphoric acid).

The α-tocopherol acetate and α-tocopherol contents were determined

using a PDA detector at 295 nm.
external standards.

Tocopherol quantification was determined using

The overall bioaccessibility of vitamin E was estimated using the

following expression:

Bioaccessibility =

Cmicelle
× 100%
CTotal

(1)

Here Cmicelle and CTotal represent the total concentration of vitamin E (α-tocopherol
acetate + α-tocopherol) in the micelle phase and in the overall system after digestion,
respectively.

The percentage of specific forms of vitamin E solubilized within the

micelle phase was also calculated using the same expression, but for α-tocopherol acetate
and for α-tocopherol separately.

The conversion of α-tocopherol acetate to α-tocopherol

in the overall system after digestion was calculated from the following expression:

Conversion =

CVE
× 100%
CTotal

(2)

Here CVE and CTotal represent the concentration of α-tocopherol and the total
concentration of vitamin E (α-tocopherol acetate + α-tocopherol) in the overall system
after digestion, respectively.
6.2.7 Statistical analysis
All measurements were performed on at least two freshly prepared samples (i.e.,
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new samples were prepared for each series of experiments) and are reported as means and
standard deviations.
6.3 Results and discussion
6.3.1 Impact of carrier oil type on biological fate of emulsions
6.3.1.1 Influence on particle size
Initially, we studied the impact of vitamin E encapsulation and carrier oil type on
the potential biological fate of emulsion-based delivery systems using a simulated
gastrointestinal tract (GIT) model.

A series of emulsions containing 2.5 wt% lipid

phase were produced using either long chain triglycerides (LCT) or medium chain
triglycerides (MCT). Emulsions containing lipid phases with four different compositions
were prepared: LCT (100% LCT); vitamin E in LCT (25% α-tocopherol acetate + 75%
LCT); MCT (100% MCT); and, vitamin E in MCT (25% α-tocopherol acetate + 75%
MCT).
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Figure 6.1a Influence of vitamin E encapsulation and carrier oil type on the mean
particle diameter (d32) of oil-in-water emulsions passing through different stages of a
simulated gastrointestinal tract.

Key: LCT = 100% LCT; LCT-VE = 25% α-tocopherol

acetate + 75% LCT; MCT = 100% MCT; MCT-VE = 25% α-tocopherol acetate + 75%
MCT.
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Figure 6.1b Influence of vitamin E encapsulation and carrier oil type on the particle size
distributions of emulsions after passage through the small intestinal stage of a simulated
gastrointestinal model.

See caption to Figure 6.1a for Key.
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Figure 6.1c Particle size distributions of emulsions containing LCT at different stages of
a simulated gastrointestinal tract.
The influence of vitamin E encapsulation and carrier oil type on the mean particle
diameter after each stage of the simulated GIT model was measured (Figure 6.1a).

The

full particle size distributions of selected samples were also compared: (i) emulsions
containing different carrier oil types after the small intestine stage (Figure 6.1b);
emulsions containing LCT at different stages of the GIT model (Figure 6.1c).

All the

initial emulsions had monomodal particle size distributions and relatively small mean
particle diameters (d32 = 228 to 270 nm). The droplets in the LCT emulsions were
slightly larger than those in the MCT emulsions, and the droplets in the emulsions
containing vitamin E were slightly larger than those containing no vitamin E, which may
have been due to differences in oil phase viscosities.

The size of the droplets produced

by high pressure homogenization is known to increase as the viscosity of the oil phase
increases [60, 273].

After passage through the simulated mouth and gastric stages, the

mean particle diameter remained relatively small (d32 < 400 nm), suggesting that the oil
droplets were fairly stable to aggregation under these conditions (Figures 6.1a and 6.1c).
Recent studies have shown that oil droplets coated by the same quillaja saponin extract
used in this work (Q-Naturale®) were relatively stable to changes in pH and salt
concentration [274].

Any saponin molecules adsorbed to fat droplet surfaces would not

be expected to be hydrolyzed by proteases (pepsin) in the gastric juices, which can cause
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instability of protein-coated fat droplets.

In addition, we would not have expected any

saponin molecules adsorbed to the fat droplets surfaces to be displaced due to
competitive adsorption processes since the oral and gastric fluids used in this study did
not contain any highly surface-active substances.
After passage through the simulated small intestinal stage there was a large
increase in mean particle diameter (Figure 6.1a) and evidence of large particles in the
particle size distributions (Figure 6.1b) for all emulsions studied.

These results indicate

that there was a marked reduction in the physical stability of the emulsions after exposure
to small intestinal conditions.

Several physicochemical phenomena may explain the

observed reduction in emulsion stability in the small intestinal stage.

First, the intestinal

juices contained bile salts and phospholipids that are highly surface active molecules that
may have displaced some or all of the quillaja saponins from the oil droplet surfaces.
Second, the intestinal juices contained pancreatic lipase that is capable of adsorbing to oil
droplet surfaces and converting triacylglycerols (such as those in LCT or MCT oils) into
free fatty acids (FFAs) and monoacylglycerols (MAGs).

The digestion products of

lipolysis may accumulate at the oil-water interface or move into the surrounding aqueous
phase depending on their molecular weight and the presence of bile salts, phospholipids,
and calcium [257, 259].

The oil droplet size may therefore change appreciably as a

result of alterations in their internal and interfacial compositions.

One would expect that

the removal of FFA and MAG digestion products from the fat droplet surfaces would
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lead to a reduction in particle size [275, 276].

On the other hand, one would expect that

droplet coalescence promoted by lipid digestion would lead to an increase in droplet size
[275, 276].

Consequently, the overall influence of lipid digestion on fat droplet size

may be complicated.

It should also be noted that particle size measurements made on

complex colloidal systems containing mixtures of different particles (such as those
produced by lipid digestion) should be treated with some caution.

The software used by

commercial particle sizing instruments to analyze light scattering measurements usually
assumes that the particles are spherical, dilute, and have well-defined refractive indices.
In practice, the colloidal suspension resulting from lipid digestion may contain
undigested fat droplets, partially digested fat droplets, mixed micelles and various other
colloidal structures.
6.3.1.2 Influence on particle charge characteristics
Changes in the electrical characteristics of the particles in the emulsions were also
measured after each stage in the simulated gastrointestinal tract to provide some
information about changes in interfacial properties (Figure 6.2).

Initially, all of the oil

droplets coated by quillaja saponin were highly negatively charged (-40 to -46 mV),
which has previously been attributed to the ionization of carboxyl groups (-COO-) on the
saponins at neutral pH [274]. All of the droplets remained highly negative after passage
through the simulated oral stage, although there was some reduction in the magnitude of
their negative charge (Figure 6.2).

The fact that the charge remained highly negative
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can be attributed to the neutral conditions within the mouth, whereas the slight changes in
charge may be due to adsorption of some ionized components from the simulated saliva
to the droplet surfaces, e.g., minerals or mucin [270].
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Figure 6.2 Influence of vitamin E encapsulation and carrier oil type on the electrical
characteristics ζ-potential of the particles in oil-in-water emulsions passed through
different stages of a simulated gastrointestinal tract.

See caption to Figure 6.1a for Key.

The magnitude of the electrical charge on the droplets decreased appreciably after
they were incubated in simulated gastric fluid, and the charge depended somewhat on
carrier oil type (Figure 6.2).

The emulsions containing MCT had a slightly negative

charge (≈ -6 mV), whereas those containing LCT had a slightly positive charge (≈ +0.5
mV).

The origin of this difference in the charge on droplets containing different types
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of oils is currently unknown.

One possible explanation is that the different oils phases

contained different types and concentrations of ionic impurities (such as free fatty acids
or phospholipids).

Previous studies have shown that the electrical charge on oil droplets

coated by quillaja saponin goes from highly negative at pH 7 to close to zero at pH 2,
which was attributed to protonation of the carboxyl groups (-COOH) at pH values below
their pKa values [274]. The low net charge on the oil droplets under gastric conditions
can therefore be largely attributed to this effect.

The fact that there was little change in

the mean particle diameter of the droplets under simulated gastric conditions (Figure
6.1a), suggests that the droplets were still coated by a layer of surface active material that
prevented aggregation.
The electrical charge on the particles in all of the emulsions became strongly
negative after they were incubated within simulated small intestinal fluid, and the charge
depended somewhat on encapsulation of vitamin E and carrier oil type (Figure 6.2).
The negative charge on the droplets in the small intestine can be attributed to a number of
different factors.

First, the quillaja saponin has a relatively high negative charge at

neutral pH [274], so if any of these molecules remained at the particle surfaces they
would impart a negative charge.

Second, the small intestinal fluids contained

phospholipids and bile salts which are anionic surface active substances that may adsorb
to particle surfaces and generate a negative charge.

Third, lipase converts neutral

triacylglycerol molecules into anionic free fatty acids, so if any of these molecules remain
133

at the droplet surfaces they will also produce a negative charge.

As mentioned earlier, it

is not clear exactly what types of particles are detected by an electrophoresis instrument
in a complex medium that contains many different types of charged particles that can
scatter light.
6.3.2 Impact of encapsulation and carrier oil type on lipid digestion
The influence of vitamin E encapsulation and carrier oil type on the rate and
extent of lipid digestion was measured using a pH-stat method. This approach is widely
used by pharmaceutical and food researchers for the in vitro characterization of lipid
digestion under simulated small intestinal conditions [148, 277, 278].

The pH-stat

method measures the amount of alkali (0.25 M NaOH) that had to be titrated into the
digestion mixture to maintain neutral pH after addition of simulated small intestinal fluids
containing lipase, bile salts, and CaCl2.
In general, there was a rapid initial production of free fatty acids during the first
few minutes of the digestion reaction, followed by a more gradual increase at longer
times (Figure 6.3), indicating that lipase was able to rapidly interact with the emulsified
TAGs and convert them into FFAs and MAGs.

Nevertheless, there were some distinct

differences between emulsions prepared using different oil phases: (i). The extent of lipid
digestion was higher for MCT- than LCT-emulsions; (ii) the extent of lipid digestion was
higher for emulsions containing vitamin E than those containing no vitamin E.

A

number of earlier studies have reported that lipids containing medium-chain fatty acids
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are digested more rapidly and extensively than those containing long-chain fatty acids
[257, 259, 279].

A number of physiochemical explanations have been proposed to

account for this phenomenon.

First, medium-chain FFAs have a higher water

dispersibility than long-chain FFAs [257, 259].

Consequently, the medium-chain FFAs

produced during MCT digestion rapidly migrate into the aqueous phase surrounding the
droplets, thereby allowing lipase to continue reacting with undigested MCT molecules
within the oil droplet core. Conversely, the long-chain FFAs produced during LCT
digestion tend to accumulate at the droplet surfaces, thereby inhibiting the ability of
lipase to interact with the undigested LCT molecules within the droplet core [266].
Efficient digestion of LCT requires that there are enough bile salts and free calcium ions
present within the aqueous phase to ensure that the long-chain fatty acids are effectively
removed from the droplet surfaces through solubilization or precipitation [279].

The

fact that the measured FFAs released was higher for the emulsions containing vitamin E
than the equivalent emulsions containing no vitamin E may be attributed to the ability of
lipase to cleave the ester bond of the α-tocopherol acetate molecule, thereby releasing
α-tocopherol (Figure 6.4).

135

120

FFA released (%)

100

80

60

40

MCT
MCT-VE

20

LCT
LCT-VE

0
0

20

40

60

80

100

120

Digestion Time (min)

Figure 6.3 Effect of vitamin E encapsulation and carrier lipid type on rate and extent of
lipid digestion measured using an in vitro digestion model.
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Figure 6.4 Conversion of α-tocopherol-acetate to α-tocopherol during in vitro digestion.
Our results suggest that >100% of FFAs were released from the MCT samples at
longer digestion times (Figure 6.3).

This apparent discrepancy can be attributed to the

way that the percentage of FFAs released from the lipid droplets during in vitro digestion
was calculated.

There are two main assumptions underlying this calculation: (i) only

two FFA molecules are released per TAG molecule; (ii) there are no other components
within the system that release protons during the in vitro digestion process. In practice,
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these assumptions may not be completely valid [269].

Some of the MAGs produced

during digestion may have been further hydrolyzed to FFAs and glycerol, so that more
than two FFA molecules were formed from each initial TAG.

There may have been

other components within the system that produced protons during the digestion reaction
(e.g., proteins, phospholipids, or vitamin E), which would require the addition of extra
alkali to neutralize them.
6.3.3 Impact of carrier oil type on vitamin E bioaccessibility
In this section, we examined the impact of carrier oil type on the bioaccessibility
of vitamin E after passage through the simulated GIT.

After the small intestine stage,

digesta were collected and centrifuged, which led to the formation of two distinct layers:
a white “sediment” phase at the bottom and a watery “micelle” phase above it. Visually,
the micelle phases were either optically transparent (MCT & MCT-VE) or slightly turbid
(LCT & LCT-VE).

The micelle phase was collected and its particle size distribution

was measured before and after filtration.

The bioaccessibility of the vitamin E was

determined by measuring the concentrations of α-tocopherol and α-tocopherol acetate in
the micelle phase and the total digesta using solvent extraction and HPLC.
The particle size distribution of the micelle phase isolated from the digesta of the
LCT-emulsion before and after filtration using a 0.45 µm pore size filter is shown in
Figure 6.5.

In the unfiltered samples, a broad range of differently sized particles was

observed with diameters ranging from around 140 to 5,500 nm, which could have been
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due to the presence of mixed micelles, vesicles, and non-digested oil droplets.

As

expected, there was an appreciable decrease in the number of large particles present in
the micelle phase after filtration.

In practice, the mixed micelles and vesicles containing

lipid digestion products must pass through the mucous layer that coats the epithelium
cells prior to absorption. The mucous layer can be considered to act like a biological
filter, with a critical cut-off point for particle penetration being reported to be around 400
nm [280].

Filtering the micelle layer prior to analysis may therefore provide a more

accurate representation of the potential bioavailability of a lipophilic compound that must
be carried by colloidal structures through the mucous layer to the epithelium cells.

For

this reason, we filtered the micelle phases collected from the digesta prior to further
analysis.
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Figure 6.5 Particle size distribution of the “micelle” phase collected after digestion and
centrifugation of LCT-emulsions. Measurements were made before and after filtration
(0.45 µm pore size) of the micelle phase.
The mean particle diameters and turbidities of the micelle phases collected from
the LCT-emulsions were larger than those collected from the MCT-emulsions (Figure
6.6), which indicates that they contained larger particles.

These larger particles may

have been comprised of non-digested triacylglycerol oil, since the pH-stat measurements
indicated that not all of the LCT was digested after the small intestine stage (Figure 6.3).
Alternatively, they may have been due to the formation of larger colloidal structures by
the LCT digestion products.

The mean droplet diameters were slightly smaller for

emulsions containing vitamin E than for emulsions containing no vitamin E, which
suggested that the presence of this lipophilic molecule altered the structure of the
non-digested oil droplets or the colloidal particles formed from digestion products
(Figure 6.6).
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Figure 6.6 Influence of carrier oil type on the mean particle diameter (measured after
filtration) and appearance of the micelle phase after in vitro digestion.
The concentrations of α-tocopherol acetate and α-tocopherol in the micelle phase
and within the total digesta were measured after in vitro digestion (Figure 6.7).

These

measurements indicated that some of the α-tocopherol acetate was converted to
α-tocopherol during the in vitro digestion process, and that the amount of vitamin E
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solubilized within the micelle phase depended on carrier oil type and the molecular form
of the vitamin E.

The influence of carrier oil type on the overall bioaccessibility of

vitamin E and the total amount of α-tocopherol acetate converted to α-tocopherol is
shown in Figure 6.8.

The overall bioaccessibility of vitamin E was around 17 % when

MCT was used as the carrier oil but around 39 % when LCT was used.

The

solubilization of lipophilic components in the micelle phase usually increases as the total
amount of mixed micelles available increases.

Our lipid digestion experiments

indicated that MCT was actually digested to a greater extent than LCT (Figure 6.3) and
therefore the total concentration of FFAs and MAGs that could form mixed micelles
should have been larger for MCT.

On the other hand, the solubilization capacity of

mixed micelles also depends on the nature of the FFAs and MAGs present.

Long chain

fatty acids can form mixed micelles that have a larger solubilization capacity for some
lipophilic substances than medium chain fatty acids, presumably because they can
accommodate larger non-polar molecules.

Corn oil contains relatively long chain fatty

acids (e.g., C16 and C18) while MCT contains medium chain ones (e.g., C8 and C10),
which would therefore account for the observed difference in solubilization capacity for
vitamin E.

The α-tocopherol molecule has a non-polar chain that is 14 carbon atoms in

length (Figure 6.4).

This non-polar chain may be too long to easily be accommodated

within the monolayers formed by the medium chain fatty acids resulting from MCT
digestion, but it may be able to fit within the monolayers formed by the long chain fatty
141

acids resulting from LCT digestion.

The fact that the colloidal structures were larger in

the LCT-emulsions than in the MCT-emulsions after lipid digestion (Figure 6.6)
provides some support for the differences in the structure of the mixed micelles formed.
Our results are in agreement with research in the pharmaceutical industry that has shown
that many highly lipophilic drugs have a higher bioaccessibility when administered with
LCT than with MCT [281, 282].
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Figure 6.7 Influence of carrier oil type on the concentrations of α-tocopherol and
α-tocopherol acetate within the micelle phase and the total digesta after in vitro digestion
of emulsions.
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Figure 6.8 Influence of carrier oil type on the total bioavailability of Vitamin E
(α-tocopherol + α-tocopherol acetate) and the conversion of α-tocopherol acetate to
α-tocopherol after in vitro digestion of emulsions.
There were appreciable amounts of sediment formed in many of the samples after
centrifugation (Figure 6.6).

This sediment contains dense insoluble matter formed

during the passage of the samples through the simulated gastrointestinal tract, such as
aggregated digestive enzymes, bile salts, minerals, and calcium salts of free fatty acids.
It is possible that some of the vitamin E acetate or vitamin E was trapped within the
sediment phase.
6.3.4 Impact of carrier oil type on α-tocopheryl acetate to α-tocopherol conversion
As mentioned earlier, vitamin E is often used in an esterified form within foods
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and other commercial products because the free form is highly unstable to oxidation [223,
224].

Previous studies suggest that the bioaccessibility of vitamin E may depend on its

molecular form, i.e., α-tocopherol versus α-tocopherol acetate [260-263]. We therefore
calculated the amount of α-tocopherol acetate that had been converted to α-tocopherol
after in vitro digestion (Figure 6.8). Carrier oil type had an appreciable influence on this
process, with the extent of conversion being about 29% for the LCT-emulsion and 17%
for the MCT-emulsion.

This result suggests that the conversion of α-tocopherol acetate

to α-tocopherol occurred more readily when LCT was used as the carrier oil than when
MCT was used.

Interestingly, there was a close correlation between the extent of

conversion and overall vitamin E bioaccessibility (Figure 6.8).

A possible explanation

for this phenomenon is that vitamin E acetate incorporated into mixed micelles is more
susceptible to de-esterification by lipase than vitamin E acetate encapsulated within oil
droplets. The fact that a greater fraction of vitamin E was present within the micelle
phase for the LCT-emulsion would then account for the observed increase in the
hydrolysis of the acetate form.

Alternatively, there may have been a competition

between the triacylglycerol and the vitamin molecules for hydrolysis by lipase. The
MCT molecules were digested more readily than the LCT molecules (Figure 6.3), and
therefore the rate of vitamin E acetate hydrolysis may have been less when MCT
molecules were present in the oil phase due to this competitive effect.
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Table 6.1. Percentage of vitamin E present in the micelle phase after lipid digestion and
centrifugation of the emulsions.
MCT
8.6 ± 0.1
18.9 ± 0.9

Vitamin E
Vitamin E Acetate

LCT
60.3 ± 3.4
29.9 ± 4.3

The data presented in Figure 6.7 was used to calculate the fraction of vitamin E
present in the micelle phase for α-tocopherol and α-tocopherol acetate for both the LCTand MCT-emulsions (Table 6.1).

This data showed that a higher fraction of the free

form (α-tocopherol) was present in the micelle phase than the esterified form
(α-tocopherol acetate) for LCT, but the opposite was true for MCT.

At present the

molecular or physicochemical basis of this phenomenon is unknown, but it may be
related to the compatibility of vitamin E molecules for mixed micelles and other different
kinds of colloidal structures. For example, the removal of the acetate group may change
the interaction of the vitamin E molecule with the polar head groups of the surface-active
molecules that form the palisade layer of the mixed micelles.
6.4 Conclusions
The purpose of this study was to determine the influence of carrier lipid type on
the bioaccessibility and hydrolysis of emulsified α-tocopherol acetate using a simulated
gastrointestinal tract.

We have shown that α-tocopherol acetate can be effectively

encapsulated within oil-in-water emulsions using either medium chain triacylglycerols

145

(MCT) or long chain triacylglycerols (LCT) as a carrier oil.

The rate and extent of lipid

digestion was higher for MCT-emulsions than for LCT-emulsions, which was attributed
to differences in the water dispersibility of the medium and long chain fatty acids formed
during lipolysis.

On the other hand, the total bioaccessibility of vitamin E after

digestion was higher for LCT-emulsions than for MCT-emulsions, which was attributed
to the greater solubilization capacity of mixed micelles formed from long chain fatty
acids due to their ability to better accommodate lipophilic vitamin E molecules.
Moreover, the conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion
was also considerably higher for LCT-emulsions than for MCT-emulsions.
In summary, our results suggest that LCT was a more effective carrier lipid than
MCT for increasing the overall bioaccessibility of emulsified vitamin E.

These results

have important implications for designing effective emulsion-based delivery systems for
oil-soluble vitamins.
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CHAPTER 7
VITAMIN E AND VITAMIN E ACETATE SOLUBILIZATION IN MIXED
MICELLES: PHYSICOCHEMICAL BASIS OF BIOACCESSIBILITY
7.1 Introduction
Vitamin E has various antioxidant and non-antioxidant biological activities that
have been reported to provide health benefits to humans, such as reducing cardiovascular
disease, diabetes, and cancer [244-246]. However, the physiological basis of many of
these claimed health effects have still not been clearly elucidated [246, 247].

Vitamin E

is widely used as an ingredient by the pharmaceutical, food, and supplement industries
due to its perceived health benefits [216, 248].
The expression “vitamin E” actually refers to a class of molecules that have
related chemical structures and biological activities, with the most widely used being
α-tocopherol (Figure 7.1). The incorporation of α-tocopherol into commercial products is
often challenging due to its chemical instability, poor water-solubility, and highly
variable bioavailability [215, 249]. α-Tocopherol is a polyunsaturated lipid that is highly
susceptible to oxidation and it may therefore be lost during the processing, transport,
storage, or utilization of commercial products [223, 224].

Consequently, the esterified

form of α-tocopherol (α-tocopherol acetate) is often used as a source of vitamin E in
pharmaceutical, food, and supplement products because it has better chemical stability
than the free form [250].

Both the free and esterified forms of α-tocopherol are highly
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non-polar molecules that have low water-solubilities, which means they cannot simply be
dispersed within aqueous-based products [163, 251].

Instead, they must be encapsulated

within a suitable delivery system, such as a microemulsion, nanoemulsion, or emulsion
[23, 212, 215].

After a product has been ingested, it is important that the vitamin E has

a high oral bioavailability so that it can deliver its potentially beneficial health effects.
However, the oral bioavailability of vitamin E may vary widely (< 1% to 100%)
depending on the chemical form ingested and the nature of the delivery system used [119,
255].

This wide variability causes problems in determining an appropriate level of

vitamin E to incorporate into a commercial product, and so it is critical to understand the
major factors influencing bioavailability.
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Figure 7.1 Structures of the various molecules used to form mixed micelles in this study.
The oral bioavailability of vitamin E depends on a number of physicochemical
and physiological processes that occur within the human gastrointestinal tract.

Initially,

the vitamin E should be released from the delivery system, then incorporated into “mixed
micelles” in the small intestine, and then transported across the mucus layer where it is
absorbed by epithelium cells [248, 256]. The solubilization of vitamin E into mixed
micelles plays a critical role in determining its overall oral bioavailability.

The term

“mixed micelles” actually refers to a group of different colloidal species that are capable
of solubilizing lipophilic components, such as micelles, vesicles, bilayers, and liquid
crystals [283-285].

Mixed micelles are formed from bile salts and phospholipids

present in the bile and pancreatic juices secreted by the small intestine, as well as from
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any free fatty acids (FFA) and monoacylglycerols (MAG) produced due to hydrolysis of
ingested triacylglycerol molecules by lipase [257].

Studies have shown that the

bioaccessibility of highly lipophilic components tends to increase as the total amount of
mixed micelles available in the small intestine increases, but also depends on the
structural organization of the mixed micelles formed after lipid digestion [257-259].
The chemical form of the vitamin E has also been shown to play an important role in its
bioaccessibility.

Some studies have reported that α-tocopheryl acetate is less

bioaccessible than α-tocopherol [260-263], whereas others have reported little difference
[225].
In a recent study using a simulated gastrointestinal tract model, we found that the
bioaccessibility of vitamin E was higher in emulsions prepared using a long chain
triglyceride (LCT) than those prepared using a medium chain triglyceride (MCT) (Yang
and McClements, 2013).

We also found that the bioaccessibility of α-tocopheryl acetate

was lower than that of α-tocopherol.

These differences were attributed to differences in

the ability of the mixed micelles formed by lipid digestion to solubilize the vitamin E
molecules: long chain fatty acids form larger mixed micelles than medium chain fatty
acids, and can therefore solubilize larger lipophilic molecules; α-tocopheryl acetate is
longer than α-tocopherol and is therefore more difficult to be incorporated into smaller
mixed micelles.

The purpose of the current study was to better understand the role of

the chemical state of vitamin E (α-tocopherol versus α-tocopheryl acetate) and the
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composition of the mixed micelles (bile salts, phospholipids, and fatty acids) on vitamin
bioaccessibility.

A well-defined in vitro model (emulsion titration assay) was used to

quantify the kinetics and extent of vitamin solubilization in mixed micelles so as to
provide a more detailed mechanistic understanding of the physicochemical processes
involved [286, 287].

A number of previous researchers have also used mixed micelle

solutions as model systems for solubilization of lipophilic components, such as free fatty
acids [288], carotenoids [289-291] and vitamin E [154].

The current study should

provide information about the major factors influencing the bioaccessibility of vitamin E
that will facilitate the rational design of more effective delivery systems.
7.2 Materials and methods
7.2.1 Materials
Sodium cholate (NaC), sodium deoxycholate (NaDC), vitamin E, oleic acid, and
linoleic acid (Figure 7.1) were purchased from the Sigma Chemical Company (St. Louis,
MO).

1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased from Avanti

Polar Lipids, Inc. (Alabaster, AL).

All other chemicals used were of analytical grade.

Double distilled water was used for the preparation of all solutions and emulsions.
7.2.2 Mixed micelle solution preparation
7.2.2.1. Optimization of Preparation Method
Initially, a series of experiments was carried out to determine the optimum
method for preparing mixed micelle solutions to use in the emulsion titration assay.
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All

the final mixed micelle solutions contained a bile salt concentration of 20 mM (40%
NaDC and 60% NaC), but they varied in the preparation method used and in the presence
of other constituents: bile salts (BS); phospholipids (PL); long chain fatty acids (LCFA);
medium chain fatty acids (MCFA).
BS: Bile salts (20 mM) were dispersed within an aqueous buffer solution (PBS
buffer, pH 7.0).
BS+PL (After): Phospholipid (1.6 g/L lecithin, lysolecithin, or DOPC) was
dissolved in an organic solvent (methanol ∶	
  chloroform, 1∶1,	
  v/v), placed in a glass flask,
and then the organic solvent was removed by nitrogen evaporation. An aqueous bile
salt solution (20 mM, pH 7.0) was then added to the flask and the system was sonicated
for 30 min.
BS+PL (Before): Phospholipid (1.6 g/L lecithin, lysolecithin, or DOPC) and bile
salt (10 mM) were dissolved in an organic solvent (methanol ∶	
   chloroform, 1∶1,	
   v/v),
placed in a glass flask, and then the organic solvent was removed by evaporation.

An

aqueous bile salt solution (10 mM, pH 7.0) was then added to the flask and the system
was sonicated for 30 min.
BS+PL + LCFA or MCFA (Before). In this case, phospholipid (2 mM, 1.6 g/L
DOPC), bile salt (10 mM) and fatty acid (2 mM, 1.6 g/L linoleic acid or octanoic acid)
were dissolved in an organic solvent (methanol ∶	
  chloroform, 1∶1,	
  v/v), placed in a glass
flask, and then the organic solvent was removed by evaporation.
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An aqueous bile salt

solution (10 mM, pH 7.0) was then added to the flask and the system was sonicated for
30 min.
7.2.2.2. Optimized System
Once an optimum system had been identified, this was used in the remainder of
the studies.

The type and levels of constituents used to prepare the mixed micelle

solutions were based on those previously reported in the literature [292-294], with some
slight modifications as reported below.

First, a solution of 10 mM bile salt (NaC,

NaDC), 2 mM DOPC and 4 mM FAs in chloroform:methanol (1:1, v/v) solvent was
prepared.

The organic solvent was then removed by blowing nitrogen on the sample at

ambient temperature so as to form a thin lipid film on the glass vessel. Phosphate buffer
(10 mM, pH 7.4) was then added to the glass vessel containing the lipid film, and the
resulting mixture was sonicated for 30 min at room temperature, which resulted in the
formation of a transparent aqueous solution containing the mixed micelles.
7.2.3 Vitamin emulsion preparation
Vitamin emulsions were prepared by homogenizing 10 wt% lipid phase (Vitamin
E or Vitamin E acetate) with 90 wt% aqueous phase.

The aqueous phase consisted of

surfactant (2 wt% bile salt) and buffer solution (10 mM sodium phosphate buffer, pH 7.0).
A coarse emulsion premix was prepared by blending the lipid and aqueous phases
together using a high-speed mixer (Bamix, Biospec Products, Bartlesville, OK) for 2 min
at room temperature. Fine vitamin emulsions were formed by passing the coarse
153

emulsions through an air-driven microfluidizer (Microfluidics, Newton, MA, USA).
The coarse emulsions were passed through the homogenization for 4 passes at 9,000 psi.
7.2.4 Particle characterization
The mean particle diameter, particle size distribution, and electrical charge of
mixed micelles were determined.

The mean particle diameter and particle size

distribution were measured using dynamic light scattering (Nano-ZS, Malvern
Instruments, Malvern, UK). The electrical charge (ζ-potential) was determined using
electrophoretic mobility measurements (Nano-ZS, Malvern Instruments, Worcestershire,
UK). Samples were placed in a capillary test tube that was loaded into the instrument.
Samples were equilibrated for 1 min inside the instrument before data were collected
over at least 10 sequential readings and analyzed using the Smoluchowski model.
7.2.5 Emulsion titration assay
An emulsion titration assay [286] was used to quantify the rate and extent of
vitamin solubilization in mixed micelle solutions (Figure 7.2).

Aliquots of vitamin

emulsion were injected into mixed micelle solutions and then the turbidity was measured
over time, or after 3 h storage (mixed micelles containing fatty acids) or overnight
storage (mixed micelles without fatty acids) at room temperature.
7.2.6 Turbidity measurements
Turbidity measurements were used to monitor the solubilization of the injected
vitamin emulsions after they were added to the mixed micelle solutions. The turbidity
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was determined using an UV-visible spectrophotometer at 600 nm (Ultra-spec 3000 pro,
Biochrom Ltd, Cambridge, UK). The turbidity was measured over time after an aliquot of
vitamin E emulsion was added to the micelle solution (solubilization kinetics) or after a
specified storage period.
7.2.7 Optical microscopy measurements
A Nikon optical microscope (Nikon Eclipse 80i, Nikon Instrument Inc., Melville,
NY) with a 40× objective lens was used to capture images of selected emulsion samples.
An aliquot of sample was placed on a glass microscope slide and then a digital image was
captured and stored.
7.2.8 Statistical analysis
All measurements were performed on at least two freshly prepared samples (i.e.,
new samples were prepared for each series of experiments) and were reported as means
and standard deviations.
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Figure 7.2 Schematic representation of emulsion titration assay used to monitor the
solubilization of vitamin droplets in mixed micelle solutions. A: Stock vitamin emulsion
(1 wt% bile salt, 10 wt% vitamin, 89 wt% aqueous phase). B: mixed micelle solution.
Regime I: vitamin concentration < CSat - all vitamin solubilized in swollen micelles;
Regime II: vitamin concentration ≈ CSat - mixture of swollen micelles and
non-dissolved vitamin droplets; Regime III: vitamin concentration > CSat – predominance
of non-dissolved vitamin droplets [295]
7.3 Results and discussion
7.3.1 Influence of preparation method on mixed micelle properties
The purpose of this series of experiments was to determine the most appropriate
method of preparing mixed micelle solutions for studying vitamin solubilization using the
emulsion titration assay.

For this method it is important that the initial mixed micelle
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solution is optically transparent, and so we examined the influence of composition and
preparation method on the formation of clear mixed micelle solutions.
The mixed micelles formed in the human body are compositionally and
structurally complex, and their properties depend strongly on the nature of an ingested
food, particularly the type and amount of lipids present [257, 296].

Mixed micelles

contain bile salts, phospholipids, and cholesterol from the small intestinal fluids, as well
as monoacylglycerols (MAG) and free fatty acids (FFA) from any lipid digestion
products.

These surface-active lipids self-assemble into a “mixed micelle” colloidal

dispersion, which may contain micelles, vesicles, and liquid crystalline phases that vary
in composition, dimensions, and structure [297, 298].
For fundamental studies of the physicochemical phenomenon associated with the
solubilization process it is advantageous to use simulated mixed micelle solutions with
well-defined properties.

A number of different methods of preparing simulated mixed

micelle solutions have been reported in the literature [292-294, 299, 300].

These

methods differ in the types and amounts of constituents used, as well as in the methods
used to prepare the mixed micelles.

The composition of model mixed micelle systems

is usually chosen to be much simpler than that of real mixed micelles for a number of
reasons: (i) to improve the ease and reproducibility of sample preparation; (ii) to facilitate
data interpretation; (iii) to enable comparison of data between different research groups.
Hence, they typically contain one or two bile salt components, a single phospholipid
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component, and a limited number of lipid digestion products (such as FFA and MAG),
rather than a highly complex mixture of many different components.

Previous studies

indicate that the properties of the mixed micelle phase formed also depend on the
preparation method.

In this study, we therefore examined the influence of composition

and preparation method on the formation of mixed micelle solutions.

In particular, we

investigated the influence of order of bile salt addition (before or after solvent
evaporation) and phospholipid type (lecithin, lysolecithin, or DOPC) on the appearance,
particle size, and electrical charge of mixed micelles.
7.3.1.1 Influence of order of addition
Initially, we examined the influence of adding the bile salts to the phospholipids
(lecithin) before or after evaporation of the organic solvent.

In the absence of

phospholipids, the bile salt solution was optically transparent (Figure 7.3a).

When the

bile salt solution was added to a vessel containing dried phospholipids (i.e., after solvent
evaporation), the resulting solution was highly turbid (Figure 7.3a) and contained a
population of relatively large particles, i.e., d > 100 nm (Figure 7.3b). On the other hand,
when the bile salts were mixed with the phospholipids first and then the mixture was
dried (i.e., before evaporation), the resulting solution was fairly clear (Figure 7.3a) and
the majority of particles were relatively small, i.e., d < 10 nm (Figure 7.3b).

These

results indicate that mixing a portion of the bile salts with the phospholipids prior to
solvent evaporation leads to the formation of smaller colloidal particles in the system.
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Presumably, the bile salts and phospholipids intermingled more easily when they were
dispersed in organic solvent and then dried together, thus enabling them to form mixed
micelles upon reconstitution with an aqueous solution.

When the bile salts were added

after the phospholipids had been dried, it may have been difficult for them to be
incorporated into the colloidal structures formed when the phospholipids were rehydrated
(e.g., vesicles).
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Figure 7.3a Electrical characteristics and appearance of mixed micelle solutions formed
by mixing bile salts with phospholipids (lecithin) either after or before evaporation of the
organic solvent.
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Figure 7.3b Particle size distributions (measured by dynamic light scattering) of mixed
micelle solutions formed by mixing bile salts with phospholipids (lecithin) either after or
before evaporation of the organic solvent.
The electrical characteristics of the colloidal structures formed also depended on
the preparation method (Figure 7.3a).

In the absence of phospholipids, the bile salts

had an appreciable negative charge, which can be attributed to the presence of anionic
carboxyl groups (-COO-) [301].

The negative charge on the mixed micelles containing

bile salts and phospholipids (≈ -30 to -40 mV) was appreciably higher than that on the
bile salts alone (≈ -14 mV), which is due to the fact that lecithin contains anionic
components such as phosphatidic acid.

The mixed micelles formed by adding the bile

salts before solvent evaporation were considerably more negatively charged than those
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formed by adding bile salts after solvent evaporation, suggesting that there were some
changes in the structural organization of the ionized groups in the different types of
colloidal particles formed.
Similar results were found when lysolecithin or DOPC were used as the
phospholipid rather than lecithin, i.e., the mixed micelle solutions were turbid and
contained large particles when the bile salts were added before solvent evaporation, but
were clear and contained small particles when the bile salts were added after solvent
evaporation (data not shown).

For this reason, we determined that adding the bile salts

to the phospholipids prior to solvent evaporation was the most suitable approach for
preparing clear mixed micelle solutions.
7.3.1.2 Influence of phospholipid type
We then compared the influence of phospholipid type on the properties of mixed
micelle solutions.

In this case, a fraction of the bile salts were mixed with the

phospholipids before solvent evaporation to facilitate the formation of clear mixed
micelle solutions containing small particles.

Mixed micelle solutions prepared using a

pure phospholipid (DOPC) were less turbid (Figure 7.4a) and contained smaller particles
(Figure 7.4b) than those prepared using either lecithin or lysolecithin.

This

phenomenon may have been due to some water-insoluble impurities in the lecithin and
lysolecithin samples (e.g., triacylglycerols and sterols) that could not easily be
incorporated into the mixed micelle structures [302].
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In addition, lecithin and

lysolecithin contain a number of different types of phospholipids and some of these may
promote the formation of colloidal structures other than simple micelles, e.g.,
phosphatidylethanolamine, phosphatidylinositol, and phosphatidic acid [303].

For this

reason, we concluded that DOPC was the most suitable phospholipid for preparing
transparent mixed micelle solutions.
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Figure 7.4a Influence of phospholipid type on electrical characteristics and appearance
of mixed micelle solutions formed by mixing bile salts and phospholipids (lecithin,
lysolecithin, or DOPC) before solvent evaporation.
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Figure 7.4b Influence of phospholipid type on particle size distributions of mixed
micelle solutions formed by mixing bile salts and phospholipids (lecithin, lysolecithin, or
DOPC) before solvent evaporation.
The electrical characteristics of the colloidal structures formed when bile salts
were added before solvent evaporation also depended on phospholipid type (Figure 7.4a).
Mixed micelles containing lecithin or lysolecithin had relatively high negative charges (≈
-40 to -50 mV), whereas those containing DOPC had much smaller negative charges (≈
-14 mV).

As mentioned earlier, DOPC has a net neutral charge whereas lecithin and

lysolecithin contain anionic phospholipids (such as phosphatidic acid).
7.3.2 Influence of fatty acid type on mixed micelle properties
In a previous study using a simulated gastrointestinal tract (GIT) model, we found
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that the bioaccessibility of vitamin E was considerably higher when it was encapsulated
in emulsions prepared using corn oil (LCT) than in medium chain triglyceride (MCT) oil
(Ying and McClements, 2013).

This difference was attributed to the fact that the mixed

micelles containing long chain fatty acids (LCFA) generated by digestion of corn oil had
a higher solubilization capacity than those formed from the medium chain fatty acids
(MCFA) resulting from digestion of MCT.

One of the main purposes of the present

study was therefore to examine the influence of fatty acid type on the solubilization
properties of mixed micelles.

The dominant fatty acids in corn oil are 18-carbon

unsaturated fatty acids and therefore we used linoleic acid (C18:1) to represent them [304,
305], whereas the dominant fatty acids in MCT are 8- and 10-carbon saturated fatty acids
and therefore we used octanoic acid (C8:0) to represent them [306].

Mixed micelles

were prepared by mixing bile salts, DOPC, and fatty acids in organic solvent, evaporating
the solvent, and then rehydrating them using an aqueous bile salt solution.

All mixed

micelle solutions were passed through a 440 nm filter prior to analysis to mimic passage
through the mucus layer that coats the epithelium cells, since the pore size of the mucus
layer has been determined to be around this dimension [280].
The mean particle diameter and full particle size distribution of mixed micelle
solutions with different compositions were measured (Figures 7.5a and 7.5b).

All the

mixed micelle solutions had a monomodal particle size distribution and contained
relatively small particles (d ≈ 5 nm) suggesting that simple micelles were present (rather
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than vesicles or other colloidal structures).

There was an appreciable increase in the

mean particle diameter of the mixed micelles when both types of free fatty acids were
added to the bile-phospholipid system, with the increase being larger for the long chain
fatty acids (C18:1) than for the medium chain fatty acids (C8:0).

This increase in the

diameter of the micelles may account for the increase in solubilization capacity of mixed
micelles in the presence of free fatty acid digestion products observed using simulated
gastrointestinal models (Yang and McClements, 2013).

Nevertheless, the overall

increase in the mixed micelle size due to the presence of the free fatty acids was
relatively small.

The influence of fatty acid type on the electrical characteristics of the

particles in the mixed micelle solutions were also measured (Figure 7.5c).

The negative

charge on the mixed micelles was appreciably higher in the systems containing fatty
acids (-36 to -40 mV) than in their absence (-15 mV), which can be attributed to the
anionic nature of the free fatty acid head groups (-COO-).
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Figure 7.5b Influence of mixed micelle composition on the mean particle diameter
measured using dynamic light scattering.

Key: BS = bile salts (NaC and NaDC); PL =

phospholipid (DOPC); MCFA = medium chain fatty acid (C8:0); LCFA = large chain
fatty acid (C18:1).
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Figure 7.5c Influence of composition on the electrical characteristics of mixed micelles.
Key: BS = bile salts (NaC and NaDC); PL = phospholipid (DOPC); MCFA = medium
chain fatty acid (C8:0); LCFA = large chain fatty acid (C18:1).
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Figure 7.5d Appearances of mixed micelle solutions with different compositions before
and after one day storage
The mixed micelle solutions containing free fatty acids remained transparent for a
few hours after preparation, but they did become turbid after they were stored overnight
at refrigerated or ambient conditions (Figure 7.5d).

Examination of these samples

using an optical microscope showed that they contained some large liquid crystalline
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structures, suggesting that some self-association of the lipid molecules had occurred
during storage.

Thus, the emulsion titration assay should be carried out within a few

hours of preparing the mixed micelle solutions containing fatty acids to ensure they
remain transparent.
7.3.3 Influence of structure and composition on solubilization capacity of mixed
micelles
Previous research has reported that the presence of mixed micelles in the
intestinal lumen improves the solubility and adsorption of lipophilic bioactive
components [307, 308].

As mentioned earlier, we previously found that vitamin E

(α-tocopherol) and vitamin E acetate (α-tocopheryl acetate) had a higher solubility in
mixed micelles formed from long chain fatty acids than medium chain fatty acids (Yang
and McClements, 2013). In this section, we examined the influence of mixed micelle
structure and compositions on the solubilization of vitamin E and vitamin E acetate in
mixed micelles using the emulsion titration assay.

This method involves titrating

aliquots of vitamin emulsions into an aqueous mixed micelle solution (Figure 7.2), and
then measuring the change in turbidity.
Immediately, after an aliquot of vitamin emulsion was added to the mixed micelle
solution the turbidity was relatively high due to light scattering from the vitamin droplets
(Figure 7.6a).

When the vitamin emulsion was added to a buffer solution (containing

no mixed micelles) the turbidity remained high over time, indicating that no
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solubilization occurred.

However, when the vitamin emulsion was added to a mixed

micelle solution the turbidity decreased over time (Figure 7.6a), indicating that
solubilization occurred, i.e., vitamin molecules moved from the droplets into the mixed
micelles causing a reduction in the number and/or size of the droplets thereby reducing
the degree of light scattering.

The solubilization process was relatively slow, taking

over an hour for the turbidity to reach a final constant level for the vitamin E systems.
The rate and extent of solubilization was slower for the vitamin E acetate systems (data
not shown).

The solubilization process was also confirmed using optical microscopy

measurements.

Immediately after a vitamin emulsion was added to a mixed micelle

solution large fat droplets could be observed, but after 3 hours of solubilization they had
disappeared (Figure 7.6b).
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Figure 7.6a. Change in turbidity over time after 25 µl of vitamin E emulsion was injected
into 3 mL of mixed micelle solutions with different compositions (pH 7.4).
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Figure 7.6b Optical microscopy images of vitamin droplets immediately after injection
into mixed micelle solutions (BS+PL) and after 3 hours.
2.5

Turbidity (cm-1)

2

1.5

1
Buffer
BS
BS+P

0.5

BS+P+MCFA
BS+P+LCFA
0
0

0.05

0.1

0.15

0.2

0.25

VE Acetate Concentration (wt%)

0.3

Figure 7.6c Change in turbidity with increasing vitamin E acetate concentration in mixed
micelle solutions with different compositions.
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Figure 7.6d Change in turbidity with increasing vitamin E acetate concentration in mixed
micelle solutions with different compositions.
The solubilization capacity of the mixed micelle solutions was determined by
measuring the turbidity of solutions containing different types and amounts of vitamin
after overnight storage to ensure that full solubilization had occurred (Figure 7.6c,d).
The solubilization capacity depended on the composition of the mixed micelles as well as
on the molecular form of the vitamin.

For both vitamin E and vitamin E acetate, the

turbidity increased linearly when the fat droplets were added to pure buffer solution (no
mixed micelles), which can be attributed to the fact that no solubilization occurred.
Hence, the amount of light scattering by the mixed systems increased as the fat droplet
concentration increased.

When vitamin E acetate was titrated into any of the mixed
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micelle solutions the increase in turbidity with vitamin concentration was somewhat less
than for titration into pure buffer solution, which suggested that a small amount of the
vitamin was solubilized within the micelles (Figure 7.6c).

On the other hand, when

vitamin E was titrated into the mixed micelle solutions they initially remained transparent
over a range of vitamin concentrations suggesting that all of the vitamin droplets had
dissolved.

Once a certain vitamin concentration was exceeded the turbidity of the

mixed micelle solutions increased, which suggested that the micelles had become
saturated with vitamin and the vitamin droplets no longer dissolved. The vitamin E
concentration where this increase in turbidity was first observed depended on mixed
micelle composition: BS + PL > BS + PL + MCFA ≈ bile + BS + PL + LCFA > BS
(Figure 7.6d).
The maximum solubilization capacity (Csat) of the mixed micelles was estimated
by finding the intersection point of two straight lines drawn through the data at relatively
low and at high vitamin concentrations [295].

The low concentration range included

those solutions where there was little change in turbidity with increasing vitamin,
whereas the high concentration range included those solutions where there was an
approximately linear increase in turbidity with increasing vitamin.

In general, we found

that the solubilization capacity of the mixed micelles was higher for vitamin E than that
for vitamin E acetate (Figure 7.7), which is consistent with our previous experiments
using a simulated GIT model (Yang and McClements, 2013).
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The origin of this effect

can be attributed to the smaller molecular dimensions of the non-esterified form of
α-tocopherol making it easier to be accommodated within the hydrophobic core of the
mixed micelles.

The solubilization of vitamin E acetate in mixed micelles containing

fatty acids was slightly higher than in those containing no fatty acids, which is again in
agreement with our previous studies.

On the other hand, the influence of mixed micelle

composition on the solubilization capacity of vitamin E did not follow the expected trend.
The solubilization capacity was actually higher in the mixed micelles containing bile and
phospholipids than in those containing bile, phospholipids, and fatty acids.

In addition,

the solubilization capacity of the mixed micelles containing LCFAs was fairly similar to
those containing MCFAs, whereas in the simulated GIT experiments we found a
considerably higher bioaccessibility of vitamin E in emulsions prepared using LCFAs
rather than MCFAs (Yang and McClements, 2013).

One reason for this effect may have

been because the mixed micelles containing MCFAs or LCFAS prepared in this study
had fairly similar dimensions (Figure 7.5), and might therefore be expected to
accommodate fairly similar sized lipophilic molecules.

Previous studies have also

reported that the solubilization of α-tocopherol was fairly similar in mixed micelles in the
absence and presence of free fatty acids (MCFAs or LCFAS) [300].
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Figure 7.7 Solubilization capacity of mixed micelle solutions with different compositions
for vitamin E and vitamin E acetate.
There are a number of possible physicochemical mechanisms that might account
for the difference between the results of the emulsion titration assay and experiments
carried out using GIT models.

First, the mixed micelles used in this study contained

free fatty acids (FFA), but they did not contain monoacylglycerols (MAG), which are
also digestion products of triacylglycerols.

Studies in the pharmaceutical industry have

shown that the solubilization of α-tocopherol in mixed micelles containing MAGs was
appreciably higher than mixed micelles containing FFAs [300].

Second, when a GIT

model is used to study the bioaccessibility of lipophilic bioactive components there will
be various other types of colloidal structures formed during lipid digestion, such as
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vesicles and liquid crystals that may play an important role in the solubilization of
oil-soluble vitamins.

Third, in the emulsion titration assay the oil-soluble vitamins must

move from vitamin droplets into micelles, but in the simulated gastrointestinal model the
vitamins are trapped within fat droplets that also contain triacylglycerols that are
hydrolyzed by lipase during the lipid digestion process.

The continuous formation of

FFAs and MAGs at the fat droplets during digestion, and their subsequent movement into
the surrounding aqueous phase, may also play an important role in the solubilization of
oil-soluble vitamins.

Finally, the simulated intestinal fluids used within GIT models

contain various other components that may impact the solubilization process, such as
calcium ions that form insoluble calcium soaps with long chain FFAs [309].

Clearly,

further research is needed to establish the molecular basis for differences in the
solubilization capacities of mixed micelle phases with different compositions and
structures.
7.4 Conclusions
The purpose of this study was to utilize a well-defined model system to determine
the influence of mixed micelle composition and structure on the solubilization of
oil-soluble vitamins.

Initially, we establish an appropriate procedure for preparing

transparent mixed micelle solutions containing bile salts, phospholipids, and free fatty
acids.

Mixed micelle solutions were formed that contained relatively small particles (d

≈ 5 nm) whose precise size depended on system composition.
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An emulsion titration

assay was then used to study the solubilization of vitamin E and vitamin E acetate
emulsions in the mixed micelle solutions.

The solubilization capacity of the mixed

micelle solutions was higher for vitamin E than for vitamin E acetate, which was
attributed to differences in the ability of the vitamin molecules to be incorporated into the
micelle structures.

We did not find a strong influence of free fatty acid type (C8:0 versus

C18:1) on the solubilization capacity of the mixed micelles, which was different from
results obtained using a simulated gastrointestinal model.

This study provides an

improved understanding of the influence of mixed micelle composition and structure on
the solubilization of α-tocopherol and α-tocopheryl acetate, which may be useful for the
design of emulsion-based delivery systems for oil-soluble vitamins.
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CHAPTER 8
ENHANCING VITAMIN E BIOACCESSIBILITY: FACTORS IMPACTING
SOLUBILIZATION AND HYDROLYSIS OF Α-TOCOPHEROL ACETATE
ENCAPSULATED IN EMULSION-BASED DELIVERY SYSTEMS
8.1. Introduction
The term “vitamin E” refers to a group of naturally occurring compounds that
have common molecular, physicochemical, and biological features, with α-tocopherol
being the most biological active form [310].

As well as its important role as an essential

nutrient, vitamin E may also provide additional health benefits, such as reducing
cardiovascular disease, diabetes, and cancer due to its antioxidant and non-antioxidant
biological activities [244, 311, 312].

Vitamin E can also protect lipids in foods against

oxidation due to the ability of α-tocopherol to trap peroxyl radicals, which are responsible
for the initiation of lipid oxidation [87, 88].

The food industry is therefore interested in

fortifying functional foods and beverages with vitamin E due to its antioxidant activity
and potential health benefits [22].

However, the incorporation of α-tocopherol into

many commercial products is a challenge because of its relatively low chemical stability,
water-solubility, and bioavailability [244, 311, 312].
Emulsion-based delivery systems are especially suitable for encapsulating,
protecting and delivering lipophilic bioactive components, such as ω-3 fatty acids,
carotenoids, curcuminoids phytosterols, and oil-soluble vitamins [3, 22, 163].
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A

considerable amount of research has already been carried out to identify the major factors
affecting the bioavailability of lipophilic bioactive molecules encapsulated within
emulsion-based delivery systems, such as particle size, physical state, and interfacial
properties [313-316].

It is important that any encapsulated bioactive component has a

high oral bioavailability so that it can effectively deliver its health benefits after ingestion.
However, a number of physicochemical and physiological processes occur within the
human gastrointestinal tract that impact the oral bioavailability of lipophilic vitamins
[275, 276].

After ingestion, vitamin E is usually released from the food matrix,

solubilized within mixed micelles in the small intestine, and then transported to the
epithelium cells where it is absorbed [256, 317].

Mixed micelles are complex colloidal

structures formed from bile salts and phospholipids present in the intestinal fluids, as well
as free fatty acids and monoacylglycerols generated by lipid hydrolysis.

The

bioaccessibility of oil-soluble nutraceuticals, vitamins and drugs has previously been
shown to increase when the amount of mixed micelles present within the intestinal fluids
increases, which typically occurs as the amount of co-ingested digestible lipids
(triacylglycerols) increases [257, 296]. The bioaccessibility also depends on the nature of
the mixed micelles formed after lipid digestion, i.e., the composition and nature of the
colloidal structures formed [257-259].

Indeed, highly lipophilic components

encapsulated using delivery systems containing long chain triglycerides (LCT) have been
reported to have a higher bioaccessibility than those containing medium chain
180

triglycerides (MCT) (Figure 8.1), which can be attributed to the ability of the mixed
micelles formed by LCT to incorporate larger lipophilic molecules [318, 319].
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Figure 8.1 Structures of long chain triglyceride (glyceryl trioleate, C18:1) and medium
chain triglyceride (glyceryl trioctanoate, C8:0) used in this study
The chemical form of the vitamin E present within a food or beverage product
also influences its bioavailability.

Vitamin E is often incorporated into foods in an

esterified form (α-tocopherol acetate) because it has a higher chemical stability than the
non-esterified form (α-tocopherol) [250].

However, the esterified form of vitamin E has

a lower bioaccessibility than the free form, presumably because it is more difficult to
incorporate into mixed micelles [260-263].

Consequently, the bioavailability of vitamin
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E would be increased if there were greater conversion of α-tocopherol acetate to
α-tocopherol in the gastrointestinal tract due to the presence of digestive enzymes.
Numerous factors influence the digestion of emulsified triglycerides by
pancreatic lipase and the subsequent formation of mixed micelles, including droplet
surface area, interfacial composition, carrier oil type, calcium ions, bile salts, and
phospholipids [271, 279, 320].

Calcium ions have been identified as playing a

particularly important role in the digestion of emulsified LCTs.

In the absence of

calcium, long-chain free fatty acids (FFAs) accumulate at the oil-water interface and
inhibit further lipid digestion, presumably by preventing lipase from reaching
non-digested lipids at the core of the emulsion droplets [321].

The presence of calcium

ions facilitates lipid digestion due to the formation of insoluble calcium soaps that
remove long-chain FFAs from the emulsion droplet surfaces, thereby allowing the lipase
to remain in close contact with the non-digested lipids [322-327].

One might expect the

bioaccessibility of oil-soluble vitamins to increase in the presence of calcium ions since
then more LCTs would be digested, leading to the release of more vitamin molecules
from the lipid droplets and to the formation of more mixed micelles capable of
solubilizing them.

On the other hand, calcium ions may interact with mixed micelles

and form insoluble complexes that actually reduce the bioaccessibility of oil-soluble
vitamins by preventing them from being absorbed [328].

The rate and extent of lipid

digestion in emulsion-based delivery systems comprised of MCT (rather than LCT) have
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been shown to be much less sensitive to calcium ions [271].

Research is therefore

needed to determine the potential effect of carrier oil type and calcium ions on the
bioaccessibility of emulsified oil-soluble vitamins.
In a recent study using a simulated gastrointestinal tract (GIT) model, we found
that the bioaccessibility of vitamin E was higher in emulsions prepared using LCTs than
in those prepared using MCTs [318].

The LCT (corn oil) and MCT used in that study

were food-grade oils containing a mixture of different triacylglycerols.

In a follow up

study, we used model mixed micelles assembled from well-defined fatty acids (C8:0 or
C18:1) to provide further insights into the impact of MCT and LCT digestion products on
vitamin E solubilization [329]. However, we did not find an appreciable difference
between the vitamin E solubilization capacity of mixed micelles prepared from C8:0 or
C18:1.

The apparent discrepancy between these two studies may have been due to

differences in the nature of the lipids used or due to differences in the simulated
gastrointestinal conditions used.
The purpose of the current study was therefore to use a simulated GIT model to
establish the influence of carrier oil type (C8:0 versus C18:1) and small intestinal
composition (bile, calcium, and phospholipids) on the bioaccessibility of emulsified
vitamin E. The information gained from this study will be useful for designing more
effective emulsion-based delivery systems for these important lipophilic bioactive
components.
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8.2 Materials and methods
8.2.1 Materials
Sodium cholate (NaC), sodium deoxycholate (NaDC), glyceryl trioleate, and
glyceryl trioctanoate were purchased from the Sigma Chemical Company (St. Louis,
MO). 1, 2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased from Avanti
Polar Lipids, Inc. (Alabaster, AL).

Vitamin E acetate was kindly supplied by BASF

(Florham Park, NJ). Lipases from porcine pancreas pancreatin and bile extract (porcine)
were also obtained from the Sigma Chemical Company (St. Louis, MO).
chemicals used were of analytical grade.

All other

Double distilled water was used for the

preparation of all solutions and emulsions.
8.2.2 Vitamin E emulsion preparation
Vitamin E emulsions were prepared by homogenizing 2.5 wt% lipid phase
(Vitamin E acetate : triacylglycerol = 1:1) with 97.5 wt% aqueous phase.

The aqueous

phase was comprised of surfactant (0.5 wt% bile salt) and buffer solution (10 mM sodium
phosphate buffer, pH 7.0).

A coarse emulsion premix was prepared by blending the

lipid and aqueous phases together using a high-speed mixer (Bamix, Biospec Products,
Bartlesville, OK) for 2 min at room temperature.

Fine vitamin E emulsions were

formed by passing the coarse emulsions through an air-driven microfluidizer
(Microfluidics, Newton, MA, USA).

The coarse emulsions were passed through the

homogenizer for 4 passes at 9,000 psi.
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8.2.3 Particle characterization
Mean particle sizes and particle size distributions of initial emulsions and
samples exposed to GIT conditions were measured using static light scattering
(Mastersizer 2000, Malvern Instruments, Malvern, UK), while their electrical charge
(ζ-potential) was measuring by electrophoretic mobility (Nano-ZS, Malvern Instruments,
Worcestershire, UK).

The mean particle diameter, particle size distribution, and

electrical charge of mixed micelles were determined by dynamic light scattering and
electrophoretic mobility (Nano-ZS, Malvern Instruments, Malvern, UK).

Samples were

equilibrated for 1 min inside the instrument before data were collected over at least 10
sequential readings and analyzed using the Smoluchowski model.
8.2.4 In vitro small intestine digestion
Each emulsion sample was passed through a simulated small intestine model.
Samples (10 ml) were added to a clean beaker, mixed with 20 mL pH 7.0 PBS buffer and
then incubated in a water bath (37 ºC) for 10 min, and then adjusted to pH 7 using NaOH
solution (range from 0.05 to 1 M).

The mixture was then incubated for 2 h at 37 ºC with

simulated small intestinal fluids (SSIF) of different compositions (Table 8.1). SSIFs with
five different compositions were prepared: bile extract without CaCl2; bile extract with
CaCl2; bile salts (NaC and NaDC) without CaCl2; bile salts (NaC and NaDC) with CaCl2;
bile salts (NaC and NaDC) with CaCl2 and DOPC. A pH-stat (Metrohm, USA Inc.) was
used to monitor and control the pH (at pH 7.0) of the digestion solution after the sample
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and SSIF were mixed [271].

The amount of alkali solution (0.25 M NaOH) that had to

be added to the reaction chamber to maintain the pH at 7.0 was recorded, and used to
determine the percentage of free fatty acids (FFA) released from the system (McClements
& Li, 2010a).

A control (containing bile salts but no oil) was run under the same

conditions as the samples, and the amount of alkali titrated into the reaction chamber for
the control was subtracted from that for the samples before calculating the FFA released.
Samples were also taken for physicochemical and structural characterization after 2 h
incubation in the small intestinal stage.
Table 8.1 Compositions of the simulated small intestinal fluids (SSIFs) used in the study:
NaC

=

sodium

cholate;

NaDC

=

sodium

deoxycholate;

DOPC

=

1,

2-dioleoyl-sn-glycero-3-phosphocholine (phospholipid).
SSIF
Bile Extract
Bile Extract
& Ca

2+

Bile Salts
Bile Salts &
Ca

2+

Bile Extract
4 mL (187.5
mg)
4 mL (187.5
mg)
0

0

Bile Salts &
Ca2+ &
DOPC

0

NaC

NaDC

DOPC

CaCl2

0

0

0

0

0

0

0

4 mL (73.22 mg NaC and
114.06 mg NaDC)
4 mL (73.22 mg NaC and

0

Lipase
2.5 mL (60
mg)

1m L (110

2.5 mL (60

mg)

mg)

0

2.5 mL (60
mg)

1m L (110

2.5 mL (60

mg)

mg)

4 mL (73.22 mg NaC, 114.06 mg NaDC and

1m L (110

2.5 mL (60

36 mg DOPC)

mg)

mg)

114.06 mg NaDC)
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8.2.5. Bioaccessibility determination
Vitamin E is solubilized within mixed micelles consisting present in the
intestinal lumen before uptake into intestinal epithelial cells [330].

The fraction of

lipophilic bioactive compounds solubilized within the mixed micelle phase is usually
regarded as the bioaccessibility [119, 331].

The bioaccessibility of vitamin E was

determined using a method described previously [318].

Briefly, the digesta resulting

from small intestine digestion of the samples was collected and then centrifuged (4000
rpm; CL10 centrifuge, Thermo Scientific, Waltham, MA, USA) at 25 ºC for 40 min.
Samples after centrifugation separated into an optically opaque sediment phase at the
bottom, a relatively clear aqueous phase in the middle, and sometimes a thin oily or
creamed phase at the top.

The middle phase was assumed to be the “micelle” phase that

solubilized the vitamin E.

Vitamin E was extracted from the middle phase using an

organic solvent mixture (1:3 isopropanol and isooctane) at 1:5 and then centrifuged at
1750 rpm for another 10 min.

1 mL of the top layer was removed and dried using

nitrogen evaporation and stored in the -80 ºC refrigerator prior to further analysis.
Before detection by HPLC, samples were dissolved in 200 µL methanol.

The vitamin E

concentrations in the samples were determined using HPLC (Shimadzu, Kyoto, Japan). A
C18 reverse phase column (150 - 4.6 mm, 5 µm, Beckman Coulter) was used for the
chromatographic separation of α-tocopherol acetate and α-tocopherol.
the mobile phase was 1.0 ml/min.

The flow rate of

An isocratic elution was carried out using
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HPLC-grade solvent (95% methanol and 5% double distilled water containing 0.5 %
phosphoric acid).

The α-tocopherol acetate and α-tocopherol contents were determined

using a PDA detector at 295 nm. Tocopherol quantification was determined using
external standards.

The overall bioaccessibility of vitamin E was estimated using the

following expression:

Bioaccessibility =

Cmicelle
× 100%
CTotal

Here Cmicelle and CTotal represent the total concentration of vitamin E (α-tocopherol
acetate + α-tocopherol) in the micelle phase and in the overall system after digestion,
respectively.

The percentage of specific forms of vitamin E solubilized within the

micelle phase was also calculated using the same expression, but for α-tocopherol acetate
and for a-tocopherol separately.

The conversion of α-tocopherol acetate to α-tocopherol

in the overall system after digestion was calculated from the following expression:

Conversion =

CVE
× 100%
CTotal

Here CVE and CTotal represent the concentration of α-tocopherol and the total
concentration of vitamin E (α-tocopherol acetate + α-tocopherol) in the overall system
after digestion, respectively. A preliminary experiment was carried out to estimate the
recovery of the total tocopherols using the solvent extraction and HPLC analysis method
described above. The recovery of the total tocopherols (VE + VE acetate) was always >
90%, which indicates that the methods used were appropriate.
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8.2.8 Statistical analysis
All measurements were performed on at least two freshly prepared samples (i.e.,
new samples were prepared for each series of experiments) and were reported as means
and standard deviations.
8.3 Results and discussion
8.3.1 Impact of SSIF composition and carrier oil on gastrointestinal fate of
emulsions
Initially, we studied the influence of SSIF composition and carrier oil type on the
potential gastrointestinal fate of emulsion-based delivery systems using a simulated small
intestine model (pH-stat).

Vitamin-fortified emulsions containing 2.5 wt% lipid phase

were produced using either long chain triglycerides (C18:1) or medium chain
triglycerides (C8:0) as carrier oil.

The emulsions were then mixed with SSIFs with

different compositions: bile extract (with and without CaCl2); pure bile salts (with and
without CaCl2); and, pure bile salts with CaCl2 and phospholipids (DOPC).

The

influence of SSIF composition and carrier oil type on particle characteristics after
digestion were then measured.
8.3.1.1 Influence on particle size
For both MCT-VE and LCT-emulsions, the initial systems (before digestion)
had monomodal particle size distributions (PSDs) and relatively small mean particle
diameters (d = 140-150 nm) (Figures 8.3a-c).
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The properties of the vitamin-fortified

emulsions were also measured after they were exposed to the simulated small intestinal
model: mean particle diameters (Figure 8.3a) and PSDs (Figures 8.3b and 8.3c).
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Figure 8.2 Structures of the various molecules used for the simulated small intestine fluid
(SIF) in this study: Sodium cholate (NaC); Sodium deoxycholate (NaDC) and
phospholipid (DOPC).
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Figure 8.3a Influence of carrier oil type and simulated small intestine fluid composition
on the mean particle diameter (d32) of oil-in-water emulsions after passing through a
simulated small intestine tract.
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Figure 8.3b Influence of carrier oil type and simulated small intestine fluid composition
on the particle size distribution of MCT-VE emulsions passing through the simulated
small intestine tract.
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Figure 8.3c Influence of carrier oil type and simulated small intestine fluid composition
on the particle size distribution of LCT-VE emulsions passing through the simulated
small intestine tract.
After passage through the simulated small intestinal stages, the mean particle
diameters of all samples increased and there was evidence of large particles in the PSDs
(Figures 8.3a-c).

The composition of the simulated small intestinal fluids (SSIFs) had a

pronounced influence on the particle size of the emulsions after digestion.

The presence

of bile extract in the SSIF caused little change in particle size, but the presence of pure
bile salts (NaC and NaDC) caused an appreciable increase in particle size.

The presence

of calcium ions in the SSIFs caused a large increase in mean particle diameter (Figure
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8.2a) and there was evidence of large particles in the PSDs for both MCT- and
LCT-emulsions (Figures 8.2b and 8.2c).

The presence of these large particles indicates

a marked change in the structure of the systems after exposure to small intestinal
conditions, which may be due to several physicochemical phenomena.

The pancreatic

lipase in the SSIFs will adsorb to the lipid droplet surfaces and convert the
triacylglycerols (TAGs) into free fatty acids (FFAs) and monoacylglycerols (MAGs).
The products of lipid hydrolysis may move into the surrounding aqueous phase or remain
at the droplet surfaces depending on their water-dispersibility, which is related to their
chain length [257, 259].

Long chain FFAs tend to remain at the droplet surface (in the

absence of bile salts or calcium), whereas short and medium chain FFAs tend to move
into the aqueous phase.

Lipid digestion may therefore reduce the size of the initial lipid

droplets due to removal of FFA and MAG digestion products from their surfaces [275,
276].

On the other hand, partially digested lipid droplets may be more prone to droplet

coalescence due to the change in their interfacial properties, which would lead to an
increase in particle size [275, 276].

It should also be noted that the light scattering

instrument is sensitive to all kinds of particles that scatter light within the sample, which
includes any mixed micelles or insoluble calcium complexes formed after digestion
[327].
The measured particle size did not change much after MCT-VE or
LCT-emulsions were exposed to SSIFs in the absence of calcium, regardless of whether
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bile extract or pure bile salts were used (Figures 8.3a-c).

This may have occurred

because some of the lipid droplets were not digested and retained their original size, but
this is unlikely since the pH-stat measurements (described below) indicated that lipid
digestion had occurred.

It is therefore possible that the mixed micelles formed by lipid

digestion were of a similar size to the original lipid droplets in the system.
In general, the droplet sizes were appreciably larger when the SSIFs contained
bile salts than when they contain bile extract (Figure 8.3a).

Bile extract from porcine is

a complex mixture that contains various bile salts, phospholipids and other components,
whereas the bile salts only contained pure NaC and NaDC.

Hence, the concentration of

actual bile salts in the system would be higher for the pure bile salts than for the bile
extract, which may have led to the formation of more insoluble complexes with calcium.
In addition, the mixed micelles formed by pure bile salts may have been larger than those
formed by bile extract.
Another complication associated with interpreting the results of light scattering
measurements in complex colloidal dispersions is associated with data analysis.

The

software used to calculate the particle size distribution of a colloidal dispersion from its
light scattering pattern usually assumes that the particles are spherical, dilute, and have
well-defined refractive indices.

However, the colloidal dispersions resulting from lipid

digestion contain a complex mixture of particles with different compositions and
structures, such as undigested lipid droplets, partially digested lipid droplets, micelles,
195

vesicles, and various other colloidal structures. Light scattering results should therefore
be treated with some caution for this type of complex colloidal dispersion.
8.3.1.2 Influence on particle charge characteristics
In this section, changes in the electrical charge on the particles in the samples
after digestion were measured to provide some information about possible changes in
interfacial composition (Figure 8.4).

Initially, all of the oil droplets coated by bile salts

were highly negatively charged (-61.6 mV for MCT emulsions and -63.7 mV for LCT
emulsions), which can be attributed to ionization of the bile salts.

At neutral pH, bile

salts have an appreciable negative charge due to the presence of anionic carboxyl groups,
i.e., -COO- [301].

The particles in all the samples were negative after exposure to the

simulated small intestine stage, although there was some reduction in the magnitude of
their negative charge (Figure 8.4).

The negative charge on the particles may be a result

of some of the initial bile salts remaining at the droplet surfaces, as well as due to the
absorption of other anionic surface active species from the digestion medium. The
reduction in droplet charge may have been because some of the bile salts were displaced
by FFAs or because of the increase in ionic strength in the system [332].
The charge on the particles present in the digesta was less negative in the
presence of calcium ions (-21 to -32 mV) than in their absence (-44 to -52 mV) for both
carrier oil types, which can be attributed to binding of cationic Ca2+ ions to the surfaces
of the anionic droplets and mixed micelles, as well as some electrostatic screening effects
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[332].

The negative charge was higher on the particles present in LCT-emulsions than

those present in MCT-emulsions after digestion (Figure 8.4) which may be due to the
fact that glyceryl trioleate contains long chain fatty acids (C18:1) that accumulate at
oil-water interfaces, whereas glyceryl trioctanoate contains medium chain fatty acids
(C8:0) that tend to move into the surrounding aqueous phase [333].
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Figure 8.4 Influence of carrier oil type and SSIF composition on the electrical
characteristics (ζ-potential) of the particles in oil-in-water emulsions passed through
simulated small intestine.
It should be noted that it is not clear exactly what types of particles are detected
by an electrophoresis instrument in a complex colloidal dispersion that contains different
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types of charged particles that scatter light.

Moreover, since measurements were made

on diluted and stirred samples, the nature of the particles in the measurement cells might
be different from the particles in the original undiluted samples.

One should therefore

be cautious when interpreting the results from electrophoresis measurements on this type
of complex colloidal dispersion.
8.3.2 Impact of SSIF composition and carrier oil type on lipid digestion
In this part of the study, the influence of carrier oil type and SSIF composition
on the rate and extent of lipid digestion was measured using the pH-stat method, which is
widely used in pharmaceutical and food research for this purpose [271, 277, 322,
334-337].

The principle of the pH-stat method is to measure the volume of alkaline

solution (0.25 M NaOH) required to neutralize the free fatty acids (FFAs) released from a
sample when incubated in SSIFs containing lipase.

This information is then used to

calculate the percentage of FFAs released from the sample, assuming that a maximum of
two FFAs are released per triglyceride molecule.
Generally, there was a rapid initial increase in the volume of NaOH added to the
emulsions during the first few minutes of incubation in SSIFs, followed by a more
gradual increase at longer times (Figure 8.5).

This result suggests that lipases in the

SSIFs were able to quickly adsorb to the lipid droplet surfaces and convert encapsulated
TAGs into FFAs and MAGs. Nevertheless, vitamin-fortified emulsions prepared using
different types of carrier oil exhibited quite different behavior.
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In the absence of

calcium, the rate and extent of lipid digestion was appreciably higher for MCT-emulsions
than for LCT-emulsions (Figure 8.5e), which is in good agreement with previous studies
[257, 259, 279]. As mentioned earlier, long-chain FFAs accumulate at lipid droplet
surfaces in the absence of calcium ions [333], which inhibits digestion by preventing
lipase molecules from reaching non-digested TAGs at the core of the lipid droplets [321].
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Figure 8.5a Effect of calcium (CaCl2) on the rate and extent of lipid digestion in
MCT-VE emulsions determined using a pH-stat method with SSIF containing bile extract
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Figure 8.5b Effect of calcium (CaCl2) and phospholipids (DOPC) on the rate and extent
of lipid digestion in MCT-VE emulsions determined using a pH-stat method with SSIF
containing pure bile salts (NaC and NaDC).
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Figure 8.5c Effect of calcium (CaCl2) on the rate and extent of lipid digestion in
LCT-VE emulsions determined using a pH-stat method with SSIF containing bile extract.
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Figure 8.5d Effect of calcium (CaCl2) and phospholipids (DOPC) on the rate and extent
of lipid digestion in LCT-VE emulsions determined using a pH-stat method with SSIF
containing pure bile salts (NaC and NaDC).
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Figure 8.5e Influence of carrier oil type and bile salt type on the rate and extent of lipid
digestion in vitamin E fortified emulsions measured using a pH-stat method.

The SSIFs

all contained calcium.
The influence of calcium and phospholipid addition on the titration of FFAs
during in vitro digestion was also studied (Figure 8.5).

For MCT-emulsions, the

presence of calcium ions in the SSIF did not cause an appreciable alteration in lipid
digestion (Figures 8.5a and 8.5b).

However, for LCT-emulsions, the addition of

calcium ions led to an appreciable increase in the final amount of lipid digestion products
generated (Figures 8.5c and 8.5d).

These measurements clearly show that calcium ions
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have a major impact on lipid digestion in LCT-emulsions but not in MCT-emulsions,
which is in agreement with previous research [327].
number of physicochemical mechanisms.

This result may be explained by a

First, a certain amount of calcium is required

as a co-factor to activate pancreatic lipase [338, 339].

Thus, the lower extent of FFA

production in the absence of calcium may be partly due to the fact that the enzyme was
not in its most active form. However, this is unlikely to be important because lipid
digestion still occurred in the MCT-emulsions in the absence of calcium.

Second,

calcium ions bind to long-chain FFAs generated during the digestion of emulsified LCT
and form insoluble calcium soaps that remove them from the droplet surfaces [322, 323,
326, 327].

The precipitation of these long-chain fatty acids enables lipase molecules to

come into close contact with the remaining non-digested lipids and facilitate their
digestion [340].

The digestion of emulsified MCT is less dependent on calcium ions

because the lipid digestion products (medium-chain FFAs) are more water-dispersible
and rapidly move into the surrounding aqueous phase, thereby enabling lipase to continue
operating at the droplet surfaces.

Calcium ions may also impact lipid digestion by

affecting other characteristics of emulsions, such as droplet aggregation [341, 342].
Anionic lipid droplets may become flocculated in the presence of cationic calcium ions
due to ion binding and electrostatic scattering screening effects, which may reduce the
ability of lipase to interact with the lipid droplet surfaces [145, 343].
For both MCT-VE and LCT-emulsions, the addition of phospholipids (DOPC)
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into the SSIFs increased the final extent of lipid digestion.

This may have occurred

because phospholipids facilitated the ability of the lipase to interact with the emulsified
TAGs, or because the phospholipids were themselves hydrolyzed and released FFAs.
Based on the amount of DOPC (36 mg) present in the SSIF, and the assumption that one
FFA is released per phospholipid molecule, we calculated that about 1.8 mL of 0.25 M
NaOH would be required to neutralize any fatty acids produced due to phospholipid
hydrolysis.

This value is quite close to the difference between the volumes of NaOH

required to neutralize calcium-containing samples in the presence and absence of DOPC
(Figures 8.5b and 8.5d).

We therefore conclude that the increased amount of alkali

required for the samples containing DOPC is mainly due to the hydrolysis of the
phospholipid by digestive enzymes in the SSIFs.
8.3.3 Impact of SSIF composition and carrier oil type on vitamin E bioaccessibility
The impact of SSIF composition and carrier oil type on the bioaccessibility of
vitamin E after passage through the simulated small intestine was also examined.

The

bioaccessibility was determined by incubating the emulsions in SSIFs for 2 hours,
centrifuging the resulting digesta, and then determining the concentration of vitamin E in
the micelle phase and overall digesta using HPLC.
The overall appearance of the digesta after exposure to SSIFs depended on
calcium content (Figure 8.6).

In the absence of calcium, samples separated into a thick

white layer at the top (“cream”), a clear or slightly turbid layer in the middle (“micelle
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phase”), and a thin white layer at the bottom (“sediment”).

The white layer at the top

probably consisted of non-digested fat droplets and possibly some large mixed micelle
structures (which are less dense than water), while the white layer at the bottom probably
contained insoluble matter such as bile salt or protein complexes (which are denser than
water).

In the presence of calcium, we only observed a single white layer (“sediment”)

at the bottom of the samples with a clear or slightly turbid layer above (“micelle phase”).
The fact that a cream layer was not observed in the samples containing calcium can be
attributed to two factors. First, calcium promoted digestion of the lipid phase (Figure
8.5), and so there would be less non-digested lipid droplets present.

Second, cationic

calcium ions (Ca2+) formed dense insoluble aggregates with anionic species, such as bile
salts and free fatty acids, which sedimented to the bottom of the tubes.
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Figure 8.6 Influence of carrier oil type and SSIF composition on the appearance of the
micelle phase after in vitro digestion of vitamin E fortified emulsions.
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Figure 8.7 Influence of carrier oil type and SSIF composition on the mean particle
diameter of the micelle phase after in vitro digestion of vitamin E fortified emulsions.
The samples were filtered using a 450 nm filter prior to analysis to simulate passage
through the mucus layer.
The mixed micelles formed in the human body are compositionally and
structurally complex colloidal dispersions whose properties depend on the nature of any
co-ingested lipids [257, 296].

Mixed micelles contain bile salts, phospholipids, and

cholesterol from the small intestinal fluids, as well as monoacylglycerols (MAG) and free

206

fatty acids (FFAs) from any lipid digestion products.

These surface-active lipids

self-assemble into the mixed micelle phase, which may contain micelles, vesicles, and
liquid crystalline phases that vary in composition, dimensions, and structure [297, 298].
The micelle phase was therefore passed through a 450 nm pore size filter before
measuring the bioaccessibility to more closely simulate gastrointestinal conditions [280,
344].

Lipophilic bioactive components solubilized within mixed micelles must pass

through the mucus layer before they can be absorbed by the human body.

The mucus

layer acts as a biological filter that only allows particles smaller than about 400 nm to
pass through [280].

Filtering the micelle layer prior to analysis may therefore provide a

more accurate representation of the potential bioavailability of a lipophilic compound that
needs to be transported by mixed micelles through the mucus layer.
In the presence of calcium ions, the size of the particles in the micelle phases
collected from the LCT-emulsions were slightly larger than those collected from the
MCT-emulsions (Figures 8.7), which suggests that that the colloidal structures in the
micelle phase formed by LCT digestion products were larger than these formed by MCT
digestion products.
The nature of the bile salts present in the SSIFs also had an influence on the size
of the structures formed in the mixed micelle phase. The particle size was larger when the
SSIF contained bile extract, than when it contained pure bile salts (Figure 8.7).

Bile

extract contains a mixture of bile salts, phospholipids, and other components [327, 345],
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which may have led to the formation of larger mixed micelles.

Indeed, when

phospholipids (DOPC) were added to the SSIF containing bile salts and calcium ions
there was an appreciable increase in the size of the colloidal structures present in the
micelle phase (Figure 8.7).

In addition, bile extract may have contained some insoluble

matter that also contributed to the light scattering signal.
The bioaccessibility of the vitamin E was determined by measuring the
concentrations of α-tocopherol acetate and α-tocopherol in the micelle phase and within
the total digesta after in vitro digestion (Figure 8.8).

Calcium ions had a major impact

on the bioaccessibility of vitamin E, which depended strongly on the nature of the carrier
oil used.

For the MCT-emulsions, the addition of calcium ions to the SSIF led to an

appreciable decrease in the bioaccessibility of vitamin E, regardless of the nature of bile
salts used.

For example, the vitamin bioaccessibility decreased from around 24% to 9%

when calcium was added to SSIFs containing bile extract, whereas it decreased from
around 31% to 1% when calcium was to SSIFs containing pure bile salts.

It is possible

that cationic calcium ions formed insoluble precipitates with mixed micelles containing
solubilized vitamin E, thereby reducing the amount of vitamin E present within the
micelle phase.

Conversely, for the LCT-emulsions, the addition of calcium ions to the

SSIF led to an appreciable increase in the bioaccessibility of vitamin E.

For example,

the vitamin bioaccessibility increased from around 22% to 32% when calcium was added
to SSIFs containing bile extract, whereas it increased from around 11% to 37% when
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calcium was to SSIFs containing pure bile salts.

In addition, there was a further

increase (to around 66%) when phospholipids (DOPC) were incorporated into the SSIFs
for the LCT-emulsions. Previous researchers have also reported that phospholipids can
increase the bioavailability of lipophilic bioactive components [346-349].

The

solubilization of lipophilic components in the micelle phase usually depends on the total
amount of mixed micelles available for transporting them across the mucus layer.

Our

pH-stat experiments show that a higher amount of lipid digestion products (FFAs and
MAGs) are formed when calcium is present during the digestion of LCT-emulsions, and
so there should be a greater amount of mixed micelles present to solubilize the vitamin E.
In addition, a greater amount of vitamin E should have been released from the lipid
droplets when more TAGs were digested.

The addition of calcium ions to the

LCT-emulsions may therefore increase the amount of vitamin E in the mixed micelle
phase.

Nevertheless, one might still expect the calcium ions to cause some precipitation

of the mixed micelles (as with the MCT-emulsions), which would reduce the amount of
vitamin E in the micelle phase. Our results suggest that the greater release of vitamin E
from the lipid droplets and the higher amount of mixed micelles formed in the presence
of calcium, outweigh the precipitation effect for the LCT-emulsions.

These results may

have important implications for the design of effective emulsion-based delivery systems
for vitamin E.

Calcium is normally present within the fluids secreted by the human

gastrointestinal tract.

This calcium may reduce the bioavailability of vitamin E
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delivered in MCT-emulsions, which might be overcome by incorporating some calcium
chelating agents in the delivery system (such as EDTA or alginate).

On the other hand,

calcium may increase the bioavailability of LCT-emulsions, and therefore it may be
advantageous to avoid the presence of calcium chelating agents in these delivery systems
or to supplement them with additional calcium.
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Figure 8.8 Influence of carrier oil type and simulated small intestine fluid composition
on the overall bioaccessibility of Vitamin E (α-tocopherol + α-tocopherol acetate) in
emulsion-based delivery systems after digestion.
Under realistic digestion conditions (i.e., samples containing bile salts, calcium
and phospholipids), the bioaccessibility of vitamin E was appreciably higher when it was
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encapsulated in LCT-emulsions than in MCT-emulsions (Figure 8.8).

The long-chain

free fatty acids (C18:1) arising from the lipolysis of glycerol trioleate (LCT) can
presumably form larger colloid structures with a larger solubilization capacity than the
medium chain fatty acids (C8:0) generated from the hydrolysis of glycerol trioctanoate
(MCT).

The α-tocopherol molecule has a non-polar chain with 14 carbon atoms (C14),

which is presumably too long to be accommodated into the micelles or vesicles formed
by medium-chain fatty acids, but short enough to be incorporated into those formed by
long chain fatty acids.

Researchers in the pharmaceutical area have also reported that

the bioaccessibility of some highly oil-soluble drugs is greater when LCT was used as a
carrier oil rather than MCT [281, 282].
8.3.4. Impact of SSIF composition and carrier oil type on vitamin E conversion
The esterified form of α-tocopherol is often used in foods and other commercial
products rather than the free form because it is more stable to oxidation during processing,
transportation and storage [223, 224].

Previous research has shown that the molecular

form of vitamin E has a major impact on the bioaccessibility of vitamin E, i.e.,
α-tocopherol versus α-tocopherol acetate [260-263].

Thus, we determined the amount

of α-tocopherol acetate converted to α-tocopherol after in vitro digestion (Figure 8.9).
Our previous research using food-grade oils showed that carrier oil type had an
appreciable impact on the hydrolysis of α-tocopherol acetate to α-tocopherol, with the
extent of conversion being about 29% for LCT-emulsions and 17% for MCT-emulsions
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[318].

This result suggests that the conversion of α-tocopherol acetate to α-tocopherol

occurred more readily when LCT was used as the carrier oil than when MCT was used
[318].

In the current study, we used purified LCT and MCT carrier oils to provide

further insights into this important effect.
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Figure 8.9 Influence of carrier oil type and SSIF composition on the conversion of
α-tocopherol acetate to α-tocopherol after in vitro digestion of vitamin E fortified
emulsions
For MCT-emulsions, the SSIF composition did not have an appreciable impact
on the conversion of α-tocopherol acetate to α-tocopherol (Figure 8.9).

Conversely, for

LCT-emulsions, the SSIF composition had a major impact on α-tocopherol acetate
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hydrolysis.

For the LCT-emulsions, the conversion of α-tocopherol acetate to

α-tocopherol increased when calcium and phospholipid were incorporated into the SSIFs
(Figure 8.9).

There therefore appeared to be a correlation between the bioaccessibility

of vitamin E and the hydrolysis of α-tocopherol acetate.

It is likely that α-tocopherol

acetate can only be hydrolyzed by digestive enzymes after it is released from the interior
of the fat droplets.

Hydrolysis may occur at the lipid droplet surfaces or after the

α-tocopherol acetate is incorporated into mixed micelles, which would account for the
increase in hydrolysis with increasing bioaccessibility.

This effect may also account for

that fact that the extent of hydrolysis was greater for the LCT-emulsions than the
MCT-emulsions in the presence of calcium ions (Figure 8.9).
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Figure 8.10a Influence of carrier oil type and simulated small intestine fluid composition
on the conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion of
MCT-VE emulsions.
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Figure 8.10b Influence of carrier oil type and simulated small intestine fluid composition
on the conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion of
LCT-VE emulsions.
Finally, we calculated the bioaccessibility of the different forms of vitamin E
(Figure 8.10).

The fraction of the non-esterified form (α-tocopherol) in the micelle

phase was higher than the esterified form (α-tocopherol acetate) for all LCT-VE samples
(Figure 8.10b) and most MCT-VE samples (Figure 8.10a), which suggests that the
non-esterified form can be incorporated into the mixed micelles more easily than the
esterified form.

The reason for the higher bioaccessibility of α-tocopherol acetate for
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the MCT-emulsions when the SSIF contained bile extract and calcium is currently
unknown.

A schematic representation of the important physicochemical events

occurring with the gastrointestinal tract based on our results is shown in Figure 8.11.

Figure 8.11a Schematic representation of influence of calcium on physicochemical
phenomena occurring within gastrointestinal tract during lipid digestion, vitamin release,
and solubilization.
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Figure 8.11b Schematic illustration of the influence of free fatty acid chain length on the
bioaccessibility of vitamin E. Long chain FFAs form mixed micelles that can easily
accommodate large VE molecules, whereas mediuc chain FFAs do not.
8.4 Conclusions
The purpose of this study was to identify the key factors impacting the
bioaccessibility of emulsified α-tocopherol acetate using a simulated small intestine
model.

We have shown that the rate and extent of lipid digestion was higher for

MCT-emulsions than for LCT-emulsions, which was attributed to differences in the
water-dispersibility of the medium and long chain fatty acids formed during lipolysis.
The addition of calcium ions to the SSIFs greatly increased the extent of lipid digestion
for LCT-emulsions, but had little effect on MCT-emulsions, which was attributed to the
ability of calcium ions to remove long-chain fatty acids from droplet surfaces.

The

addition of calcium ions and phospholipids into the SSIFS also had a major impact on the
bioaccessibility of vitamin E depending on carrier oil type.

The addition of calcium

ions greatly improved the bioaccessibility of vitamin E in LCT-emulsions, but reduced it
in MCT-emulsions.

Finally, calcium addition increased the conversion of α-tocopherol

acetate to α-tocopherol after in vitro digestion of LCT-emulsions, but had little effect on
α-tocopherol acetate hydrolysis in MCT-emulsions.
In summary, our results suggest that the bioaccessibility of vitamin E
encapsulated in emulsion-based delivery systems is strongly influence by carrier oil type,
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bile salt type, calcium ions, and phospholipids.

This information is important for

developing effective emulsion-based delivery systems for oil-soluble vitamins and testing
their potential efficacy.
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CHAPTER 9
CONCLUSION
The overall aim of this work was to create food grade nanoemulsion-based
delivery systems for encapsulating lipophilic bioactive components, such as vitamin E,
β-carotene etc., which can be applied into function foods and beverage products.

Stable

nanoemulsion-based delivery system could be successfully prepared using both low
energy and high energy methods.

The high energy method (microfluidization) was able

to produce emulsions with small droplets (r < 100 nm) using low surfactant-to-oil ratios
(< 1:10), but it required relatively expensive specialized equipment and has relatively
high operating costs.

Conversely, the low energy method (spontaneous emulsification)

is inexpensive and can be implemented using simple equipment (stirring), but it requires
high surfactant-to-oil ratios (> 5:10) to produce small droplets.

High concentrations of

surfactant levels may lead to problems in some food and beverage products, such as high
ingredient costs, off flavors, and safety concerns.

Moreover, high surfactant levels may

also cause depletion flocculation or Ostwald ripening effects.
Q-Naturale® is a natural food-grade surfactant isolated from the bark of the
Quillaja saponaria Molina tree. Q-Naturale® was found to be highly surface active, and
had similar interfacial properties as Tween 80， a synthetic non-ionic surfactant widely
used in the food industry.

Q-Naturale® was able to form oil-in-water emulsions with

relatively small droplet sizes (d < 200 nm) at low surfactant-to-oil ratios (SOR ≈ 1:10).
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These emulsions formed by Q-Naturale® were stable to droplet coalescence over a range
of pH values (2 to 8), salt concentrations (0 to 500 mM NaCl) and temperatures (20 to 90
ºC).

In addition, they had good long-term stability (one month) when stored at various

holding temperatures (5, 37, and 55 °C).

However, some droplet flocculation was

observed under highly acidic (pH 2) and high ionic strength (≥ 400 mM NaCl) conditions,
which was attributed to screening of electrostatic repulsion.

As Q-Naturale® is an

effective surfactant, it was then used to form “all natural” oil-in-water emulsions
containing α-tocopherol acetate.

Tween 80 was more effective at producing small

droplets at relatively low vitamin loadings (≤ 40%), whereas Q-Naturale® was more
effective at relatively high vitamin loadings (60% - 80%).

The size of the droplets in

the emulsions could be reduced by decreasing the vitamin concentration in the oil phase,
or increasing the amount of glycerol in the aqueous phase.
The carrier lipid type had great impacts on the bioaccessibility and hydrolysis of
emulsified α-tocopherol acetate during the in vitro digestion study.

LCT was a more

effective carrier lipid than MCT for increasing the overall bioaccessibility of emulsified
vitamin E.

The total bioaccessibility of vitamin E after digestion was higher for

LCT-emulsions than for MCT-emulsions, which was attributed to the greater
solubilization capacity of mixed micelles formed from long chain fatty acids due to their
ability to better accommodate lipophilic vitamin E molecules.

Moreover, the

conversion of α-tocopherol acetate to α-tocopherol after in vitro digestion was also
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considerably higher for LCT-emulsions than for MCT-emulsions.

The influence of

mixed micelle composition and structure on the solubilization of oil-soluble vitamins was
further studied by utilizing a well-defined model system.

Mixed micelle solutions were

formed that contained relatively small particles (d ≈ 5 nm) whose precise size depended
on system composition.

An emulsion titration assay was then used to study the

solubilization of α-tocopherol and α-tocopherol acetate emulsions in the mixed micelle
solutions.

The solubilization capacity of the mixed micelle solutions was higher for

α-tocopherol than for α-tocopherol acetate, which was attributed to differences in the
ability of the vitamin molecules to be incorporated into the micelle structures.

However,

there was no strong influence of free fatty acid type (C8:0 versus C18:1) on the
solubilization capacity of the mixed micelles, which was different from results obtained
using a simulated gastrointestinal model.
Finally, overall study of all the key factors impacting the bioaccessibility of
emulsified α-tocopherol acetate, such as calcium ions, phospholipids, carrier oil type etc.,
was taken by using a simulated small intestine model.

Calcium addition to the SSIFs

greatly improved the extent of lipid digestion for LCT-emulsions, but had little effect on
MCT-emulsions, which could be attributed to the ability of calcium ions to remove
long-chain fatty acids from interface of the oil phase and the water phase.

The addition

of calcium and phospholipids (DOPC) increased vitamin E bioaccessibility in
LCT-emulsions, but decreased vitamin E bioaccessibility in MCT-emulsions.
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The

addition of calcium also increased the conversion ratio of α-tocopherol acetate to
α-tocopherol during in vitro digestion of LCT-emulsions, but had little impact on
α-tocopherol acetate hydrolysis in MCT-emulsions.
In summary, nanoemulsions may be a highly effective delivery system for
encapsulating, transporting and protecting lipophilic bioactive components.

The

knowledge gained from this research will guide the rational design of food-grade
nanoemulsion that can be used in the future fortified foods.
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